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African American (AA) women are disproportionately affected by HIV/AIDS. The 
infection rate for AA women continues to increase, and literature lacks information 
specifically on education for AA women regarding viral suppression at diagnosis. The 
purpose of the study was to understand the lived experiences of AA women living with 
HIV in the District of Columbia, particularly how they acquired knowledge of viral 
suppression. To understand their experiences with antiretroviral medications, viral 
suppression, discrimination, and stigma, this qualitative study applied a hermeneutic 
phenomenological approach. The theories of resilience and empowerment were applied. 
Ten HIV positive AA women living in the District of Columbia were selected through 
purposeful sampling. Primary data were collected through semistructured open-ended 
interviews. Clinical data from DC Health/HAHSTA HIV Surveillance system were used 
to triangulate responses. Participants’ self-report showed 80% achieved viral suppression. 
Study findings indicate that education on the importance of viral suppression was not 
consistently provided to women at time of HIV diagnosis. Unprotected sex, men 
returning from prison, and lack of HIV education were named as factors spreading the 
infection. The consistent factor in HIV survivability for the sample were unfettered 
access to HIV treatment, availability of antiretroviral medication, self-efficacy, 
spirituality, and support group. This study promoted social change by identifying precise 
areas of HIV education for AA women to be incorporated in HIV prevention and 
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Chapter 1: Introduction to the Study 
Introduction 
Human immunodeficiency virus (HIV) affects millions of people globally. HIV is 
defined as a retrovirus which attacks the T-lymphocytes cells in the body, destroying the 
body’s defense mechanism against infections (CDC, 2019). The infected person becomes 
immune compromised, with potential to degenerate into acquired immune deficiency 
syndrome (AIDS). At this point, the person becomes symptomatic to the HIV infection, 
with symptoms including, diarrhea, rashes, weakness, and unexplained weight loss. The 
immune compromised body is then frequently attacked by opportunistic infections such 
as Pneumocystis Carinii Pneumonia (PCP), fungal infections, syphilis, Hepatitis B, 
Hepatitis C and Mycobacterium avium complex (MAC), among others (Panel on 
Opportunistic Infections in HIV-Infected Adults and Adolescents, 2018). HIV virus is 
transmitted through unprotected sexual intercourse with an infected person, sharing 
needles and syringes during injection drug use, from mother to child, and transfusing 
HIV contaminated blood (WHO, 2018b) 
In 2017, there were 36.9 million people living with HIV around the world and 
35.1 million of them were adults, while 1.8 million were children under the age of 15 
(United Nations on AIDS, 2018).  According to United Nations, about 940,000 people 
died of the disease in 2017 and 35.4 million since the disease epidemic began (2018). In 
the United States, an estimated 1.1 million people have been infected with HIV (Center 
for Disease Control and Prevention [CDC], 2019a).  The CDC also estimates that 38,700 
new infections occur yearly (2019a). HIV was first reported in 1981 among men who 
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have sex with men (MSM) in Los Angeles (CDC, 1981). However, in the last 3 decades, 
the trend in the prevalence of diagnosed HIV infection has changed affecting every 
demographic: race, ethnicity, age group, males and females (CDC, 2019a). Overall, in 
2017, more than 7,000 women were diagnosed with HIV in the United States (CDC, 
2019a). Women made up 19% (7,401) of the total 38,739 new HIV diagnoses in 2017 
(CDC, 2019b). The CDC further noted that African Americans females make up 13% of 
the United States female population. However, 59% of all the women infected with HIV 
in the United States are African American (AA) females (CDC, 2019b). In contrast, 
Hispanic females make up 17.4% of the female population, but 16% of the disease 
burden (CDC, 2019b). White females are 61.2% of the female population but have 
prevalence rate of 20% (CDC, 2019b). There is an overall downward trend for new 
infections across the United States. This downward trend is not true for all groups, 
however. The CDC (2016a) reported an increase of HIV infections among 25 to 34 year-
olds African American women for the 3 consecutive years of 2012, 2013 and 2014. 
In 2014, the number of HIV infections was high among African American 
females in the United States, at 4,208, compared to Hispanic/Latino females at 1,111 HIV 
infections and White females at 988 infections during the same year (CDC, 2017). A 
similar pattern emerged in 2015, with the number of HIV infections for AA females at 
4,075, Hispanic/Latino females at 1,052, and White females at 962 infections (CDC, 
2017). In 2016, new HIV diagnosis trends based on race and gender remained consistent 
with AA women engaged in heterosexual contact disproportionately affected at 4,189 
HIV infections. White women infected through heterosexual contact were at 1,032 and 
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Hispanic/Latina women infected through heterosexual contact were at 1,025 infections 
(CDC, 2017).  Skarbinski, et al. (2015), in their analysis, confirmed reduction of HIV 
transmission rates along the care continuum. However, even in an analysis of reduction 
rates, their analysis showed increases in new infections among AA women.  The steady 
increase in HIV infection among AA females remains a concern.  
New infection in the District of Columbia is consistent with national rate, with 
AA women being disproportionately affected by HIV/AIDs. In 2011, the HIV prevalence 
rate in the District of Columbia was above epidemic level at 2.5% and the prevalence rate 
among AA females was at 2.6% (District of Columbia/Department of Health//HIV/AIDS, 
Hepatitis, STD and TB Administration [DC/DOH/HAHSTA] Annual report, 2012). In 
2018, the overall HIV prevalence rate fell to 1.8% (DC/DOH/HAHSTA, 2017) while 
prevalence rate among AA women was 1.6%. This exceeded the prevalence rates for 
Latino and White women which were 0.3% and 0.01% respectively (Figure 1). Put 
another way, the general population of African American (AA) female in the District is 





Figure 1. HIV prevalence by race/ethnicity and gender identity, District of Columbia, 
2018. From “Annual epidemiology& surveillance report: data through December 2018”, 
DC/DOH/HAHSTA (2019). 
HIV has no cure. As a chronic disease, HIV is treatable with effective active 
medications. The hallmark clinical benefits of HIV treatment and engaging in HIV care is 
achieving viral suppression (AIDSinfo, 2019). In this status, the virus is undetectable in 
the blood and leads to improved health outcomes (Panel on Antiretroviral Guidelines for 
Adults and Adolescents [DHHS Guideline], 2018). However, adherence to lifelong 
medications remains a challenge (National Institute of Allergy and Infectious Diseases, 
2013). Holstad, Dilorio, & McCarthy (2011) found that low adherence to HIV medication 




In the 2016 District of Columbia HIV annual report, summarized in Figure 2 
below, among AA women living with the disease, 97.5% were linked to care at some 
point. Amongst which 77.7% are retained in care, 57.7% had more than one medical 
visit. In the same report, 75.8% were ever virally suppressed while 61.7% were 
suppressed at last known viral status in the year (DC/DOH/HAHSTA, 2017). 
 
Figure 2. 2016 Care dynamics among women living in DC, by selected characteristics. 
From “Annual epidemiology & surveillance report: data through December2016” 
DC/DOH/HAHSTA (2017). 
There is little data in the existing body of HIV/AIDS research that focuses on 
African American women in order to understand their perspectives on viral suppression. 
This data is critical to create informed interventions that will be effective in reducing the 
infection rate in this subpopulation and support healthy living with HIV/AIDS. Available 
literature shows a gap in understanding of viral suppression and its effect on the lived 
experiences of AA women. It is imperative that women who are HIV positive learn the 
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importance and meaning of viral suppression. The social change in this study is the 
potential to increase knowledge to prevent HIV transmission and also increase the quality 
of life for AA women who have the disease. 
Available literature shows women of reproductive age (15-49 years) are mostly 
impacted with HIV (CDC, 2019c, CDC 2018a, DC/DOH/HAHSTA, 2017, World Health 
Organization, 2006). In 2017, 13% of new HIV diagnoses were among young women 
ages 13-24 (CDC, 2019c). Eighty six percent of these young women were infected 
through heterosexual contact. The social implication of HIV among young African 
American women includes transmission to newborn, known as vertical transmission. This 
can happen either in the uterus, during birth or while breast feeding (AIDSinfo, 2019b). 
In addition, HIV infected people suffer stigma, and various forms of discrimination. At 
the same time, some African American women have been infected at young age and 
living well with the disease for many years. This study expects to understand the 
resiliency in African American women infected with HIV that may have contributed to 
their experiences living and surviving the infection. This study will also attempt to 
understand the role of empowerment to surviving the infection. 
Another potential for social change is using key findings in this study to develop 
interventions geared towards viral suppression among the African American community. 
The interventions may be implemented in various clinics to help other HIV positive AA 
women thrive and live well with the disease. The new knowledge will impact the 
development and planning of the Mayor’s “Ending the HIV Epidemic Campaign. 
7 
 
Chapter 1 is a synopsis of the epidemiology of HIV and the implication of the 
disproportionate rate of infection among women, particularly African American women. 
Specifically, viral load suppression will be discussed as a point of reference among this 
disproportionately affected population. In this chapter, I include the background of the 
study, problem statement, purpose of the study, and research questions. Other topics 
summarized in this chapter included the theoretical framework applied to the study, 
nature of the study, significance of the study, assumptions, scope and delimitations, and 
limitations of the study. Some technical terms such as CD4 count, viral load suppression, 
vertical transmission, phenomenology, and resiliency are defined to ensure 
comprehension. 
Background of the Study 
The United States witnesses approximately 40,000 HIV infections every year 
(CDC, 2019d). Meanwhile, HIV prevention focuses mainly on MSM in general, and 
young Black MSM in particular. However, the infection rate among African American 
females is at 1.9 % of new infections in the District of Columbia (DOH/DC/HAHSTA, 
2017) and accounted for 4,189 new infections in 2016 in the United States (CDC, 2017). 
This has led Haverkos, Chung and Perez (2003) to inquire if there is an HIV epidemic 
among heterosexuals in the United States, found insidious and underestimated HIV 
epidemics among AA heterosexual community and recommended immediate mitigation 
strategies.   
Many studies have examined HIV/AIDS surveillance data.  Hall, Espinoza, 
Benbow and Hu (2010) statistically analyzed 2007 data in 12 metropolitan areas and 
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found that 0.3% to 1% of the populations in each area lived with HIV. Researchers report 
that over the course of the epidemic, the composition of infected population has changed 
to include more infections among persons of color. This change in the HIV epidemic 
from white males who have sex with men to AA females is one of the reasons for my 
research focus.  HIV diagnoses for African American females was 4,931 in 2011, 4,666 
in 2012, 4,307 in 2013, 4208 in 2014, 4,075 in 2015, and 4,189 in 2016 (CDC, 2017). 
According to the same report, these number are significantly above the diagnoses of 
heterosexual African American men. For heterosexual AA men, 2,449 were newly 
diagnosed in 2011, 2,257 in 2012, 2,059 in 2013, 1,997 in 2014, 2,048 in 2015, and 1,926 
in 2016. Diagnoses among Hispanic females were 1,189 in 2011, 1,054 in 2012, 1, 050 in 
2013, 1,111 in 2014, 1,052 in 2015 and 1,025 in 2016 (CDC, 2017).  Diagnoses among 
White females in the same years were 1,014 in 2011, 970 in 2012, 913 in 2013, 988 in 
2014, 962 in 2015, and 1,032 in 2016. (CDC, 2017). 
 Hall et al. (2013) found that 857,276 persons with HIV in the United States had 
not achieved viral suppression, which is the key outcome of HIV treatment and 
subsequent reduction in transmission.  Lanier et al. (2013) used surveillance data on HIV 
positive AA women in the District of Columbia to explore sociocultural correlates for 
HIV progression to AIDS. Among 3,050 women with complete data in this study, 59.4% 
had progressed to AIDS and, at their most recent medical visit, 36.4% had a CD4 count 
<200 cells; 18.8% of the participants progressed to AIDS within 12 months of diagnosis. 
The researchers found no relationship for progressing to AIDS with poverty, educational 
level, or census tract. In this analysis, 25% of women did not have the typical risk factors 
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for acquisition of HIV except that 50% reported heterosexual sex. While African 
American women made up 48.5% of the estimated population of the District of Columbia 
in 2015, they accounted for 94.1% of all female HIV cases living in the District in 2016 
(DC/DOH/HAHSTA, 2017). 
Lending credence to the high need for this study is the analysis by Nwangwu-Ike, 
Hermandez, An, Huang, and Hall (2015) that shows HIV diagnosis is decreasing among 
females, but the highest rate remains for African American females. For African 
American women, acquiring higher education did not result in a decrease in AIDS cases 
(Horton, 2013).  Epidemiological patterns showed African American females ages 15-35 
years were still vulnerable to AIDS death but at a reduced rate. Most importantly, 
disparities exist in viral suppression for African Americans and younger females (Hall et 
al, 2013; Nwangwu-Ike et al., 2015; Gray, et al., 2013). Virally suppressed HIV infected 
persons are less likely to transmit HIV (Skarbinski, et al., 2015). Viral suppression 
reflects the result of a viral load test (i.e., the level of HIV in a person’s body is very low 
[<200 copies/ml] or undetectable). Suppressed viral load improves the health of the 
person living with HIV, increases survival, and reduces risk of transmitting HIV 
(AIDSinfo, 2019). 
Researchers have examined problems of nondisclosure of HIV status among low 
literacy populations to ascertain if there are potential risks or protective factors for HIV 
prevention and sexual behaviors. Polansky, Teti, Chengappa, and Aaron (2015) noted 
that 79% of women in a monogamous committed relationship disclosed to partners, 
compared to only 43% of women with multiple partners. In this study, none of the 
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women with multiple nonprimary partners disclosed HIV status. Self-disclosure of HIV 
status was positively associated with closeness and commitment among low-income 
urban African American women.   
When disclosure of HIV status increases, transmission decreases, and stigma also 
reduces (Heggeness, Brandt, Paulus, Lemaire & Zvolensky, 2017). Stigma is regarded as 
a major barrier that prohibits HIV positive persons from seeking care and receiving the 
benefits of HIV treatment. According to Buseh and Stevens (2007), African American 
women experience stigma socially, internally, and externally. Stigma also has deep roots 
in gender, race, ethnicity, class, sexuality, and culture, and continues to be seen as a great 
impediment to reducing HIV transmission (Valdiserri, 2002). Reducing stigma should be 
incorporated in many educational programs. A study by Coleman, Tate, Gaddist and 
White (2016) in a faith-based community noted lower HIV related stigma among 
females, people who had a higher education, people who knew someone with HIV/AIDS, 
and people who knew a gay person. Black churches have embarked on numerous health 
related outreach programs among the black community but stigma in black churches 
continues to affect the conduct of HIV related health activities (Pryor, Gaddist, & 
Johnson-Arnold, 2015). 
Another significant predictor of HIV infection is acquisition of sexually 
transmitted diseases.  High rates of sexually transmitted diseases offer some explanation 
for increased incidences of HIV (Reif, Geonnotti & Whetten, 2006; Kanekar & Sharma, 
2009), as STD compromises the integrity of the sexual tract for easier acquisition of the 
virus during nonprotective sex. In 2016 in the District of Columbia, 8,569 people were 
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diagnosed with Chlamydia, 3,797 gonorrhea diagnoses and 181 Syphilis were recorded 
(DC/DOH/HAHSTA, 2017).  
As HIV continues to affect communities, especially the African American 
community, treatment of HIV is assessed using the continuum of care. The care 
continuum is a system currently used to assess and measure the efficacy of HIV treatment 
from the early initiation of diagnosis through a continuum of five steps. The steps of care 
include the number of people diagnosed, linked to care, engaged in care, prescribed 
antiretroviral medication, and virally suppressed (CDC, 2017). In the District of 
Columbia, the continuum of care begins with the number of HIV cases diagnosed and 
living in the District, time person was linked to care, retained in any care, and virally 
suppressed. Reduction in infection is one of the benefits of adhering to antiretroviral 
medication.  An observational study conducted by Rodger et. al (2016) supported the 
importance of HIV treatment. The study included 1238 HIV discordant MSM and 
heterosexual couples to observe HIV transmission during condomless sex. The HIV 
positive partner was virally suppressed and on antiretroviral medication. Although, the 
study reported 10 HIV transmissions among the MSM couples and one in a heterosexual 
couple, none of the transmission was phylogenetically linked, therefore, the couple 
transmission was zero for the study. In other words, the discordant couple did not 
acquired HIV through their partners.  Furthermore, the research findings of this study 
corroborate the results of the randomized control trial known as HIV Prevention Trials 
Network (HPTN052) in which HIV infection was reduced by 96% if an HIV positive 
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partner is taking and adhering to antiretroviral medication (Cohen, McCarley, & Gamble, 
2011).   
HIV treatment therefore works as prevention of HIV transmission. This supports 
the fact that when infected people engage early in treatment, they receive the full benefit 
of treatment through use of antiretroviral medication. Anyone who tests positive must be 
treated immediately as poor engagement might decrease the benefit of highly effective 
antiretroviral medication (Cohen et al., 2012; Gardner, McLees, Stenier, Rio, & Burman, 
2011). Antiretroviral medications have been very effective in the treatment of HIV and 
are also highly effective in HIV prevention.   
HIV is transmitted by an infected person. Therefore, initiatives to target 
uninfected persons with antiretrovirals to prevent acquisition of HIV from infected 
person is critical to reducing infection. Uninfected individuals at risk for HIV can take 
pre-exposure prophylaxis (PrEP) to reduce risk of infection (CDC, 2019e). Efficacy in 
prevention of HIV by taking a daily antiretroviral medication called Truvada has shown 
promise. Baeten et al. (2014) demonstrated that a single antiretroviral medication, 
Tenofovir or Truvada (Emtricitabine plus Tenofovir), both provided high protection 
against acquisition of HIV-1 in heterosexual men and women as a pre-exposure 
prophylaxis. Radzio, et al. (2012) modeled the benefit of 2 weekly doses of Truvada for 
repeated exposures in Rhesus Macaques monkeys. The six animals that received Truvada 
remained SHIV negative demonstrating that vaginal and systemic levels of Truvada was 
protective against infection. The model showed effectiveness in prevention of vaginal 
transmission which might be a possibility for a simplified regimen for HIV prevention for 
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women. In a meta-analysis of seven randomized controlled trials involving 14,804 
individuals, Jiang et al. (2014) showed that PrEP was effective in reducing new HIV 
infection among populations at a high risk of infection. According to CDC (2019e), 
taking one PrEP pill a day reduced infection through sex by 90% and through injection 
drug use by 70%.  The use of additional preventive measures with PrEP adds more 
preventive value. 
PrEP is a successful method for reducing HIV infection risks in men and women. 
When prescribed, PrEP is entirely within a woman’s control to use for prevention of HIV 
in comparison to a condom. However, Truvada as a PrEP medication is underutilized 
among women at risk for HIV infection (Aaron et al., 2018). Some of the systemic 
barriers to PrEP access  are that medical providers do not offer it without insurance, lack 
of awareness among young men who have sex with men, and individual barriers 
(Bauermeister, Meanley, Pingel, Soler, & Harper, 2013; Ojikutu, et al., 2018). Although 
the referenced study was conducted among young men who have sex with men, it holds 
same for AA women. Due to the efficacy of PrEP as a prevention tool, PrEP needs to be 
discussed and encouraged among AA women as an important intervention and to reduce 
disparities. 
Adherence to HIV antiretroviral medications is critical to their effectiveness as 
they must be taken as prescribed.  In a systematic review and meta-analysis, 
nonadherence was associated with forgetfulness, travel, change of routine, desire to avoid 
side effects, pill burden, secrecy due to stigma, alcohol use, and lack of food (Shubber et 
al., 2016). In another study, a sample of AA women living with HIV were asked to 
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identify roles that their providers played in enhancing their adherence to PrEP use. They 
identified good provider-patient relationship, holistic patient care, good patient education, 
effort to model adherence, and motivation as very important to adherence (Okoro & 
Odedina, 2016).  Peer education was also mentioned as a medication adherence enhancer 
(Okoro & Odedina, 2016).  
To ensure that women adhere to a treatment regimen, many medical providers 
agree women should be assessed for readiness for antiretroviral medication before 
writing a prescription to avoid development of resistance to medication. Smith et al. 
(2013) assessed 288 HIV positive patients for readiness skills in relation to antiretroviral 
therapy (ART). Their study used a structured survey that covered self-reported 
information, motivation, and behavioral skills specific to retention in pre-ART HIV care. 
Eligible participants were 18 years and older, newly entering into care, and ineligible for 
ART (CD4 > 200cell/mm3). Seventy five percent of patients in the sample were women. 
The findings identified eight information deficits, eight motivation deficits, and eight 
behavioral deficits. The researchers argued that HIV positive patients could benefit from 
facilitated social support, further education about the immune system, additional social 
motivation to build positive attitudes, and increased positive interactions with medical 
staff. The study also found that self-efficacy might be related to viral suppression and 
subsequent positive health outcomes.  
Unfortunately, high functioning or self-declared commitment does not necessarily 
translate into medication adherence for better health outcomes. In a randomized 
intervention program for women being released from prison, high confidence and 
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expectations of ability to manage disease prior to their release for prison did not 
materialize postrelease (Haley et al., 2014). Some of the reasons identified included 
substance use, relapse, stressful life experiences, and stigma.  
There are no studies that focus on women’s lived experiences with HIV infection 
and their understanding of viral suppression. In addition, there is no research on young 
black women’s perspectives on living with HIV, barriers and challenges to medication 
adherence, and their views on HIV within the black community. No research has applied 
self-efficacy as a construct of empowerment theory and resilience to understand viral 
suppression and adherence to antiretroviral medication among AA women in the District 
of Columbia. Yet, it is paramount to understand the vulnerability of this population to 
HIV infection and their own understandings of the epidemic. Study findings can be 
applied to interventions across the spectrum of age and ethnicity both in the affected and 
infected to stem the tide of HIV infection in the study population. 
Problem Statement 
African American females account for 94.3% of new HIV infections among 
women in the District of Columbia (DC/DOH/HAHSTA, 2017).  African American non-
Hispanic women are nine times more likely to be infected with HIV/AIDS than any other 
race or ethnicity (Sionean et al., 2014). Thus, understanding the vulnerability of this 
population to HIV infection is essential to public health. Efforts to study this 
phenomenon have taken different directions. In the realm of social determinants, Hatcher 
et al. (2012) observed that women with high and moderate negotiating power with their 
sexual partners were less likely to engage in risky behavior than those with low 
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negotiating power. Others have studied the effects of low levels of education on HIV 
infection (Melton, 2014), the shortage of available partners for college educated AA 
women (Newsome, Airhihenbuwa & Snipes, 2014), and the role of multiple sexual 
partners and prior sexually transmitted diseases (Norwood, 2011). Buseh and Stevens 
(2007) made an effort to understand how HIV positive women respond to stigma as a 
barrier to care and how women engage family or peer support and become advocates to 
fight stigma. Pollini, Blanco, Crump and Zuniga (2011) confirmed that isolation and 
stigma are important barriers to engaging in HIV medical care among persons of color. 
The possibility of a connection between adherence, sexual risk, viral load, and HIV 
infected women prescribed ART has also been investigated (Holstad, Dilorio, & 
McCarthy, 2011). With about 30 antiretroviral medications now available, being HIV 
positive has been transformed from a death sentence to manageable infection (Chen et al., 
2013). However, while the overall infection rate has been decreasing in the U.S., that has 
not been the case for AA women.   
There remains a lack of information on AA women’s knowledge and 
understanding of viral suppression. Consequently, resulting survival rates, reduction of 
risk of transmission, and improved health outcomes at diagnosis is lacking for this 
population. Taking antiretroviral medication is known to reduce the viral load in the 
blood, leading to a competent immune system when viral suppression is achieved 
(Cohen, McCauley & Gamble, 2012). Achieving viral suppression is key to reducing 
HIV infection as it ensures a reduction of the community level viral load. According to 
Brawner (2014), community viral load is a population marker of infectivity of people 
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living in a geosocial area. Decreased community viral load and increased HIV testing are 
associated with reduction in new HIV infections (Das et al., 2010).  Viral suppression 
reflects the result of a viral load test in which the level of HIV in a person’s body is very 
low (<200 copies/ml) or undetectable (Cohen, McCauley & Gamble, 2012; Pollini et al., 
2011).  Unfortunately, a younger age is associated with late initiation of care after 
diagnosis and a longer time to achieve viral suppression (Pollini et al., 2011; Eshleman, 
et al., 2017). There is a gap in an understanding of viral suppression and its effect on the 
lived experiences of AA women. This study added to the literature by describing HIV+ 
AA women’s understanding of viral suppression and how it affects their lives and 
relationships.  
Purpose of the Study 
The purpose of this study was to increase understanding of HIV infection and 
viral suppression from the perspectives of young AA women living with HIV. The study 
used a phenomenological approach to uncover the lived experiences of HIV positive AA 
women and viral suppression, including how HIV positive individuals are discriminated 
against in the community and experience strong stigma from family and friends, as 
reported by Buseh and Stevens (2007). Another aspect of this study was to use a feminist 
lens to understand black women’s unequal position in relation to HIV infection. In 
pursuance to understand the lived experience, it is important to understand increases of 
HIV infection among this group through the lens of empowerment theory. 
Under empowerment theory, women are asked to identify the source of 
disenfranchisement internally and take charge of their life decisions. As articulated, 
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empowerment theory posits that entering into the world of the abused or oppressed helps 
to empathize and understand their needs. Empowerment is the process utilized to enhance 
the personal, interpersonal, and political power of an individual to ensure better life 
outcomes (Turner & Maschi, 2015). In this theory, the participants know better. My study 
findings support gender as the basic framework that conditions women to an increased 
risk of HIV infection. In an analysis of HIV/AIDS disease burden among AA women, 
Brawner (2014) proposed a gender responsive model as an initial step to dialogue and 
examination of HIV/AIDS as a social issue. Issues of gender roles and socialization may 
have to be explored more to understand the HIV vulnerability among African American 
women. One in 32 AA women may be diagnosed with HIV in her lifetime (CDC, 2014), 
making geo-behavior critical. Geo-behavior basically refers to where one lives, what one 
does and with whom, which all link to vulnerability to HIV infection (Brawner, 2014). In 
addition, my study findings contributed knowledge and understanding of power 
relationships, social constructs and social positions concerning HIV infection.  
Furthermore, understanding experiences of women as it pertains to their clinical 
status, especially achieving viral suppression, is vital to ending HIV infection among 
women. Ensuring viral suppression through antiretroviral medication is a prelude to the 
end of HIV/AIDS (United Nations AIDS, 2014). Examining the lives of this group of 
women provided an opportunity to learn how they experience the disease, what 
prevention methods may be most effective, and how their experiences link to achieving 




Three main questions drove the direction of the study. 
Research Question 1: What is the lived experience of AA women with HIV/AIDS 
in DC? 
Subquestion 1a: What are their daily routines of medication adherence? 
Subquestion 1b: What challenges constitute stigma and discrimination that they 
face in daily living? 
Research Question 2: How do HIV positive women describe/explain viral    
suppression? 
Research Question 3: How do HIV positive women explain/describe the high rate 
of HIV infection among AA in the District? 
Theoretical Foundation 
For this study, I used two theories as foundational. The first theory was resilience 
theory. I used this theory to understand platform of positive- strength, protective factors 
and adaptive abilities that people with adversity develop instead of a focus on the deficits. 
The second theory was empowerment theory, applied to better understand how 
empowerment can aid to overcome trauma and adversity. In this section, I briefly 
describe each theory and why I used them for this study.    
Resilience Theory 
According to Luthar, Cicchetti, and Becker (2000), resilience is a “construct 
connoting the maintenance of positive adaptation by individuals despite experiences of 
significant adversity” (p 543). In an argument on the most applicable definition of 
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resilience, Panter-Brick asserted that resilience is not a one-time achievement but 
sustained over time as it harnesses resources along the continuum of care (Southwick et 
al., 2014). 
Resilience has no agreed upon definition but emerged from the field of 
psychology and Freud’s assumptions that early negative experiences in life produces an 
adult with psychopathology. Garmezy, a clinical psychologist, looked at resilience in two 
disciplines, psychoanalysis and development. The researcher looked at the underlying 
reasons for the differences in outcomes of these two groups of schizophrenic patients. 
One group is competent, as demonstrated in the lives of the stable patients who are 
married, have children, and keep jobs (Rolf, 1999). They still experience schizophrenic 
episodes, but they recover with shorter stays in hospitals and were integrated into their 
community. The other group had longer stays, up to 13 years or more in institutions. The 
differences in outcomes of these two groups formed the premise and need to study the 
underlying difference in these patients, with a focus on areas such as cognitive skills, 
motivation, and protective factors (Harlow, 2009). 
Empowerment Theory 
A second theory applied in this study is empowerment theory. In this theory, 
women living under a patriarchal social system are subservient to men, lacking privileges 
that their male counterparts enjoy (Maier, 2016).  Empowerment theory posits that 
entering the world of the abused or oppressed helps in empathizing and understanding 
their needs if the researcher themselves is not in the abused or oppressed group. 
Empowerment is the process utilized to enhance the personal, interpersonal, and political 
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power of an individual to ensure better life outcomes (Turner & Maschi, 2015). In this 
theory, the impacted population knows better.  Empowerment theory turns inwards for 
women to identify the source of disenfranchisement internally and take charge of their 
life decisions.  
In this study, resiliency theory was studied with respect to empowerment theory. 
As AA women, vulnerability to HIV is not determined entirely by engaging in risky 
behavior but can also include geo-behavior. Thus, it is important to better understand 
how empowerment can aid to overcome trauma and adversity, as well as initially 
connecting with and moving along the continuum of HIV care.  
Conceptual Framework 
My study employed the resilience construct from developmental and social 
variables. This was more of how nurture shapes nature. There were questions of home 
disciplines and family culture to learn when adaptive capacity or behaviors were acquired 
or developed. My study tried to understand resilience on the platform of positive- 
strength, protective factors and adaptive abilities instead of a focus on the deficits.  
Although Rutter (2013) states that findings from studies that incorporated resilience may 
not translate into clear prevention and treatment ideas because of the dynamic views of 
different individuals to adversities, it can provide some positive leads to research.  
What are the factors that may contribute to this resilience? An additional method 
used in the study included the creation of a time life trajectory. A sample of AA women 
was chosen to create their time life trajectories. From qualitative interviews, I collected 
data and created timeline beginning from when HIV infection was first diagnosed to 
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indicating experiences along the continuum of HIV care. According to Yates and Masten 
(2014), a resilience concept guided study allows the researcher to emphasize competence 
and successful adaptation to overcoming negative challenges. 
Research designed with a combination of resiliency and empowerment theories 
will provide information, motivation, behavioral skills, self-efficacy, social interaction 
that is useful in exploring the lived experiences of African American women. Semi 
structured interview questions were constructed using resilience and empowerment, self-
efficacy, and social variables to ascertain or construct the meaning of HIV infection as 
unique to each individual participant. The focus was on strength (either innate or built 
from family interactions), overcoming adversity, staying on medication, and achieving 
positive health outcomes. 
Nature of the Study 
This qualitative study applied a phenomenological approach. Open-ended 
questions were used to conduct in-depth interviews of 10 women. The interviews were 
recorded, and audio materials transcribed. This approach has philosophical implications 
and tends to reduce individual experiences to a description of the meaning of the 
phenomenon: “what” the people experienced and “how” they experienced it (Creswell, 
2013).  
This study also used triangulation to validate and verify information obtained 
from the women interviewed by drawing on clinical outcome information of viral 
suppression from the DC Health HIV database. Triangulation according to Rudestam and 
Newton (2015) is getting information from different sources as a way to corroborate 
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evidence. HIV clinical indicators, CD4 count and viral load were extracted from District 
of Columbia Health (DC Health) HIV Surveillance System. CD4 count and viral load of 
sample of AA women who tested HIV positive across some years, 2000, 2010, 2015 and 
2018 were extracted and used as data and information triangulation.  
This led to a deeper understanding of the phenomena. This qualitative approach 
allowed HIV positive AA women to describe their own lived experience with HIV/AIDS, 
discuss these clinical outcomes, and share with others. Edmund Husserl and Martin 
Heidegger are the two main authors of phenomenology as a qualitative approach. This 
methodology hinges on the assumption that reality consists of phenomena, as understood 
in the conscious. The uniqueness of individuals and how different individuals attribute 
meaning to similar life experiences and how a phenomenon is understood is also referred 
to as interpretive phenomenology (Burkholder, Cox, & Crawford, [Eds.], 2016; 
Rudestam & Newton, 2015; Kelly, n.d.). A phenomenological study identified 
participants from among individuals who have the relevant lived experiences in order to 
understand the experiences to make meaning to others. The results or findings can further 
be developed to influence policies and practices.  
In this phenomenological study, the experiences of the participants were 
interpreted using the hermeneutic loop. The hermeneutic loop originated from the Greek 
god Hermes, known to be a messenger. It is used in the discipline of philosophy to 
explore and interrogate experiences. As a cyclical loop, the hermeneutic loop lends 
credence that to understand the whole, it can only be understood by understanding the 
influences of the different parts (Harris, 2015). This also means that any misinterpretation 
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of a part will distort the meaning of the whole. Each person’s experience was different 
and has meaning only to that person. As such, in analysis of the data, each experience 
was understood as all the parts are joined together to bring out the meaning of the whole 
experience. To understand the meaning of the HIV experience of a participant, the cycle 
starts with a question about the event (HIV infection), and sorts through actions or speech 
that surrounded the event. The next part of the process led to what the participants did 
with the phenomenon (HIV infection), which corresponds to engagement with the part in 
the hermeneutic loop and reflects the challenges that trigger actions and feedback. The 
next part was to understand or reinterpret the challenges which lead to understanding the 
whole - living with HIV disease. The loop showed interrelationships within the parts and 
influences the parts to understanding the whole. 
Having a philosophical basis, phenomenological inquiry discusses a phenomenon 
as a search for wisdom. Judgments about reality are suspended and there is an angle of 
intentionality of consciousness, as reality is perceived within the individual and the 
meaning of the experience, phenomenology also allows for the inner essence, internal 
subjective experiences, to be explored. In this method of inquiry, information of 
individual’s cognitive processing structure, which is a conscious experience, is involved 
(Percy, Kostere & Kostere, 2015). Therefore, making meaning of living with HIV 
infection, and understanding what the structure of participants cognitive processing of the 
experience was key to phenomenological study. Hence phenomenology investigates the 
pre reflective conscious experiencing of an event (Percy, Kostere & Kostere, 2015, p.77)  
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All qualitative data were analyzed manually. First there was a manual 
transcription of all interviews recorded by Microsoft word voice recorder. There was a 
careful reading of the transcribed interviews line by line and sentence by sentence, re-
reading of all transcripts creating themes and memos.  
Definitions 
The following are operational definitions of technical terms used in this study. 
Human Immunodeficiency Virus (HIV): This is a virus that attacks T-lymphocytes 
cells in the body, destroying the body's defense against infections. Once the T-cells are 
attacked by HIV, the immune system becomes deficient and does not work properly 
(CDC, 2019, HIV.gov, 2019). 
CD4 cell count (T-cell): This is a type of white blood cell for which the HIV virus 
has great affinity.  HIV reduces the number of CD4 cells (T cells) in the body. A normal, 
healthy range for CD4 cells is about 500-1,500 (CDC, 2018e).  
Viral load: This is a test to measure the amount (copies) of HIV genetic materials 
in one milliliter (ml) of blood. The central treatment goal of HIV medication is to reduce 
the amount of virus in the blood to the lowest measurable or detectable by the technology 
used. HIV RNA can be detectable up to < 20 copies/ml of blood. (NAM Publication, 
2018, CDC, 2017e, 2018e)). 
Acquired Immunodeficiency Syndrome (AIDS): When the CD4 count drops below 
200 as result of advanced HIV disease, a person is diagnosed with AIDS. This damage to 
the immune system makes it increasingly difficult for the body to fight off infections and 
some other diseases (CDC, 2018b).  
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Opportunistic Infections (OIs):  These are infections that occur more frequently 
and are more severe in individuals with weakened immune systems, including people 
with HIV. Opportunistic infections take advantage of a very weak immune system to 
cause infections in the immunocompromised person. Opportunistic infections include 
Pneumocystis carinii Pneumonia (PCP), Candidiasis (fungal infections), Mycobacterium 
avium complex (MAC), toxoplasmosis, cytomegalovirus (CMV) infection, varicella-
zoster virus (VZV) infection, cryptococcal infection, histoplasmosis, Hepatitis B, 
Hepatitis C, bacterial respiratory diseases, bacterial enteric diseases, syphilis, Human 
papillomavirus, and others (Panel on Opportunistic Infections in HIV-Infected Adults and 
Adolescents, 2018). 
Antiretroviral Therapy (ART): This therapy is characterized by the use of HIV 
medication to treat HIV infection. There are six classes of highly effective antiretroviral 
drugs, namely: nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside 
reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PI), integrase inhibitors 
(INSTIs), fusion inhibitors (FIs) and chemokine receptor antagonists (CCR5 antagonists) 
(AIDSinfo, 2019a). The general recommendation for HIV treatment is a combination of 
at least three antiretroviral medications from at least two classes of drugs.  
Viral Suppression: Viral suppression reflects the result of a viral load test, i.e., 
when the level of HIV in a person’s body is very low (<200 copies/ml) or undetectable. 
Suppressed viral load improves the health of the person living with HIV, increases 
survival and reduces the risk of transmitting HIV (DHHS Guideline, 2018). The key goal 
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of ART is to achieve and maintain durable viral suppression. Thus, the most important 
use of viral load testing is to monitor the effectiveness of therapy after initiation of ART. 
HIV Treatment: This involves adhering to treatment regimen/guidelines including 
using antiretroviral medications that slow disease progression. Treatment adherence 
increases the likelihood that the infected person will live out a normal life free from 
disease complications. 
Treatment Guidelines: This is guidance from the U.S. Department of Health and 
Human Services that recommends how an HIV positive person should be treated with 
ART, when to start treatment, what to use, and how to monitor and ensure positive health 
outcomes are achieved (AIDSinfo, 2019). 
Treatment Adherence: This includes initiating care with an HIV provider (linkage 
to care), regularly attending appointments (retention in care), and adherence to 
antiretroviral therapy (ART). The concept of a “continuum of care” has been used to 
describe the process of HIV testing, linkage to HIV care, initiation of ART, adherence to 
treatment, retention in care, and virologic suppression (CDC, 2018b). 
HIV Testing: An HIV test detects if there is HIV genetic material present in a 
person. Three types of testing are available: antibody tests, combination tests 
(antibody/antigen tests), and nucleic acid tests (NATs). Antibody tests detect HIV 
antibodies in blood and the mouth’s mucosal membrane. HIV antibodies develop 3 to 12 
weeks in readiness to fight the virus once the body is infected. Combination tests 
(antibody/antigen tests) detect both HIV antibodies and HIV antigens in blood. This type 
of testing detects infection before antibodies form as it takes about 2 to 6weeks to detect 
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antigens. NATs detect HIV in the blood 7 to 28 days after infection (AIDSinfo, 2018). 
The Centers for Disease Control and Prevention (CDC) recommends universal testing for 
people aged 13 to 64 years old and more often for people who engage in high HIV risk 
activity. High-risk behaviors include unprotected sex (sex without a condom) with 
someone who is HIV positive or whose HIV status you don’t know; having sex with 
many partners; and injecting drugs and sharing needles, syringes, or other drug 
equipment with others. CDC also recommends that all pregnant women be tested for HIV 
early in pregnancy (AIDSinfo, 2018). 
HIV prevalence: This refers to the number of persons living with HIV at a given 
time and is used in epidemiology to estimate the probability that a person selected at 
random from a population will have the disease. CDC reports prevalence as the number 
of persons living with HIV infection in a given population at a given time where a 
prevalence rate is calculated per 100,000 people (CDC, 2016, CDC, 2017). 
HIV incidence: This is defined as the number of newly HIV infected persons in a 
specific time period. An HIV incidence rate is in turn generated by dividing the estimated 
number of newly infected people at a specific period by the number of people at risk 
(CDC, 2016). 
Pre-exposure prophylaxis (or PrEP): This refers to any medication taken by a 
person who does not have HIV to lower the risk of infection. The person must be 
adherent to the medication and take as directed (CDC, 2019g). Baeten, et al. (2014) 
demonstrated that Tenofovir alone and a combination of Emtricitabine plus tenofovir for 
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pre-exposure prophylaxis both provided high protection for acquisition of HIV-1 in 
heterosexual men and women.  
Stigma: A mark of disgrace related to someone’s circumstances either due to 
incarceration, disease, mental health or something else that a society looks down on. 
Usually the negative belief is unfair and affects the health of the person who stigmatized. 
HIV stigma affects testing, engagement, and staying in HIV care, leading to more 
infections (Berger, Ferrans & Lashley, 2001; Valdiserri, 2002). 
Health disparity: The greater occurrence of a disease in a particular population is 
known as health disparity, which might be observed according to gender, race, education 
or even geographical location (CDC, 2014). Health disparity is also defined as a 
particular health difference between groups that could be socially, economically or 
environmentally engineered (HealthyPeople.gov, 2019).  
Non-disclosure: The failure to reveal information about one’s health. Many HIV 
infected individuals prefer not to inform their sexual partners or intimate friends about 
their HIV status due to fear of stigmatization and other social reasons. The prevalence of 
non-disclosure is three times higher among black African heterosexual men who have sex 
with men (MSM; Daskalopoulou, et al., 2017). 
Vertical transmission: This refers to HIV transmission from an HIV-infected 
mother to her child during pregnancy, labor and delivery, or breastfeeding (through breast 
milk) (AIDSinfo, 2018b) 
Heterosexual transmission: Heterosexual transmission of HIV is considered to 
have occurred when someone infected with HIV denies any other risk factors except 
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sexual contact with the opposite sex who is infected with HIV (Haverkos, Chung & 
Perez, 2003). 
Phenomenology: Derived from philosophy, it is a method of inquiry that studies 
appearances instead of reality. It is the study of experiences, how they are experienced, 
structures of the experiences as subject to the person’s point of view. Experiences that 
can be studied through a phenomenological approach include imagination, thought, 
emotion, desire, volition, and action (Mastin, 2009; Percy, Kostere & Kostere, 2015)). 
Feminism: The advocacy of equality for women’s rights as part of efforts to 
correct the powerlessness, domination and oppression of women by another gender in the 
social, political, and economic arenas (Turner & Maschi, 2015). 
Empowerment: According to Rahman (2013), empowerment includes the 
processes that lead people to perceive themselves as able and entitled to make decisions 
and involves undoing negative social construction so that people come to see themselves 
as having the capacity and the right to act and influence decisions. Empowerment can be 
defined within three dimensions. One is personal—the development of a sense of self, 
individual confidence, and capacity, along with undoing the defects of internalized 
oppression. Second is the rational dimension, which consists of developing the ability to 
negotiate and influence the nature of a relationship and decisions made within it. The 
third dimension is collective, which includes involvement in political structures, but 
might also cover collective action based on cooperation rather than competition (Rahman, 
2013). Empowerment enables women to take control of their lives to achieve a set of 
goals and demands to actualize a change in social structures detrimental to their lives. 
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Self-Efficacy: This is a belief in an individual’s ability to succeed in specific 
situations or accomplish a task. An individual’s sense of self-efficacy can play a major 
role in how they approach goals, tasks, and challenges, and in their capability to attain 
designated types of performance (Artino, 2012). 
Collective efficacy: This refers to the ability of members of a community to 
control the behavior of individuals and groups in the community. It describes what group 
members are willing to do to improve their lives.  Collective efficacy is the willingness to 
intervene and the capacity for informal social control as members collectively agree on 
what is acceptable behavior and reinforce it among themselves (Higgins & Hunt, 2016). 
Assumptions 
One assumption associated with this study is that participants are eager to share 
their stories and truthfully recant events in their lives. However, accurately sharing life 
stories might be difficult as time has elapsed and sometimes recall of information might 
be hard. To mitigate against this assumption, participants were asked the same question 
in different ways, to try to elicit information to answer the research questions. Another 
assumption is thinking that women of the age criteria were willing to open up about their 
sexual activities and because the researcher is AA, that participants were comfortable and 
willing to share their stories. That participants who previously consented to participate 
will follow through to complete the session is another assumption. No one was forced to 
participate. To address this last assumption, all interviews were conducted in a relaxed 
environment. I reinforced to participant that the study was done in good faith and was 
respectful if a participant refused to answer a question or felt uncomfortable in any way. 
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Scope and Delimitations 
Positive health outcomes during HIV antiretroviral therapy are characterized by 
progressive reduction of the HIV virus in the blood (Eshleman et al., 2017). The 
undetectable level and sustained viral load suppression denotes positive outcomes. This 
means at this stage of disease, comorbidities are reduced (Granich et al., 2015) and 
symptoms of the disease are almost nonexistent as an HIV positive individual lives a 
normal life span as any other non-HIV positive person (CDC, 2016b, CDC, 2019a). It is 
important that this information be shared with HIV positive women at the time of entry 
into care. Education on the benefits of viral suppression is key as it may become the 
motivation for retention, engagement, and adherence to care and treatment. Miedema, 
Maxwell, and Aggleton (2011) emphasized that education is needed and might be central 
to increasing young people’s awareness and reducing vulnerability to HIV acquisition. A 
search of the literature did not result in any articles where such education was the 
foundation of the information provided to HIV positive African American women. In a 
study of urban AA in the South, Klein, Sterk and Elifson (2016) found Athat only 43% of 
the participants had knowledge of HIV infection and transmission, and the authors 
recommended establishing HIV educational and intervention programs for AA adults at 
risk for infection. Some young HIV-positive parents (born with HIV) largely agreed that 
being a role model for their children was a motivation to pursue education and 
employment, while fear of discrimination hindered disclosure of status (Fair, Allen, 
Trexler, & D’Angelo, 2017; Valdiserri, 2002). 
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The specific focus of this study is HIV+ AA women’s understanding of viral load, 
viral suppression, and transmission at diagnosis and along the continuum of care. It is 
important to document AA women’s perceptions about HIV knowledge and their 
experiences at diagnosis and in HIV care. It is also pertinent to know when women knew 
about all the benefits of viral load suppression and how such knowledge may or may not 
have influenced adherence to care. The findings result in an understanding of how to 
improve women’s experiences upon diagnosis and engagement in care. This study 
focused on heterosexual AA women living with HIV. The research study was conducted 
in the District of Columbia where there was access to the population. The results of the 
research is limited and not representative of all HIV positive women living in the District 
of Columbia. Excluded from the HIV positive AA in this study are those who are not 
heterosexual. Other excluded groups are women who are outside of the age being studied 
or had never been on antiretroviral medication. 
Limitations 
One limitation of this study is the validation of information from participants. 
Describing one’s lived experience necessitates a good strategy to ensure accurate 
information is obtained. Patton (2015) discussed four types of triangulation of data that 
could help reduce this issue, namely triangulation of qualitative sources, mixed 
triangulation, analytical triangulation, and theory/perspective triangulation. Substantial 
information can be obtained through triangulation of the different sources of information 
and crosschecking against theories and multiple sources of data. According to Carter, 
Byrant-Lukosius, DiCenso, Blythe and Neville (2014), data source triangulation ensures 
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that information collected from multiple sources are used for validation of information 
collected to have a different perspective of the data. Triangulation helps to make sense of 
any inconsistent or conflicting data (Patton, 2015). The data was triangulated by 
including interviews against documents, data from the DC Department of Health, and 
viral load and CD4 count tests were triangulated against interview documents. Other 
methods for assessing the quality of the data include conducting peer review, for 
example, passing the information through peers who acted as fact checkers against other 
external sources or through peer debriefing (Creswell, 2013). 
The findings in this study are not generalizable outside of my study sample and 
the District of Columbia area. It is typical for a phenomenological study to not 
necessarily be generalizable, though they nonetheless offer in-depth exploration of a 
topic. Another major limitation in this qualitative inquiry is my bias as researcher. 
Validation of this research plan started from ensuring that researcher bias and prejudice 
about people with HIV who are not engaged in care (Aziz & Smith, 2011) and other 
prejudices was discussed to allow for objectivity of data. Creswell (2013) called it 
clarifying researcher bias, where the researcher makes known experiences and prejudices 
that may affect the credibility of the results ahead of time. 
Another limitation included my potential for asking leading questions which may 
suggest answers to participants. Further, there is the limitation of the power relationship 
between the researcher and the participants. One caution in any phenomenological 
research approach was to ensure that the interviewer did not influence the contents of a 
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participant’s description. My knowledge of HIV/AIDS must not affect participants’ 
actual experience by making sure that questions were crafted objectively. 
Significance of the Study 
Guidelines from the National HIV/AIDS Strategy, United States Department of 
Health and Human Services (DHHS), and other national policies for HIV treatment have 
provided benchmarks and made milestones in the treatment of the disease. There are very 
effective antiretroviral medications now available that are nontoxic in contrast to the first 
generation medications, all working towards good quality treatment for HIV (DHHS 
Guideline, 2018). However, conspicuously missing in research are women’s lived 
experiences with HIV and how such experiences may facilitate infection when viral 
suppression is not achieved. At the same time, the United States alone sees at least 40,000 
new infections yearly and high prevalence among women of childbearing age (CDC, 
2018c). For 3 consecutive years (2012, 2013 and 2014) when new infections showed a 
downward trend, there continued to be spikes in infections in the 25 to 34 age group 
(CDC, 2019f). One study that targeted young HIV positive parents (who perinatally 
acquired HIV) noted that the parents’ motivation to be role models to their children led to 
pursuit of education and employment (Fair, Allen, Trexler, & D’Angelo, 2017). This was 
done with the hope to protect their children from discrimination and stigma. Yet, the 
same parents were found to be afraid to disclose HIV status to their children for fear of 
stigma. The infection rate continues to decline in the United States, and although mother-




This study has significant impact in addressing health disparities in the study 
population. According to Meyer, Yoon, and Kaufmann (2013), health disparities exist 
when differences in health outcomes are seen among different populations. The 
importance of health disparities in public health discourse includes burden of diseases 
among particular populations compared to others, lack of access to care and specialty 
care, and low socioeconomic status (Meyer, et al., 2013). Provision of quality care varies 
depending on the population and part of the country, and differences in cost of care also 
exist. In their analysis, Johnson et al. (2013) discussed the characteristics of people with 
HIV diseases in an effort to portray the disparities that exist in the lives of those with this 
infection and in their use of antiretroviral medication for treatment. The expert panel on 
the treatment guidelines noted that one of the goals of HIV treatment is achievement of 
viral suppression at least 8 to 24 weeks on antiretroviral therapy and having improved 
CD4 count (DHHS Guideline, 2018).  
Another positive social change was in the advancement of HIV/AIDS research, 
treatment, and prevention.  Moreover, this study provided information that align with the 
90-90-90 initiative newly adopted by many nations to end AIDS by 2020 (United Nations 
AIDS, 2014). The 90-90-90 initiative is intended to spur more focused efforts in 
countries’ progress in helping people living with HIV access treatment, get diagnosed, 
and achieve viral suppression and positive health outcomes (International Association of 
Providers in AIDS Care [IAPAC], 2015). The end of HIV/AIDS is contingent upon 
diagnosing all infected persons and providing access to antiretroviral medication to 
ensure viral suppression. HIV treatment is very important in ending the HIV epidemic, 
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normalizing survival, preventing HIV-related illnesses, averting AIDS related deaths, 
preventing new infections, and saving money (United Nations AIDS, 2014). The 90-90-
90 initiative aims to have 90% of all people living with HIV know their HIV status, have 
90% of all people so diagnosed receive sustained antiretroviral therapy, and have 90% 
receiving such therapy achieve viral suppression (United Nations AIDS, 2014). 
Summary  
 I discussed the epidemiological synopsis of the HIV/AIDS infection in the 
District of Columbia, the United States, and the world as a whole in chapter 1. The 
background information and the disproportionate infection among AA women. This 
chapter also included knowledge of viral load suppression among AA women as a 
reference to improved health outcome.  Other topics summarized in this chapter included 
the study’s theoretical framework, nature, assumptions, scope, delimitations, limitations, 
and significance.  
Chapter 2 provides information on the literature review conducted for this study 
to establish relevance of the problem. Chapter 3 restates the research questions and the 
central concepts used to design the study and the reason for their selection. Chapter 4 
presents information on the demographics of the participants, the setting, data collection, 
analysis, and evidence of trustworthiness. The last chapter, Chapter 5, will provide an 
interpretation of the findings, a discussion on limitations, recommendations, an 




Chapter 2: Literature Review 
Introduction 
The HIV epidemic in AA communities, especially AA women, continues to 
attract attention. The public health implications of the epidemic and the recognition of 
continued health disparities have led to some targeted interventions. Unfortunately, the 
CDC (2019f) continues to record high rates of HIV infection, with the most recent annual 
estimate being 40,000 new HIV infections in the United States in 2015. AA are 
disproportionately affected. AA non-Hispanic women are 9 times more likely to be 
infected with HIV/AIDS than any other race/ethnicity (Sionean et al., 2014).  
Several studies have identified possible factors associated with the 
disproportionate burden of HIV in AA women. Hatcher, Kumbakumba, Tsai and 
Dworkin (2012) noted that the ability to have sexual negotiating power with partners may 
reduce the infection rate. Low levels of education have also been shown to be associated 
with HIV infection (Melton, 2014) while Newsome, Airhihenbuwa, and Snipes’ (2014) 
results indicated that a lack of college-educated partners is a contributing factor to HIV 
infection among AA women. The role of stigma as a barrier to care has also been studied 
to determine how it fuels infection (Buseh & Stevens, 2008; Pollini, Blanco, Crump and 
Zuniga, 2011) 
Literature Search Strategy 
In an effort to identify relevant sources in order to study this issue in greater 
depth, I conducted multiple library searches using different databases. CINAHL Plus 
included the full text of many of the articles reviewed. Through ProQuest, the 
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Dissertation & Theses @ Walden University database was accessed to search for 
additional articles. Other databases searched included PubMed, NCBI, Mendeley Library, 
STAT!Ref, Essential Evidence Plus POEMS, Walden University Academic Search 
Complete, and SAGE. In addition, high level searches were conducted on the World 
Health Organization and CDC websites. Newer articles relevant to research, including 
those possibly published after I conducted the initial literature searches, were received via 
email through subscriptions to CAB Direct; Research Gate; the New England Journal of 
Medicine Journal Watch HIV/AIDS; the Health and Medicine Division of the National 
Academies of Science, Engineering, and Medicine; AIDS Patient Care and STDs; and 
AIDS Research and Treatment.  Some of the identifiers and key words used for the search 
included women AND HIV/AIDS; African American AND HIV/AIDS; risky sexual 
behaviors; public health education; HIV prevention health promotion; HIV testing; HIV 
epidemiology; HIV mortality; HIV AND condom use; poverty AND women; depression 
AND HIV/AIDS; District of Columbia AND HIV/AIDS; resilience theory; empowerment 
AND women; marginalization AND women; social support AND HIV/AIDS; HIV/AIDS 
health literacy; sexually transmitted diseases; HIV stigma; phenomenology; 
hermeneutics; AND reproductive health; and barriers to disclosure AND HIV status.  In 
the search for relevant peer review articles, I also signed up with the National Library of 
Medicine (NLM) at the National Institute of Health (NIH) to have relevant articles 
emailed directly to the researcher. Although I ended up not using the request system, it 




Theory and Origin 
Two main theoretical concepts guide this study: resilience theory and 
feminist/empowerment theory. Resilience theory is derived from two areas of study—
namely, child psychiatry and developmental psychology (Vernon, 2004).  A resilience-
guided study allowed me to emphasize competence and the successful adaptation to 
overcome negative challenges. And empowerment theory posits that empowered people 
take action necessary to create social and personal behavioral change. Proponents of 
empowerment theory have developed theory constructs to apply at the individual, 
organizational, and community levels. The two theories are expounded below. 
Resilience theory.  
The school of thought emerged from Freud’s assumptions that early negative 
experiences in life produce an adult with psychopathology. Expert researchers such as 
Michael Rutter, Norman Garmezy, and Eliot Rodnick applied this assumption in their 
study of child psychiatry and development (Harlow, 2009; Rolf, 1999; Vernon, 2004). 
Many scholars have defined resiliency theory, a fairly new research theory and approach, 
in different ways depending on the approach or issue under investigation. In the United 
States, the clinical psychologist Norman Garmezy, who helped develop the theory, 
examined resilience in two disciplines: psychoanalysis and development. Garmezy 
studied resilience to understand what he and his colleague identified as a distinction 
between “process” chronic schizophrenic and a “reactive” stable schizophrenic (Rolf, 
1999). The researchers explored the underlying reasons for the differences in outcomes of 
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these two groups of patients. They found that one group was competent, as demonstrated 
in the lives of the stable patients who were married, had children, and maintained their 
jobs. Members of this group still experienced schizophrenic episodes, but they recovered 
with shorter stays in hospital and are integrated into their community. The other group 
had longer stays in institutions, lasting 13 years or more. The differences in outcomes of 
these two groups formed the premise and need to study the underlying differences in 
these patients, with a focus on areas such as cognitive skills, motivation, and certain 
protective factors (Harlow, 2009). 
However, researchers have not yet established a single authoritative definition of 
resilience as experts formulate definitions from differing approaches. In a panel 
discussion during a conference of the International Society for Traumatic Stress Studies 
in 2013, various experts agreed that resilience is a complex construct leading to different 
definitions depending on the area of reasoning (Southwick et al., 2014). In a summary of 
all definitions generated during this conference, Southwick et al. noted resilience as the 
ability to bend but not break, bounce back, and perhaps even grow in adverse life 
experiences. Resilience is a “construct connoting the maintenance of positive adaptation 
by individuals despite experiences of significant adversity” (Luthar, Cicchetti, & Becker, 
2000, p. 543). Other interesting definitions included “stable trajectory of healthy 
functioning after an adverse trauma,” “capacity of a dynamic system to adapt 
successfully,” and a “process to harness resources to sustain well-being” (Southwick et 
al., 2014). In her argument on the most applicable definition, Dr. Catherine Panter-Brick 
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asserted that resilience is not a one-time achievement but sustained over time as it 
harnesses resources along the continuum of care (Southwick et al., 2014). 
Scholars study resilience theory from different approaches. Determinants of 
resilience are viewed through genetic, epigenetic, developmental, demographic, cultural, 
economic, and social perspectives (Southwick et al., 2014). Jackson and Miller (2014) 
used an ecological approach, where a resiliency-enhancing approach was integrated into 
an ecological model to explore AA women’s interactions with the environment, 
individuals, the community, and society when describing inequities in education, value of 
education and self-efficacy, commitment, mentoring, and faith and spirituality. The 
authors further examined resilience in relation to inequities in education, faith and 
spirituality, self-efficacy, and the need for mentors.  
I applied resiliency theory with respect to empowerment theory in this study. AA 
women’s vulnerability to HIV had not been entirely determined by their engagement in 
risky behavior; it included geo-behavior, which basically refers to where one lives, what 
one does, and with whom—all of which link to vulnerability to HIV infection (Brawner, 
2014). Thus, it was important to develop a deeper understanding of how empowerment 
aided in overcoming trauma and adversity as well as initially connecting with and 
moving along the continuum of HIV care. 
Feminist/empowerment theory. 
 A second theory applied in this study is feminism/empowerment theory. 
Feminism is a socio and political construct that tries to observe the interaction of gender 
to power relations (Perkins & Zimmerman, 1995). Th empowerment theory posits that 
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entering into the world of the abused or oppressed helps empathize and understand their 
needs. Empowerment is the process utilized to enhance the personal, interpersonal, and 
political power of an individual to ensure better life outcomes (Turner & Maschi (2015). 
According to this theory, the impacted population knows better. 
Although the debate about whether empowerment is an outcome or a process 
rages on (Carr, 2003; Luthar et al., 2000; Perkins & Zimmerman, 1995; Sadan, 2004), 
this study followed the process approach, which implied that women in this study 
experienced a personal transformation at some point, with a consciounesses powerful 
enough to seek and engage in care. Carr (2003) called such an empowering action 
conscientization, which is necessary to create social and personal behavioral change. 
However, Rahman (2013) advised caution to ensure that empowerment does not manifest 
as an exclusionary bias against men—an adversarial orientation and subversive logic that 
may threaten harmony in the home—as conscientization that excludes men is dangerous. 
Gender empowerment should be inclusive of all and be a matter of a change of values. 
This line of thought was explored and considered when empowerment theory was 
applied. 
Empowerment ensures that thoughts and beliefs about self-changes and the image 
of self are enhanced—namely, that an empowered person wields his or her own power 
and is motivated to move in the right direction toward a defined positive goal. Moran 
(2015) clearly depicted the application of feminist theory as empowerment by exploring 
the self through therapy, looking at uncertainty in normal responses to oppression without 
a traditional assessment, while exploring upbringing, family life, and religious affiliation. 
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Moran (2015) further emphasized that the strength of the client is hyperbolic, which 
means reaction to adversity may be exaggerated. The client is an expert on his or her own 
life, with exploring a range of possibilities and making informed decisions as to whether 
to change a behavior or not remaining the right decision. In this study, the 
feminist/empowerment approach functioned as a lens for understanding women’s 
unequal position to HIV and resilience in the presence of HIV infection. In particular, it 
used a gender lens that involved studying power relationships, social position, and 
women’s experiences with HIV infection. According to Turner and Maschi (2015), 
working with feminist theories with marginalized and oppressed women led to a better 
understanding, assessment, and ultimately intervention strategies to address the gender 
powerlessness experienced.  
The empowering process and outcomes differ depending on the individual and 
population under study. Perkins and Zimmerman (1995) asserted that, when it comes to 
individual empowerment, the process could include participation in a community 
organization; meanwhile, at the organizational level, empowerment might include 
collective decision-making and collective action. Individual or intrapersonal 
empowerment can be described as consisting of beliefs, attitudes, competencies, self-
determination, and efficacy. Other discourses have interpreted intrapersonal 
empowerment as the enabling of individuals to achieve personal goals through interaction 
with others, thereby making room for both personal motivation and collective action 
(Perkins & Zimmerman, 1995). 
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Rationale for Application of Resilience and Empowerment Theory 
I employed the resilience construct from developmental and social variables in 
order to demonstrate how nurture shapes nature. This included questions of home 
disciplines and family culture to determine when adaptive capacity or behaviors were 
acquired or developed. Gonzales (2003) applied resilience theory in three attributes or 
concepts: risk factors, protective factors, and resilient child. My aim was to seek to 
understand resilience on a positive platform—namely, strength, protective factors, and 
adaptive abilities—instead of a focus on the deficits. Although Rutter (2013) explained 
that findings from studies that incorporated resilience may not translate into clear 
prevention and treatment ideas because of the dynamic views of different individuals to 
adversities, they can provide some positive leads to research.  
I also looked at the evolution that transpired from such an adverse event as the 
time of HIV diagnosis to favorable adjustment when AA women are engaged in care and 
virally suppressed. Some of the infections happened in the 1980s, when the women were 
as young as 22 years old and no medication was available, but still exist in 2019. A 
metric of resilience for these women are that the virus reached an undetectable level in 
their blood. The researcher explored the factors that may contribute to this resilience. In 
the framework of epigenetics, resilience could be gene mediated due to phenotypically 
expressed skills that could withstand trauma and adverse events (Southwick et al., 2014). 
Thus, as children grow up, there might be some interpersonal role modeling by parents or 
family members that contributes to the children’s development of resilience (Fritz, de 
Graaff, Caisley, van Harmelen, & Wilkinson, 2018; Rosenberg, Baker, Syrjala, Back, & 
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Wolfe, 2013). Although discussions of epigenetics are gaining ground in efforts to learn 
about resilience, it is beyond the scope of this study. 
An additional method used in this study was the creation of a time–life trajectory. 
A sample of AA women were chosen to create their time–life trajectory. Using 
qualitative interviews, the researcher collected data and created timelines, beginning from 
when the HIV infection was first diagnosed, to indicate experiences along the continuum 
of HIV care. According to Yates, Tyrell, and Masten (2014), a resilience concept-guided 
study allowed the researcher to emphasize competence and successful adaptation in 
overcoming negative challenges. Research designed with a combination of resiliency and 
empowerment theories provided information useful for exploring the lived experiences of 
HIV-positive AA women. 
Previous Applications of Theories 
Fritz et al.’s (2018) study about childhood adversity and mental health in young 
people found a relationship between some resilience factors and increased likelihood of 
psychopathology. The researchers categorized resilience factors into three levels: 
individual, family, and community levels. Some of the resilience factors studied at the 
individual level included distress tolerance, cognitive reappraisal, self-efficacy, 
behavioral reward reactivity, emotional reward reactivity, mental flexibility, protective 
self-cognition, and socialization. At the family level, Fritz et al. (2018) included positive 
parenting, family cohesion, adolescent-and-father communication, adolescent-and-mother 
communication, extended family support, positive family climate, immediate family 
support, and quality of the parent–child relationship. Community-level resilience factors 
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included social support and friend support (Fritz et al., 2018). Although some of the 
resilience factors moderated and mediated mental health after childhood adversity, the 
authors noted that resilience factors should be studied as a complex system, not in 
isolation from one another. A study by Christman and McClellan (2012) asked women in 
academia to explain personality traits responsible for or affecting their successful 
academic pursuit and resilience in the face of challenges. The authors found a “middle 
space” that tends to break gender role assumptions in leadership to chart new boundaries.  
In another study, Washington (2008) applied resilience as hope to female 
adolescents in an alternate school program who contextualized their negative experiences 
into success stories. In their study, they recommended gender-specific programming 
efforts to provide a forum and space for impacted females to at least contribute to the 
discourse. Findings from the studies discussed thus far have further confirmed that 
resilience is not static, but moves along the continuum of different timeframes, 
conditions, and capacities to adjust to an adverse event. As patient education continues to 
evolve, there is an expectation that patients will actively participate and advocate for 
themselves, illustrating and depicting empowered patients. Fumagalli, Radelli, Lettieri, 
Bertele, and Masella (2015) described three areas where empowerment theory has been 
used. First, as a participative behavior where psychologists defined it as a form of 
intrinsic motivation to perform tasks (Huang, Shi, Zhang & Cheung, 2006). Secondly, in 
research as an interactive process through which people experience personal and social 
change that enabled them to take actions that positively affected their life (Lord & 
Hutchison, 1993), and thirdly, as an emergent state of adaptability to difficulty and 
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challenges. Bowers, Kreutzer, Cannon-Browers, and Lamb (2017) discussed some 
emergent states as the second order of positive emotions, self-efficacy, and positive 
affect. 
When researchers applied empowerment theory to reproductive experiences over 
the life course, they found a strong determinant of the current state of empowerment as 
one that emerges immediately after marriage (Lee-Rife, 2010). According to Lee-Rife’s 
(2010) study conducted in India, incorporating influences of prior life events, such as 
abortions, stillbirths, and miscarriages, shape a woman’s current state of empowerment 
and became one factor that lowered violence in marriage.   
The concept of empowerment has also been applied in the primary prevention of 
HIV/AIDS and has been proven effective in many CDC-funded interventions (Beeker, 
Guenther-Grey, & Raj, 1998). In Pinto, Rahman, and Williams’ (2014) study, women in 
prison with limited re-entry knowledge participated in 12 one-hour program sessions 
embedded with empowering information. At the end of the sessions, the women reported 
being empowered on parental rights, housing, and employment. They also had better 
advocacy skills that benefited them individually and their community (Pinto et al., 2014). 
In another study where women were given the power to use photo or pictures to illustrate 
their empowered status, participants showed increased self-esteem, critical thinking 
skills, and control over life challenges and HIV; they also had increased access to 
resources that improved health choices and behavior (Teti, Pichon, Kabel, Farnan, & 
Binson, 2013). In her discussion about empowerment in healthcare settings, Funnell 
(2016) described moving away from the traditional patient education to an 
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empowerment-based approach. This involves developing educational sessions that 
encourage the reflection of one’s life, boost self-management efforts, and improve 
problem-solving skills and engagement in clinical care, which helps make behavioral 
health changes. Schuler and Nazneen (2018) identified education as an example of an 
empowerment-based platform where changes in gender roles resulted in a reduction of 
married women experiencing intimate partner violence. Women were able to take new 
forms of employment and contribute financially to the household. 
Although HIV infection is decreasing in the United States (CDC, 2019a), its 
associated stigma does not seem to be dissipating. Discussion on the how such high 
infectivity rates affected the lives of AA women living with the disease is imperative. 
Rice et al. (2018) found that women mentioned multiple interrelated social determinants 
of health that continued to perpetuate stigma, such as gender, race, and income level. 
Continued HIV stigma may exacerbate health disparities and engagement in HIV care.  
Engaging HIV-positive women in empowering discussions helped build self-
esteem, leading to the recognition of inner strength. This might result in acquiring 
strategies to survive the disease and perhaps knowledge of what resources to access in 
order to improve one’s health. People facing adversities who pursue a purpose can 
develop a sense of meaning in life that promotes psychological health with lower levels 
of depression (Du, Li, Chi, Zhao, & Zhao, 2017). In addition, I posed questions to HIV 
positive women about their life experiences in general. Listening and learning about their 
experiences and challenges, along with how these challenges were overcome or are still 
being worked through and provided some clarity on the women’s lived experiences. 
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According to Yates, Tyrell and Masten (2014), a resilience-guided study allowed the 
researcher to emphasize competence and the successful adaptation to overcome negative 
challenges. Therefore, the theories of resilience and empowerment are particularly suited 
for this study. 
Literature Review 
HIV is on epidemic level in the United States and disproportionately affects AA 
women. The epidemiology of HIV in the District of Columbia continues to see a rise of 
new infections among AA women. However, HIV viral suppression leads to positive 
health outcomes especially for women on antiretroviral medications. The search for 
relevant literature that adequately discussed HIV viral suppression and infection was 
thoroughly researched using different relevant key variables. 
 
African American Women and HIV/AIDS Epidemics 
When more than 1% of a population has HIV, the CDC defines it as an epidemic 
(CDC, 2017b). At the onset of HIV in the 1980s, there was a steady increase in infections 
until the advent of effective medications in the 1990s, from nucleoside reverse 
transcriptase inhibitors (NRTIs) such as Zidovudine (AZT) and non-nucleotide reverse 
transcriptase inhibitors (NNRTIs) to protease inhibitors (PIs). HIV prevention has 
primarily focused on gay men, targeting mainly young black men who have sex with 
men. However, a marginalized group might be being neglected: young African American 
females. Haverkos, Chung, and Perez (2003) confirmed the HIV epidemic among 
heterosexuals by showing the greatest percentage increases in this population over time. 
In 2016, AA females accounted for 11% of all HIV diagnoses (CDC, 2019h) and 595 of 
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all new female HIV diagnoses in 2017 (CDC, 2019b). Skarbinski et al. (2015) found a 
reduction in HIV transmission rates along the care continuum, yet between 2012 and 
2014, AA women 25–34 years old continued to see spikes in infections (CDC, 2016b). 
Among all HIV-infected females living in the District of Columbia, AA females 
accounted for 92.5% of new infections in 2015 (District of Columbia Department of 
Health, HIV/AIDS, Hepatitis, STD and TB Administration [DC/DOH/HAHSTA], 2016), 
a percentage that increased to 94.1% in 2016 (DC/DOH/HAHSTA, 2017). In 2018, of the 
12,322 HIV cases living in the DC EMA, black women accounts for 22% of the cases 
(DC/DOH/HAHSTA, 2019).  
In Washington, DC, non-Hispanic AA females have the highest rate of infection 
among all women, having more than 6 times and nearly 50 times greater prevalence rates 
compared to women of Hispanic origin and White women, respectively 
(DC/DOH/HAHSTA, 2017). HIV infection among heterosexual Black females in 2016 
was 1.6% (see Figure 1), exceeding the 1% threshold of a generalized epidemic as 
defined by the CDC. 
Knowledge of HIV Transmission among African American Women  
Transmission of HIV occurs primarily through unprotected sex, infected semen or 
vaginal fluid during heterosexual sexual contact, and mother-to-child transmission either 
in the womb or during breast feeding (Drayton & Grant, 2017; CDC, 2018a,). HIV can 
also be transmitted through the sharing of contaminated drug paraphernalia (Skarbinski et 
al., 2015). Skarbinsk et al. (2015) found that most HIV transmission (58%) occurs 
through men who have sex with men, particularly among those between 35 and 44 years 
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old. Although heterosexually acquired HIV among women was found to be much lower, 
at 1.6%, there was no analysis of race and ethnicity in their study. 
 Klein, Sterk and Elifson (2016) discovered that HIV knowledge was especially 
low among older adults in the urban AA South, especially among older adults who have 
low educational levels and no personal knowledge of someone with HIV/AIDS. 
Henderson et al. (2004) also found that older women, regardless of marital status, had 
limited knowledge of HIV transmission through sex. Although various efforts to raise 
awareness about HIV continue, Perkins, Stennis, Spriggs, Kwegyir-Afful, and Prather 
(2014) questioned whether knowledge of HIV transmission is enough to make a 
difference. In another study conducted in urban historically Black colleges and university 
(HBCU) settings, AA youths did not perceive themselves as having a high risk of 
contracting HIV yet engaged in highly risky behavior for contracting the disease 
(Lindong, Edwards, Dennis, & Fajobi, 2017). Klein et al. (2016) studied both HIV-
negative and HIV-positive groups and found that this knowledge was not translated into 
making less risky choices. Knowledge of HIV also did not deter young girls from 
engaging in high risk behavior in detention facilities, despite elevated odds of contracting 
HIV for incarcerated AA (Baillargeon et al., 2017; Raiford, Seth, Fasula, & DiClemente, 
2017).   
HIV transmission among AA is dependent on not only risky behavior, but also 
geography. Despite efforts to reduce risk, people located in areas with higher 
concentrations of HIV-infected people still face a higher vulnerability of infection. This 
is referred to as geo-behavioral vulnerability to HIV (Brawner, 2014). Education and 
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knowledge of HIV transmission should form the foundation of every HIV education 
session in order to reduce the acquisition of HIV.  
Viral suppression also resulted in positive health outcomes for people living with 
HIV/AIDS (Cohen, McCarley, & Gamble, 2012), yet there was lack of ample research 
that  incorporated HIV viral suppression as a component of HIV education nor 
emphasized the need for viral suppression as a precursor to reducing HIV infection.  
Social Demographics of HIV/AIDS 
African Americans in the District of Columbia accounted for 82% and 94% of 
new HIV diagnoses among males and females, respectively, from 2004 to 2008 (West-
Ojo et al., 2010). The district is divided into eight wards, with Wards 7 and 8 having the 
highest prevalence of HIV. The majority (89%) of DC residents are 25 years old and 
above and have at least a high school diploma, with about 53.4% with graduate degrees 
or higher (DC/DOH, 2014). Although the median household income ($48,078) is above 
the minimum in other parts of the country, due to the high cost of living and housing in 
the district, many people live in poverty. In 2012, 14.19% of DC residents lived below 
the federal poverty level, while 26.91% and 20.95% lived at 150% and 200% of the 
federal poverty level, respectively (DC/DOH, 2014).  
Low income, low education level, and increased poverty tend to be strongly 
associated with HIV infection. Wards 2, 5, 7, and 8 show the highest number of HIV 
cases, while more new diagnoses are occurring in Wards 5, 6, and 7 
(DC/DOH/HAHTSA, 2017). The picture is the same at the national level. In 2017, 86% 
of all new infections occurred through heterosexual transmissions—an increase from 
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2016 (CDC, 2019b). During the same year, 4,189 Black heterosexual women were newly 
diagnosed, which is a much higher number compared to heterosexual Black men (1,926), 
White women (1,032), and Hispanic/Latina women (1,025) (CDC, 2017a). A study 
conducted in Baltimore, Maryland, found that testing for HIV occurred more often 
among women than men, who reported a higher number of sexual partners and/or were 
involved in illegal drug trade (Decker et al., 2015), a phenomenon which may cause 
overrepresentation in diagnosis statistics. Nonetheless, AA women are the new faces of 
HIV infection in Washington, DC, and in the nation, lagging only slightly behind Black 
men who have sex with men. The community in which someone lives and socializes 
becomes a significant factor in HIV acquisition. The higher the measurable amount of 
HIV virus in any community, the higher the rate of infection, which is usually described 
as community viral load.  
Community Viral Load 
The HIV virus is transmitted by people who are HIV positive. This basically 
means that only people who are infected can transmit the disease. The prevalence of HIV 
is in part dependent on the ongoing transmission risk fueled by high virus among 
community members. Miller, Powers, Smith, and Cohen (2013) defined community viral 
load (CVL) as the aggregation of individuals with a virus in a community. Herbeck and 
Tanser (2016) defined CVL as the mean of the individual viral load in a particular 
community. Part of the US National HIV/AIDS Strategy (NHAS) (2015) to end the HIV 
epidemic includes expanding HIV testing in the community to identify HIV-positive 
individuals and link them to HIV care and treatment. It also includes increasing the 
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proportion of HIV-positive individuals with undetectable viral loads (HIV.gov, 2011; 
NHAS, 2015).  
According to Brawner (2014), CVL is a population marker of the infectivity of 
people living in a geosocial area. Decreased community viral load and increased HIV 
testing are associated with a reduction in new HIV infections (Das, 2012; Das et al., 
2010). In one study, more than half of the participants had a high viral load associated 
with transmission risk (Kranzer, Lawn, Johnson, Bekker, & Wood, 2013). In their study, 
among the people living with HIV in a South African township, a small proportion had a 
CD4 count less than 200 while more than half had a high viral load that could benefit 
from an expansion of antiretroviral therapy (ART) treatment to reduce the virus in the 
community.  
One study of HIV-positive individuals receiving medical care in Washington, DC, 
highlighted the importance of knowing the CVL. Castel et al. (2012) demonstrated that a 
reduced CVL is associated with a reduced incidence of HIV. The biomarker of HIV 
incidence, high CVL, is observed in communities with high poverty and low high school 
graduate rates (Castel et al., 2012). CVL is used as a marker for treatment of HIV, 
helping decision-makers target areas of high viral burden and make provisions for 
enhanced access to care and treatment for such impacted communities. Das (2012) 
advocated for adequate assessment and measurement of CVL, the establishment of a 
baseline, modernized surveillance, and the following of CVL trends as a central indicator 
for success in prevention and care efforts. 
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Treatment of HIV 
 HIV is treatable and can be classified as a manageable chronic infection. On April 
17, 1998, as a result of the efforts of researchers, clinical providers, patients, the 
Department of Health and Human Services (HHS), the National Institute for Health 
(NIH), the Centers for Disease Control and Prevention (CDC), and the Henry J. Kaiser 
Family Foundation, the first guidelines for treating pediatric HIV infection were 
published, followed quickly by guidelines for treating adults and adolescents with HIV 
infection published on April 24, 1998 (Health Resources and Services Administration, 
n.d.).   
The guidelines are often updated in light of new research and treatment findings 
that might improve the quality of care for people living with HIV (AIDSinfo, 2019a; 
AIDSinfo, 2019c). The panel of experts responsible for developing and updating the 
guidelines rate certain recommendations as “A” to indicate strongly recommended 
practices, “B” for moderately recommended practices, and “C” for optional practices. 
The ratings rely on evidence-based clinical trials from randomized controlled trials; non-
randomized, observational cohort studies with long-term clinical outcomes; and expert 
opinions. The panel has recently recommended that all individuals with HIV be on ART 
regardless of their CD4 count, as ART reduces morbidity and mortality (AIDSinfo, 
2019a). ART is also recommended for individuals with HIV to prevent HIV transmission. 
ART should only be deferred for clinical/psychosocial reasons, but otherwise initiated as 
soon as possible (AIDSinfo, 2019a).  
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Guidelines for Treating Adults and Adolescents 
The panel’s most recent recommendations for effective treatment of HIV include 
taking three active antiretroviral medications from at least two classes. The most 
favorable “A” rated recommendation is for one medication from the integrase strand 
transfer inhibitor (INSTI) class and two medications from the nucleoside reverse 
transcriptase inhibitor (2NRTIs) class. The combinations of medications rated as “A1” 
and “A11” are: 
• Dolutegravir/abacavir/lamivudine, which is only for patients who are HLA-
B*5701-negative (AI), represented as “DTG/ABC/3TCa (AI) if HLA-B*5701-
negative”  
• Dolutegravir plus tenofovir/emtricitabine (AI), represented as “DTG + 
tenofovir/FTC (AI for both TAF/FTC and TDF/FTC”  
• Elvitegravir/cobicistat/tenofovir/emtricitabine (AI), represented as 
“EVG/c/tenofovir/FTC (AI for both TAF/FTC and TDF/FTC”  
• Raltegravir plus tenofovir/emtricitabine (AI for tenofovir disoproxil fumarate, AII 
for tenofovir alafenamide), represented as “RAL + tenofovir/FTC (AI for 
TDF/FTC, AII for TAF/FTC” (AIDSinfo, 2019a; DHHS Guidelines, 2018) 
Guidelines for Treating Women: Considerations for ARV in women with HIV 
Preconception counseling has been included in the DHHS guidelines to improve 
the health of women before conceiving or to ensure that conception is planned. The 
importance and benefits of preconception counseling were affirmed by the American 
College of Obstetricians and Gynecologists (ACOG) committee in September 2005. The 
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goal of such counseling is to reduce the adverse effects suffered by HIV-positive women 
of childbearing age. Simone et al. (2018) identified five thematic areas that affect 
preconception counseling and barriers to engaging in clinical care. They conducted their 
study in seven cities in the United States, with an emphasis on counseling being 
consistent across providers. Factors that affect engagement in preconception counseling 
and other care include knowledge and attitude, characteristics of the clinical facility, type 
of care coordinators, and the ability to access locations when referrals are made to other 
places. 
Extra steps are taken to prescribe the most appropriate antiretroviral (ARV) 
medication for women of childbearing age, especially during pregnancy. The Food and 
Drug Administration assigns ARVs and all other drugs to categories that consider 
whether and how the drugs should be used by pregnant women and women 
contemplating pregnancy. For a drug to be assigned category A, it must be demonstrated 
to be safe in pregnancy and pose no risk to a fetus. Unfortunately, no ARV is classified as 
category A at this time. Category B drugs are those that failed to demonstrate risk during 
testing on animals but have not been subjected to a controlled study on pregnant women. 
Category C denotes that animal reproduction studies have been conducted on the drug 
and revealed an adverse effect on the fetus; although no adequate and well-controlled 
studies on humans have been conducted yet, the potential benefits of pregnant women 
using the drug possibly outweigh the potential risks. Some ARVs fall into categories B or 
C (Jose, Wallace, Anand, & Barlett, 2014).  
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For category D drugs, studies on human subjects have demonstrated a risk of 
harm to the fetus, although the drug may still be used during pregnancy if warranted. 
Efavirenz is a category D drug (Jose et al., 2014). Women in the first trimester of 
pregnancy should especially avoid Efavirenz (AIDSinfo, 2019d). In their clinical trial, 
Brogly et al. (2010) found an elevated risk of birth defects in pregnant HIV-positive 
women who used Efavirenz during the first trimester of pregnancy. Category X shows 
harm to the fetus during animal studies; these drugs should not be used during pregnancy 
(Jose et al., 2014). 
One medication whose category status is currently challenged is Dolutegravir. 
Dolutegravir is a first-line regimen for HIV treatment (AIDSinfo, 2019e). However, it 
has been documented to cause neural birth defects (NTDs) in newborns (AIDSinfo, 
2019c; U.S. Food and Drug Administration [FDA], 2018). The use of a Dolutegravir–
based regimen for women before 8 weeks of pregnancy is no longer recommended, and if 
the female was already on Dolutegravir and virally suppressed, a change before 8 weeks 
of pregnancy is recommended. However, if the patient is already on Dolutegravir and the 
pregnancy is older than 8 weeks, then no change in medication is recommended 
(AIDSinfo, 2019e). In the meantime, the FDA has not yet removed Dolutegravir’s 
category B status.   
In addition to reducing the risk of transmission, an undetectable viral load during 
pregnancy reduces the risk of HIV transmission to the unborn child (in vivo) and the 
newborn. Although mother-to-child vertical transmission has drastically fallen in the 
United States, efforts should be maintained to ensure that young HIV-positive women 
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receive quality care to remain virally suppressed. In this way, children will not be born or 
infected with HIV. In providing ARV to women of childbearing age, efforts are also 
being made to ensure that many of the pregnancies are planned by using effective 
contraceptives. As some ARVs also interact with contraceptives, reducing their efficacy, 
ARV medication may need to be changed or extra protection may need to be used 
(Matthews et al., 2017). 
HIV Medications: Medication adherence 
Evidence for the benefits of taking ARVs as well as the resultant effect of 
reducing HIV transmission was strengthened by the HPTN 052 randomized clinical trials. 
Adherence to medication and viral suppression as a result of good adherence 
revolutionized HIV treatment and gave birth to the slogan “Treatment is Prevention.” In 
the HPTN 052 clinical trials, HIV infection decreased by 96%, and there was also a 
reduction in morbidity and mortality. Participants in the clinical trials exhibited 95% 
medication adherence along with a reduction in HIV transmission to others (Cohen et al., 
2012). These findings led researchers to advocate for early diagnosis, the early initiation 
of ARV, and consequent viral suppression.  
An earlier study by Kitahata et al. (2009) found that patients who started ARV 
immediately had better health outcomes than those who deferred medication. Combined 
with similar results from population studies, Donnell et al. (2010), Montaner et al. (2010), 
and Das et al. (2010) demonstrated that an effective strategy to reduce HIV transmission 
is to prescribe appropriate ARVs to everyone infected with HIV.  
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Continued medication adherence is especially key to improving health outcomes. 
Adhering to medication at least 95% of the time has been advocated as best adherence 
practices (CDC, 2013). Factors influencing adherence to medication may involve internal 
motivation, circumstances, peers, and provider relationships. For some women, 
adherence is especially motivated by a desire to stay alive for their children (Islam, 
Minichiello, & Scott, 2018). Okoro and Odedina (2016), studied factors that influence 
AA women’s care-seeking behaviors and adherence to HIV/AIDS medications. They 
found that the provider–patient relationship is a great resource that promotes adherence 
while relationship building influences patients’ understanding of the need to adhere to 
ART. Another study by Nokes et al. (2012) found that enhancing self-efficacy was a 
predictor of medication adherence. The authors also recommended incorporating self-
efficacy into nursing interventions to help adherence. Meanwhile, Bonacci et al. (2016) 
found that, although ARV adherence also entails refilling prescriptions, refilling 
prescriptions is a poor predictor that someone is engaged and retained in care. The 
researchers’ findings indicated that non-adherence is associated with non-retention, as 
patients who do not show up for appointments exhibit an increased risk of dropping out 
of care. Castel et al. (2016) found that about 83% of people who had ARV adherence in 
the preceding 7 days were in care, compared to 69% for people out of care. 
Care providers must analyze adherence on a regular or periodic basis to identify 
people at risk and have more conversations with patients about the benefits of medication 
adherence. An analysis of 12 years of United States Medicaid data showed that 57% of 
patients failed to restart ARV after 18 months of stopping, and many of them were 
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younger females (Zhang, Shireman, Youn, Lee, & Wilson, 2018). Older adults were more 
likely to be adherent to medical visits and phlebotomy visits and experienced greater 
levels of viral suppression (Waldrop-Valverde, Guo, Ownby, Rodriguez, & Jones, 2013). 
According to Giordano, Jacobson, Mammen, and Moreno-Walton (2017), persons 
diagnosed with acute HIV infection (AHI) in the emergency room fare better than 
established HIV patients who also visited the emergency room. Their analysis concluded 
that persons diagnosed with AHI had better linkage-to-care and greater initiation of ARV, 
with 35% of the sample experiencing viral suppression within 6 months after the 
emergency room visit. This better strategy needs to be implemented for all HIV-positive 
individuals. Nonadherence to medication often leads to low viral suppression. Robertson 
et al. (2017) performed a comparative analysis of clients who received or did not receive 
care coordination. Interestingly, in 24 months, the two groups did not show any 
significant difference in viral suppression. The noted difference was not a result of access 
to medication as everyone had access, but possibly it was due to adherence instead. 
Early diagnosis and engagement in HIV care are associated with not only better 
health outcomes, but also lower medical costs. According to one study, entry into care 
within 72 of HIV positive test results led to rapid HIV treatment, faster viral suppression, 
improved health outcomes, and reduced HIV transmission (Halperin, Butler et al., 2017). 
Gebo et al.’s (2010) analysis indicated that treating one person with HIV in 2006 in three 
states in the U.S. was $19,912, with a higher cost for people with low CD4 counts. In 
2015, the CDC estimated that it took about $23,000 per year to treat an individual with 
HIV—an increase of more than three thousand dollars (CDC, 2019i). A lifetime 
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treatment in 2010 was estimated to be $379,668 (CDC, 2019i), while the country sees 
about 40,000 new infections every year. Economically speaking, a lifetime treatment of 
HIV is definitely astronomical compared to prevention. Therefore, ensuring that 
transmission does not happen should be the priority. Adhering to medication and 
engagement in HIV treatment reduces the virus in the system, which reduces infectivity. 
As treatment amounts to prevention, ensuring that HIV-positive individuals are 
diagnosed early and put on treatments seems to be reasonable and logical. 
HIV Continuum of Care 
 The continuum of care is currently used to assess and measure the efficacy of HIV 
treatment from the early stage of diagnosis of the disease through a continuum of steps 
until there are improved health outcomes characterized by viral suppression. According 
to the Department of Health in the District of Columbia, the continuum of care begins 
with the number of HIV cases diagnosed for residents in the district, followed by the time 
linked to care, engaged in care, prescribed ARV, and virally suppressed. In 2017, 12,078 
people with HIV diagnoses were living in Washington, DC. Of these, 98% were ever 
linked to HIV care (11, 875), with 29% having sporadic care (only 1 medical visit) and 
71% in continuous care (more than one medical visit); 7, 950 (66%) were virally 
suppressed (DC/DOH/HAHSTA, 2019). Improvement in health outcome is obvious from 




Figure 3. 2018 DC HIV Continuum of care. From “Annual epidemiology report,” by 
DC/DOH/HAHSTA (2019). 
 
Figure 4. Care dynamic among HIV cases living in District of Columbia, 2016. From 
“Annual Epidemiology and Surveillance Report 2017,” by DC/DOH/HAHSTA (2017). 
 
The District of Columbia fares better than the nation as a whole when it comes to 
viral suppression. According to CDC data, only 49% of the 1.1 million persons with HIV 
in the U.S. achieved viral suppression in 2014 (CDC, 2017a), which increased to 51% in 




Yet a look at the performance of specifically the Ryan White program in 
Washington, DC, reveals the possibility of even better health outcomes. The Ryan White 
HIV/AIDS Treatment Extension Act of 2009 was created in 1990 to provide a system of 
services that helps persons living with HIV in the United States to achieve improved 
health status (Health Resources and Services Administration, 2016). Grants are awarded 
to sub-recipients to develop comprehensive services for individuals living with HIV and 
help optimize health. The array of services ranges from outpatient ambulatory health 
services, dental services, mental health, substance abuse, medical case management, food 
bank, and home delivered meals to psychosocial services, respite care, childcare, and 
others. The various funding parts A, A (MAI), B, B (MAI), C, D, and F of the Ryan 
White Act integrate to ensure the provision of optimal health for various populations who 
are eligible. The person must live within the region or geographic area and meet income 
qualifications (Health Resources and Services Administration, 2016).  
By December 2018, 4,229 persons with HIV living in the city were also Ryan 
White clients, while 73% (3,090) of Ryan White clients were in continuous care (i.e., at 
least 2 viral loads reported 90 days apart). Of that number, 95% (4,003) were prescribed 
antiretroviral therapy (ART) and 80% were virally suppressed (DC/DOH/HAHSTA, 
2019). The 2018 Ryan White data shows a substantially higher success rate compared to 





Figure 5. 2018 Care dynamics among Ryan White Clients, District of Columbia. From 
“Annual Epidemiology and Surveillance Report,” By DC/DOH/HAHSTA (2019) 
 
Viral Suppression and Health Outcomes 
Viral suppression reflects the result of a viral load test in which the level of HIV 
in a person’s body is very low (<200 copies/ml) or undetectable (Cohen et al., 2012; 
Pollini et al., 2011). Suppressed viral load improves the health of the person living with 
HIV, increases survival, and reduces the risk of transmitting HIV (AIDSinfo, 2019a). 
Virally suppressed HIV-infected persons are less likely to transmit HIV (Skarbinski et al., 
2015). Thus, the goal of treatment is to achieve viral suppression, where the virus is 
undetectable in the blood, there is an increased CD4 count, and there are improved health 
outcomes (AIDSinfo, 2019a).  
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Women who are HIV positive should learn the importance and meaning of viral 
suppression for their own well-being and as a means to reduce transmission. To 
understand HIV infection within the AA community, it is necessary to understand 
African American women’s knowledge of viral suppression at diagnosis and during the 
continuum of care. In 2016, viral suppression among women in Washington, DC, was 
low at 64%. Figure 6 shows that at least 25% of HIV-positive women in the district do 
not consistently engage in HIV treatment to achieve viral suppression. 
 
Figure 6. Care dynamics among women diagnosed with HIV living in Washington, DC, 
in 2016. From “Annual Epidemiology and Surveillance Report,” by DC/DOH/HAHSTA 
(2017). 
Although viral suppression is the gold standard for the goal of HIV treatment, it 
does not necessarily remove the harmful effects of viral attacks on the immune system. 
HIV infection is characterized by increased immune activation even in people with a 
suppressed viral load (Malherbe et al., 2014). However, a long interruption in treatment 
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often leads to increased immune activation and negatively affected health (Musinguzi, 
2018). In addition to improved health outcomes, viral suppression is associated with a 
decrease of new HIV cases (Montaner et al., 2010). Viral suppression is also a 
component of reduced community viral load, which in turn reduces new infections (Das 
et al., 2010). Yet as important as this is as an indicator of positive health outcomes, Black 
people are less likely to be virally suppressed. African Americans are less likely to have 
controlled viral load and medication adherence and more likely to have more 
comorbidities than Whites (Vaughan-Sarrazin et al., 2018). This scenario results in non-
retention, which is a hallmark of disengagement in care and increased inflammation.  
Positive health outcomes, according to Parrish (2012), include being alive and 
having a state of well-functioning mental, physical, and social being, while negative 
outcomes are death, illness, and a lack of wellness. Viral suppression leads to positive 
health outcomes for people who are HIV positive, including women. Various studies 
have shown that, when the HIV virus is reduced to undetectable levels (viral suppression) 
in an infected person, there is a non-transmission of the virus, even with condomless sex 
(Cohen, McCarley, & Gamble, 2011; Rodger et al., 2016; World Health Organization 
[WHO], 2018a). There is no evidence that individuals who have achieved and maintained 
undetectable levels of the virus transmit HIV to their sexual partners. This knowledge is 
fueling the campaign known as U (undetectable) = U (Un-transmittable) as a key strategy 
to ending HIV infection. 
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Stigma as a Barrier to Treatment 
Stigma is defined as a mark of disgrace related to someone’s circumstances due to 
incarceration, disease, mental health, or something else that a society looks down on. 
Usually the negative belief is unfair and may affect the health of the individual. HIV 
stigma negatively affects testing, engagement with, and staying in HIV care, which in 
turn leads to more infections (Valdiserri, 2002; Nyota, 2017). Stigma is regarded as a 
major barrier that affects HIV-positive persons from seeking care and receiving the 
benefits of HIV treatment. Stigma leads to a negative self-image that can prevent 
individuals from seeking treatment and can delay treatment. Studies have found an 
association between stigma and reduced initiation of antiretroviral medication, low 
retention in care, and non-adherence (Logie et al., 2018; Sangaramoorthy, Jamison, & 
Dyer, 2017). 
According to Buseh and Stevens (2008), African American women experience 
stigma socially, internally, and externally. Stigma has deep roots in gender, race, 
ethnicity, class, sexuality, and culture and will continue to be seen as a great impediment 
to reducing HIV transmission (Valdiserri, 2002, Nyota, 2017). Reducing stigma should 
be incorporated into many educational programs. Coleman, Tate, Gaddist, and White’s 
(2016) study in a faith-based community found lower HIV-related stigma among females 
who have higher education, know someone with HIV/AIDS, and/or know a gay person. 
Black churches have embarked on numerous health-related outreach programs in the 
Black community, but stigma in Black churches continues to affect the provision of HIV-
related health activities (Pryor, Gaddist, & Johnson-Arnold, 2015).  
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AA women who experience such barriers as stigma, denials, and depression and 
who lack a support network may be able to mitigate these issues by obtaining resources 
from their healthcare provider (Petralia, 2016). According to Stewart, Hong, and Powell 
(2018), multifaceted intervention approaches may provide relief and improve the HIV 
continuum of care. AA churches can facilitate interventions to reduce stigma, get 
involved in providing a social support network, provide HIV education, act as agents that 
link HIV-positive women to care, and provide support groups. AA experience stigma in 
both the community and healthcare settings. Therefore, there is a need to understand the 
interactions of all these issues as they apply to AA women with HIV in Washington, DC. 
Logie et al. (2018) observed that stigma has a negative influence on the initiation and use 
of HIV medications among women living in Canada.  
Any intervention that could eliminate or reduce stigma may increase adherence to 
treatment and medication and thus improve health outcomes.  I had planned this study 
towards understanding AA women’s lived HIV experiences during such challenges. The 
review of existing literature did not identify any research on AA women’s HIV timeline 
and resilience. 
HIV/AIDS and Health Disparities 
The CDC (2014) defined health disparity as the greater occurrence of a disease in 
a particular population. It might occur in association with gender, race, education, or even 
geographical location (CDC, 2018d). Health disparity is also defined as a particular 
health difference between groups, which could be socially, economically, or 
environmentally engineered (CDC, 2018d; HealthyPeople.gov, 2018), and often affects 
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people who have challenges accessing quality healthcare. The various areas in which AA 
women experience health disparities include viral suppression for AA women infected 
with HIV (Billioux et al., 2015; Castel et al., 2016; Crepaz, et al., 2016; Hall, Tang, 
Westfall, & Mugavero, 2013; Nwangwu-Ike, Hermandez, An, Huang, & Hall, 2015; 
Torian, Xia, & Wiewel, 2014). 
Although HIV/AIDS-related deaths continue to decline with effective 
antiretroviral therapy, the District of Columbia records show that its death rate is higher 
than the nation’s, at 20.4 per 100,000 population versus 2.6 per 100,000 
(DC/DOH/HAHSTA, 2017). One of the objectives of the national HIV strategy is to 
design health programs to reduce disparities in highly affected communities, especially in 
terms of viral suppression and AIDS death (HIV.gov, n.d.; NHAS, 2015; White House 
Office of National AIDS Policy, 2016).  Washington, DC, is uniquely positioned as a 
large metropolitan city and the capital of the United States. As such it should be the 
epitome of health for all its residents. However, in 2016, AA women accounted for 94% 
of all new HIV cases in the city, an increase from 92.5% in 2015 (DC/DOH/HAHSTA, 
2017). Therefore, the need to identify reasons for HIV disparities, especially among AA 
women in the district, is critical to improve health outcomes in the city.  
Geter et al. (2018) found that, although viral suppression increased among HIV-
positive women, disparities were observed among racial and ethnic minority women. The 
researchers underscored the need to study the disparities in HIV treatment, especially 
among Black women and younger women. They also highlighted the need for gender-
based and culturally sensitive interventions.  
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Summary and Conclusions 
HIV/AIDS affects millions of people, with approximately 36.9 million people 
living with the disease as of 2017 (WHO, 2018b). Women who engage in heterosexual 
sex are disproportionately affected and, in the United States, AA women are especially 
affected (CDC, 2019b). The HIV infection rate remains a public health issue as AA 
women continue to experience increases. Fortunately, HIV treatment has evolved from 
having no medications to more than 30 active antiretroviral medications. When taken as 
prescribed, ARV works to reduce the virus in the system, resulting in viral suppression. It 
has been shown that the virally suppressed person is not infectious and does not transmit 
HIV to negative partners during times of condomless sex (Skarbinski et al., 2015; WHO, 
2018a).  
Despite the numerous articles reviewed, no research article or intervention 
discussed the importance of viral suppression at the time of diagnosis. To achieve viral 
suppression, one has to be on ARV and adhere to the treatment. In a practical best case 
scenario, an HIV-infected person who adheres to treatment could achieve viral 
suppression within 48 weeks and maintain optimal health if other comorbidities do not 
affect health (AIDSinfo, 2019a; Robertson et al., 2017). The importance of viral 
suppression and all its positive health implications are known, yet there is a dearth of 
information on education on viral suppression. 
Furthermore, AA women experience stigma in their search for HIV treatment and 
care. Social stigma of HIV-positive status remains prevalent in society, including in the 
churches that have otherwise served as refugee for the AA community for hundreds of 
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years. Stigma is a barrier to care and treatment. Stigma impedes the disclosure of HIV 
status, preventing honesty in relationships and leading to further infections (Avert.org, 
2018; Kontomanolis, Michalapoulos, Gkasdaris & Fasoulakis, 2017; Saki, Kermanshahi, 
Mohammadi & Mohraz, 2015). The stigma and silence that surround HIV is a barrier for 
the AA community’s health and well-being. 
The literature has a great deal of information on health disparities experienced by 
African Americans. AA women, in particular, are disproportionately infected with 
HIV/AIDS. In Washington, DC, alone, AA women account for 94% of new HIV 
infections (DC/DOH/HAHSTA, 2017). As the disparities continue, some HIV-positive 
women are also considered to be living well with the disease. Often infected at an early 
age, they have lived through time spans of no treatment to effective treatment.  
The review of existing literature found that it does not ask or answer questions 
regarding the characteristics of HIV-positive AA women who have survived decades of 
infection. To date, no research had ventured to look at the lives of these AA women and 
their lived experiences with HIV/AIDS, especially their knowledge of viral suppression. 
Although often infected between 18 and 25 years of age, some AA women are still living 
today. Their lessons learned should be incorporated into interventions for current younger 
HIV-infected women. The lessons learned in this study should provide information to 
help close the gap in the education and counseling on viral suppression at the time of 
diagnosis and the resultant effect on engaging and remaining in HIV treatment and care. 




Chapter 3: Research Method 
Introduction 
Learning from the experiences of HIV positive AA women is indeed vital, 
especially as their experiences relate to achieving viral suppression. Ensuring there is 
viral suppression when taking antiretroviral medication is an important precursor to 
ending HIV/AIDS (United Nations AIDS, 2014). Therefore, one of the key purposes of 
the study was to understand in greater detail how HIV positive AA women gained 
knowledge of viral suppression at their diagnosis and achieving viral suppression. The 
insights obtained provided valuable guidance when crafting prevention messages. 
Another purpose of this study was to increase the understanding of HIV infection and 
viral suppression from the perspectives of AA women who are living with HIV. The 
study used a phenomenological approach to uncover the lived experiences of HIV 
positive AA women and their viral suppression, including how HIV positive individuals 
are discriminated against in the community and further still can experience strong stigma 
from family and friends, as reported by Buseh and Stevens (2007). Another aspect of this 
study was the use of feminist lens to better understand the unequal position of black 
women in the context of HIV infection.  
The study findings supported gender as the basic framework that conditions 
women for an increased risk of HIV infection. In an analysis of the HIV/AIDS disease 
burden among AA women, a gender responsive model also furnished useful initial steps 
for new dialogue and a fresher examination of HIV/AIDS as a social issue (Brawner, 
2014). Issues related to gender roles and socialization may also have to be explored to 
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understand the HIV vulnerability of African American women. HIV infection may also 
reflect geo-behavioral characteristics. In addition, the study findings may contribute more 
knowledge and understanding of how power relationships, social constructs, and social 
positions actually impact acquisition of HIV infection.  
In Chapter 3, I detail the research design and the rationale including the research 
questions, phenomenon of study, and the research tradition that informed this study. Most 
importantly, the rationale for choosing a qualitative phenomenological design is 
discussed. The role of the researcher is an important part of this discussion. Working in 
HIV/AIDS for more than 20 years may create a certain bias that I must interrogate to 
ensure that the study was conducted in a professional manner and vigor applied. A 
detailed discussion of how researcher bias was managed is also presented.  
Another important part of Chapter 3 is my discussion of the selection of the study 
participants, methods of recruitment, the logic for that selection, the purposeful sampling, 
inclusion criteria, sample size, and saturation point. Plans for analysis and issues of 
trustworthiness in a qualitative study are also discussed. Other sections in this chapter 
include ethical issues and concerns, and how these are managed, including the actual 
steps for obtaining institutional board review (IRB) approval to conduct the study. 
Research Design and Rationale 
The three main questions that drove this study are: 
Research Question 1: What is the lived experience of African American women 
with HIV/AIDS in DC? 
Subquestion 1a: What are their daily routines of medication adherence? 
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Subquestion 1b: What challenges constitute stigma and discrimination that they 
face in daily living? 
Research Question 2: How do HIV positive women describe/explain viral 
suppression? 
Research Question 3: How do HIV positive women explain/describe the high rate 
of HIV infection among African Americans in the District? 
The Study Phenomenon 
African American females are disproportionately affected by HIV/AIDS in the 
United States and the District of Columbia in particular. The infection rate continues to 
increase within this group, even though new infections are decreasing overall across races 
and ethnicities. One of the hallmarks and clinical benefits of HIV treatment today is 
achieving viral suppression (AIDSinfo, 2019). Because viral suppression is important, 
health educators and medical providers must educate newly infected individuals on 
engaging in medical care, taking medication as prescribed, and achieving viral 
suppression. Viral suppression means having an undetectable viral load, which according 
to DHHS guidelines (2018) is when an individual has less than 200 copies of the HIV 
virus (RNA <200 copies/mL). The knowledge of AA women at diagnosis regarding viral 
suppression and during the continuum of care will be assessed. Understanding the lived 
experiences of these women and understanding what they know about the goal of 
treatment are both important. In addition, the study will look at the increase in HIV 




The most appropriate design used in this research is a qualitative study wherein 
the people experiencing the phenomenon under study were recruited and asked questions. 
The phenomenology design chosen is appropriate because HIV infection in this instance 
was studied among HIV positive women who experienced the phenomenon. 
Phenomenological inquiry also has a philosophical basis (Giorgi, 2017). There are three 
major phenomenological traditions, namely, transcendental, existential, and hermeneutic 
(Moustakes, 1994; Kafle, 2011). Transcendental phenomenology is the original form 
postulated by Husserl with the premise that experiences will have to transcend to reality 
(Sheehan, 2014; Moustakes, 1994). For this philosophical concept/focus, the researcher 
will suspend personal experiences and knowledge of the studied phenomenon so as to 
understand the “lived” experiences of the participants. Personal opinion is suspended, and 
the phenomenon is instead strictly and descriptively presented. However, challenges that 
are inherent in this school of thought is the practicability of suspending personal opinion 
using bracketing and epoche (Kafle, 2011). Transcendental phenomenology demands the 
suspension of judgment about reality and includes an actual intentionality of 
consciousness (Percy, Kostere & Kostere, 2015,).  The existential phenomenology school 
of thought argues that only an engaged individual will see the world and rejects the idea 
that a researcher should suspend personal experience in order to be effective in carrying 
out such research. (Kafle, 2011).   
The third tradition is known as hermeneutic phenomenology. This school of 
thought was presented by Heidegger and is described as a deviation from Husserl. 
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Heidegger simply posits that suspending personal opinion is difficult, and there should 
rather be an interpretation of the descriptive. A hermeneutic phenomenological approach 
is applied in this particular study and seen in two ways. The first stage was to make sense 
of what a participant is experiencing and the second stage is to interpret those experiences 
critically (Taylor, 2015). According to Mjorud, Engedal, Rosvik, and Kirkevoid (2017), 
interpreting the transcriptions of interviews of participants emphasized the hermeneutic 
aspect of the methodology. This school of thought considers the researcher to be a 
signpost that points to understanding the phenomenon during the study so as to ensure 
and enhance the knowledge of the essence and meaning that has been experienced by the 
participants (Kafle, 2011).  
In this study, the hermeneutic approach allowed the researcher to understand the 
participant’s inner essence, their internal subjective experiences, and at the same time, 
make sense of the phenomenon (Subramoney, 2015; Taylor, 2015). In this case, the 
phenomenon is actually living with HIV/AIDS. Also, for this method of research, 
participants’ own cognitive processing structures are also involved. It becomes a 
conscious experience to understand the reason for the phenomenon (Percy, Kostere & 
Kostere, 2015). This methodology hinges on the assumption that reality consists of 
certain phenomena as understood by a person’s consciousness. The uniqueness of 
individuals affects the way they process information, how different individuals will 
attribute meaning to similar life experiences, and how the phenomenon is ultimately 
understood by the person (Burkholder, Cox, & Crawford, (Eds.), 2016; Rudestam & 
Newton, 2015; Kelly, n.d.). These processes are called interpretive phenomenology.  
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A study guided by interpretive phenomenology identified the participants who 
have the relevant lived experiences in order to utilize those experiences and their 
meanings for further development of effective policies for practice. Information obtained 
using this approach was subjective. However, it does provide in-depth understanding as 
the individual experiences and meaning of the phenomenon are described in terms of 
“what” the people experienced and “how” they experienced it. (Creswell, 2013; Crosby, 
DiClemente, & Salazar, 2006). 
Role of the Researcher 
 An interpretive (hermeneutics) phenomenology approach was applied to this 
study. Interpretive phenomenology often involves four steps: Bracketing, intuiting, 
analyzing, and describing. This process means that the researcher must remove all 
preconceived ideas about HIV among AA women so as to investigate and collect an 
unbiased dataset and separate what is known of the phenomenon from the pure 
phenomenon (Van Manen, 1990). During the intuition/intuitive stage, the researcher 
focuses directly on the phenomenon and the meaning ascribed to it by those who have 
experienced it, while still continuing to analyze the data until its essence is obtained. 
Researchers are immersed in the phenomenon and must analyze it using open, axial, and 
selective coding, categorizing the data into themes until an identifiable essence is 
obtained (Tavallaei & Talib, 2010). The end stage or end process involves producing a 
description or definition of the phenomenon being studied. A phenomenological 
approach studies conscious lived experiences without theories or objective reality, but 
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rather according to how the people who are the participants in the study constructed their 
meaning of the experience.   
As the primary data collection instrument, I disclosed personal biases and 
assumptions (Creswell, 2014). I have worked on HIV/AIDS issues for more than twenty 
years. Therefore, as a researcher, I acknowledged my personal bias, beliefs, and values 
and stated them upfront. This process was needed to understand the perceptions and 
assumptions that I bring to the table (Janesick, 2011). The strategy of reflexivity was 
utilized to enhance credibility (Draper & Swift, 2010). It was my role as the researcher to 
ensure that the method of data collection was appropriate and can answer the central 
question of the study. Researchers’ techniques and strategies for sampling was very 
critical and important in all qualitative studies. 
 I do not provide clinical care to HIV positive women in the District of Columbia, 
thereby reducing the concerns about a power relations conflict. As a project officer, the 
majority of my duties related to project design, technical assistance, and organizational 
compliance with Federal and State public health laws. Due to the demographics and 
characteristics of the population of this particular study, I intend to provide incentives for 
transportation and lunch. These facilitated participants’ travel to the interview location. 
Smart-trip cards ($5.00) and a $25 for lunch was provided, with a total cost of $30 dollars 
for each participant. 
Methodology 
Most times, identifying a relevant research method is a difficult task. The most 
applicable tool must be geared towards obtaining the right information to answer the 
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research question. In this qualitative study, the right participants who have experienced 
the phenomenon must be identified and sampled. 
Participant Selection Logic 
HIV positive AA women residing in the District of Columbia are the population 
that was studied. Participants have lived with HIV for more than 10 years. These are 
generation X’ers who were born between 1960 and 1980. It is the generation that 
witnessed the onset of the HIV epidemic, lived through the early days when there was no 
treatment, but only comfort measures available when people died. The generation also 
witnessed and lived through the era of thirty different types of effective antiretroviral 
medication being developed with a consequent improved longevity. 
Purposeful Sampling 
Purposeful sampling targets a pre-existing group and usually depends on the 
research question (Crosby, DiClemente & Salazar, 2006). The most practical and best 
strategy for this particular phenomenological approach is to use group-characteristics 
sampling, and specifically search for maximum variation (heterogeneity sampling). The 
purposeful sampling technique selects a wide range of cases to gain good variation in the 
dimension of interest with two purposes in mind. The intention was to document diversity 
and also important common patterns across that diversity. Patton (2015), however, noted 
a problem with this type of sampling, as it is often difficult to select a sample that is 
representative enough of the population. This issue might lead to having a sample that is 
homogeneous and not heterogeneous. At the same time, Patton suggested ways to 
maximize the diversity, namely, by constructing criteria selected from different sites and 
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locations. In order to have a representative sample of the women who have a specific 
phenomenon, purposeful sampling was the most appropriate way to ensure that only 
members of the targeted group were selected.  
Inclusion Criteria 
The following were eligibility criteria for all participants included in this study. 
All participants were:  
•  HIV positive, 
•  African American women, 
• Between 35 and 60 years old, 
• Reside in the District of Columbia, 
• Lived with HIV for 10 years or more, and 
• Attending one of the Ryan White funded medical care clinics. 
Participants came from already known clinics providing HIV care. Each 
participant provided self-reported clinical information and demographic information used 
to confirm that criteria were met. Another strategy applied in this study was triangulation 
of data. Clinical outcomes for HIV positive AA women were extracted from DC 
Health/HAHSTA Surveillance system. The data was used to triangulate information 
obtained from the in-depth interviews during the primary data collection. The researcher 
obtained approval from the DC Institutional Review Board for Public Health (IRBPH) for 




According to Draper and Swift (2010), qualitative research looks for theoretical 
generalization instead of empirical generalization and does not require a large sample size 
to accomplish that goal. Small numbers from a rich source of information are ideal. 
Sample size is an essential part of designing any study, and according to Buckholder 
(n.d.), a researcher must ensure that the essential components are contained in the sample. 
Choosing the sample size in qualitative research was a challenge and does not need 
power calculations, which are usually linked to quantitative research design (Buckholder, 
n.d.). The golden rule is to have a sample that is large enough to obtain answers to the 
research question and not so large as to hinder successful in-depth analysis (Draper & 
Swift, 2010). A sample size should emerge within a framework of clearly stated aims, 
approach, and goals, and also be dependent on the resources available (Luborsky & 
Rubinstein, 1995). According to Patton (2015), 6-10 participants are an ideal number for 
a proper phenomenological qualitative interview size. 
In this study, a sample of 10 HIV positive AA women were drawn from the 
District of Columbia. Ryan White programs already serving these women were 
approached. Many of the organizations provide outpatient ambulatory health services and 
medical case management to residents. The main organizations that serve the majority of 





The strategy for this study meant that I started interviewing as soon as IRB 
approval was obtained. Each interview was analyzed, as more interviews were being 
conducted. This snowball type of analysis continued until no new information was 
obtained from new interviews. This was the saturation point when interviewing stopped 
(Kumar, 2005). Saturation is accepted in qualitative research, but its operationalization 
depends on the methodology. Saunders et al. (2018) identified four distinct ways of 
operationalization to ensure that further data collection and analysis does not yield any 
new information. They concluded that a saturation point should be consistent with the 
research question. This study conducted 10 in-depth interviews. However, I monitored 
for saturation point for data collection and analysis. I continued to interview and analyze 
until no new information was identified and further data collection and analyses did not 
contribute new information and are thus more interview was not necessary. 
Instrumentation 
This is the process of identifying research tool that could specifically be used to 
gather data in this qualitative study. There are different types of tools available for use. 
The most common tool applied here is the semi-structured interview protocol. Another 
instrument applied include aggregated clinical data from DC Health used for 







I developed the interview questions and protocol for the study. Constructs 
selected from resilience theory and empowerment theory were utilized to design the 
interview questions. Jacob and Furgerson (2012) suggested that interviewers ask 
questions in a particular order with easy questions asked before more difficult ones. The 
interview protocol was also flexible enough, so it can be revised on the spot when 
something interesting but not part of the script emerged. I used a script to start and end 
each interview. An expert panel and peers earlier validated the interview questions. The 
questions were also distributed to three expert researchers for their input on the content. 
This process was to ensure that the questions exactly result in gathering answers to the 
noted research questions. Another validity strategy to determine ease of comprehension 
was to administer the questions to peers also.  
 Recruitment, Participation, and Data Collection Procedures 
Solicitation to participate was advertising on fliers and brochures. These were 
made available at different organizations that receive money from Ryan White funds to 
serve people who are HIV positive.  Information about the researcher and her contact 
phone number were included on the fliers. Another strategy for recruitment was through 
medical providers who shared the study opportunity with their patients and contacted me 
about any willing participant. On a personal level, I approached patients who have 
publicly shared their HIV status that met my study criteria and ask for their participation. 
DC HIV Planning Commission on HIV/AIDS was approached with the flier to distribute 
to their contacts for interested participants to contact me. 
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Data collection method. 
Usually, a research interview is a logical sequence that is actively utilized in the 
research process. A nine-step interview process, as itemized by Creswell (2013), includes 
the use of open-ended questions that are focused on the central phenomenon being 
studied. Interview is an art of conversing used to obtain information (Patton (2015) and 
also an exchange of conversation between two or more people. Types of interviews 
include responsive interviewing, creative interviewing, active interviewing, portraiture, 
and reflective interviewing. Alshenqeeti (2014) defined the process as one that 
encourages interviewees to answer questions correctly. All interviews in this study were 
conducted one-on-one and audio recorded with appropriate equipment. The interview 
protocol validated by experts guided the discussions.  
Other strategies of good interview skills included identifying quiet location where 
a participant felt comfortable and safe, then administering and obtaining consent from the 
interviewee. The interviews were conducted in quiet safe rooms at clinics where 
participants receive clinical care. Only one interview was conducted in a private office 
space. The researcher actively listened during the interview process, was courteous and 
respectful, and ensured that the participant’s time was respected (Jacob & Furgerson, 
2012). Participants signed the consent to take part in the study. This consent form 






Primary data collected through interviews.  
Data was collected from participants in the District of Columbia by using 
interview questions that followed well scripted protocol. I interviewed participants 
individually. The interview responses were audio recorded and later transcribed. This was 
a one-time, 60- 90 minutes in-depth interview with each participant. The interviews were 
completed within six weeks of the first interview. The first interview was conducted on 
September 10 and last interview was October 22, 2019. This ensured that the data was 
collected within the same timeframe so as to reduce any effects of adverse weather, 
political developments, or other events that may influence any responses. Completing the 
data collection within six weeks ensured that the data also remained relevant within the 
same timeframe. Participants availability were accommodated as the interview sessions 
were scheduled. Data was collected using open-ended interview questions that were 
audio-recorded and then transcribed.  
During the interview, participants were asked to recall medical information for the 
timeline that relates to them. For example, if they were diagnosed in 1990, the participant 
was asked to recall their CD4 count at diagnosis, current CD4 count, viral load at 
diagnosis, current viral load, the first medication regimen they started, current 
medication, when they became engaged in HIV care, and any other pertinent information 
relevant to their lived experience. All these responses formed the bulk of the data that 
was analyzed and validated through data gathered from DC Health during the 




Data for triangulation. 
Another source of data for this study came from the District of Columbia Health 
Department (DC Health). Clinical records, specifically viral loads, CD4 counts, of 
African American women who meet the criteria for the study were extracted from the 
Department’s surveillance database. The system is highly protected with physical locks 
and electronic passwords. Anyone accessing the information was directed to a locked 
room to extract the information, and no identifying information leaves the room. For this 
study, there was no protected health information from the system and the surveillance 
team pulled the aggregated data for triangulation for the researcher. 
Clinical data on the participants was used to triangulate and validate the interview 
responses. Patton (2015) noted that triangulation is a relevant method for confirming 
consistency in the results. The time series data extracted were newly diagnosed AA 
women diagnosed in 2000, and their clinical data in 2000, 2010, 2015 and 2018. This 
process helped to identify for patterns of viral suppression and engagement in care for 
participants, and supports the clinical picture used to validate the interviews. The 
information from this objective data also support some of the self-reported responses. 
Most of the information collected by the Department of Health came through State 
Laboratories and the mandated infectious diseases reporting system. The instrument used 
by medical laboratories and medical facilities to report infectious diseases were already 
validated and used nationally. Therefore, there was no need to validate any secondary 




Follow-up plan if few participants were recruited.  
In the event that I was not able to recruit 8- 10 participants, I was to solicit the 
help of the Ryan White Consumer Advisory Council of DC Health, which met 
periodically. Another alternative strategy was to attend some of the support group 
meetings hosted by various organizations, so I could explain to their attendees the need 
for the study, the benefits for AA women, and the inclusion of incentives that covered 
transportation and lunch. A last resort measure to ensure that I recruited the number of 
women needed would have been to increase the age gap being studied to include older 
AA women. All these contingency measures were not implemented because I recruited 
the exact number of participants that I needed and stopped. 
Debriefing, exit process, and follow-up interviews.  
After each interview, each participant was debriefed on the next processes of the 
study and thanked for their participation.  The researcher reiterated the benefits of the 
study and the commitment that the participant will receive a copy of the study when 
completed. In addition, an incentive package was provided to each participant. Each 
participant will also be notified on how she had contributed to social change through their 
act of participation. Part of the debriefing process included providing the researcher’s 
contact information to the participants. Participants willingness to come back during data 




Data Analysis Plan 
Data was analyzed and grouped into specific research questions and how each 
question was answered. As the interview questions were designed with various research 
questions in mind, the collection of information was grouped in the same format. There 
were groups of responses on lived experiences related to self-efficacy, resiliency, 
empowerment, stigma, HIV as a gender issue, medication, and treatment adherence. 
Another group included the women’s experiences and knowledge of viral suppression at 
diagnosis and along their continuum of care. Clinical data for the women was arranged in 
tables to reflect clinical outcomes in a time series that runs from diagnosis to 2018. There 
were tables of descriptive statistics on the demographics of the participants. 
In this phenomenological research, data was managed by hand coding. Coding is 
a process of combining and analyzing data into categories or themes, to increase the ease 
of information retrieval at a later stage for comparison (Taylor & Gibbs, 2010, Adu, 
2013). While a code can represent a phrase or word that pulls the meaning of each bit of 
data. It is important, therefore, that the process is done as thoroughly as possible. 
Although interviews generated lot of data, thorough reading of the transcripts several 
times helped to reduce codes into a manageable number without missing important 
information. Creswell (2013) advised a good approach is to start lean and broaden later. 
Gibbs (2010) discussed many ways to approach coding, namely, line by line, sentence by 
sentence, several paragraphs together, paragraph by paragraph, and whole document 
coding. This process helped the researcher to be thorough in coding and all subsequent 
analysis. After all the information was collated, the most significant comments were 
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grouped into relevant recurring statements and themes. Then, I wrote a textual description 
of the participants’ experiences, along with a structural description or the context of each 
experience. The two write-ups were then be merged for a composite description of the 
participants’ experiences of HIV disease. The analysis included examining the diversity 
of the sample. Each case was unique, as the researcher looked for common patterns or 
traits that unify even in diversity except that all of the cases were HIV positive. There 
was no discrepant case encountered. 
Issues of Trustworthiness 
Clinical data on the AA women in this study were used to triangulate the 
qualitative data collected. Patton (2015) and Creswell (2014) proposed that qualitative 
researchers used the concept of reflexivity, which advises researchers to be conscious of 
their biases, values, and experiences in order to write and communicate more objectively. 
The credibility of data and the findings in any research is key. This focus propels 
researchers to put solid strategies in place to ensure that all data is credible, validated, and 
trustworthy. Creswell (2014) discussed various methods used for ensuring credibility, 
such as ensuring that codes are cross checked, checking transcripts for errors, and 
performing useful triangulations. 
Triangulation of data enhances the building and integrating of many sources to 
validate the information collected during interviews.  Four types of data triangulation will 
help ensure the validity and credibility of data, namely, triangulation of qualitative 
sources, mixed triangulation, analytical triangulation, and the theory/perspective 
triangulation (Patton, 2015. In this study, analytical triangulation was conducted. Data 
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from DC Health was crosschecked with medical information obtained during the 
interviews. Triangulation helped the researcher make sense of any inconsistent or 
conflicting data. Another method for ensuring trustworthiness was peer review. This 
aspect involved passing the information through peers who acted as fact checkers and 
through peer debriefings (Creswell, 2014). In addition, this study methodology is 
reproducible, as all the steps for data collection were clearly elucidated. I kept a journal 
of the daily and weekly activities being carried out during data collection, interviews, and 
communications to ensure accurate information was obtained.  Peer support was also 
utilized to discuss the credibility of the information obtained. 
Another action taken to ensure trustworthiness of the collected data was checking 
the transcripts of the recorded interviews and identifying alternative words for the ones 
provided. I also engage in member checking, which Hadi and Closs (2016) described as a 
form of ongoing validation. This was informally with the participants and during the 
interpretation of the collected information. No participants were contacted further to 
verify the information that they provided during their personal interviews. 
In addition, I used reflexive writing, which basically means putting my feelings in 
control to enable a full objective analysis void of any bias to be produced. This focus was 
needed especially during the interpretation of the findings. Hadi and Closs (2016) advised 
that researcher apply the same critical analysis to the researcher’s own knowledge of the 




This study required the use and collection of very sensitive information where 
confidentiality is important. Participants meet the inclusion criteria, consented to 
participation, and signed a confidentiality form. The protocols followed in this study was 
clearly documented to enable future researchers clearly follow the steps used in this 
research and potentially use them. 
Research on HIV/AIDS always has unique ethical and legal aspects to consider. 
Due to the nature of the disease and the stigmatization of the community associated with 
the infection, many HIV positive persons do not disclose their status. It is also illegal and 
against HIPAA rules to conduct research and disclose someone’s medical status without 
consent. All participants signed consent forms. The contents of the study/analysis was 
explained in detail to participants before signatures were obtained. Moreover, in this 
qualitative research, ahead of the data collection, all legal and ethical issues were 
discussed with each participant along with the strategies to mitigate any issue discussed. 
Two Institutional Review Board (IRB) agreements were obtained for undertaking 
this study. IRB approval number from Walden University is 08-29-19-0450160 while DC 
Health IRB approval number is IRBPH # 2019-18. Approval by each institutional review 
board was obtained as required for research with human subjects. A brief description of 
the study proposal was also submitted to the DC Health Institutional Review Board (IRB) 
as the data for triangulation was collected from the DC Health surveillance system. The 
methodology was itemized to ensure that it posed no harm to any of the participants. 
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After gaining IRB approval from both institutions, the study started and there was no 
change in the proposed methodology that needed correction or amendment. 
In addition to the ethical issues mentioned above, bias was another key problem 
that was seriously considered. Bias is the tendency to bring prejudice and subjectivity 
into the research process that may affect the findings and/or make answering the research 
questions questionable or impossible (Pannucci & Wilkins, 2010). This issue can be 
introduced at any point in the data collection. In such a case, the researcher must be able 
to set aside personal assumptions about AA women and HIV infection, set aside societal 
moral codes, and be fully open to new ideas. 
I ensured that any information provided by participants was treated as confidential 
unless required by law for disclosure. I also respected all privacy laws and followed the 
code of ethics of the health education profession (Fertman & Allensworth, 2017). To 
ensure cultural appropriateness and acceptability, all effort was made to respect each 
participant’s religious beliefs, socioeconomic status, family style, and values. (Fertman & 
Allensworth, 2017).  
All participants were given clear information on the voluntary nature of 
participation and their ability to withdraw at any time from the study. There was no 
coercion to participate. All the data collected were stored in a locked cabinet and 
electronic information password protected. The use of a $30 incentive for transportation 
and lunch was explained to all participants. This modest fund was to help and assist the 
participants’ ability to take a metro train or bus to the location of the interview and by no 
means a payment for their participation. And participants were also informed that 
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receiving these incentives did not bind them, as any withdrawal from the study can still 
be exercised even after an interview had been completed. 
Summary 
An interpretive (hermeneutics) phenomenology approach was applied to study the 
lived experiences of HIV positive AA women who reside in the District of Columbia. 
Study of the members of this population, particularly due to their HIV status and the use 
of their patient health information and records, necessitates the review and approval of 
the Walden University IRB and the DC Health IRB. Collection of data was twofold 
through an interview instrument that I developed and used secondary data from DC 
Health. The interview questions were reviewed by experts in the field of HIV research, 
who validated the questions to determine whether they had the capacity to elicit correct 
information when posed to the participants. Peers reviewed the comprehensibility of the 
interview questions to ensure they are at a 9th grade reading level. Secondary data on 
health outcomes was collected from DC Health, primarily for triangulation purposes. The 
methods of recruitment were carefully considered and outlined, and inclusion criteria 
elucidated. Data was manually coded, and nodes created When all data had been 
collected and collated, the related analyses were conducted to look for themes and 
findings that were then presented in Chapter 4. These results answered the research 
questions on the resiliency of women and offer further insight into the lived experiences 




Chapter 4: Results  
Introduction 
In Chapter 4, I describe the results of the interviews that were conducted 
individually with 10 AA women in the District of Columbia who were HIV positive. 
Using a phenomenological approach, the purpose of the study was to learn and 
understand the lived experiences and clinical outcomes of HIV positive AA women with 
an emphasis on their perspectives related to becoming informed about viral suppression 
at or after the time of diagnosis.  Another component of this study was an examination of 
how gender contributed to women’s vulnerability to HIV infection. Theories of resilience 
and empowerment were considered in analyzing the responses of the interviewed women 
who have lived with the disease from reproductive age, often had children, and have dealt 
with the disease at the same time for 10 years or more. 
The open-ended research questions were designed to elicit information on the 
lived experiences among the study participants. Three main questions drove the direction 
of the study with additional subquestions.  
Research Question 1: What is the lived experience of African American women 
with HIV/AIDS in DC? 
Subquestion 1a: What are their daily routines of medication adherence? 
Subquestion 1b: What challenges constitute stigma and discrimination that they 
face in daily living? 




Research Question 3: How do HIV positive women explain/describe the high rate 
of HIV infection among African Americans in the District? 
In this chapter, I discuss the setting of the interviews at the various organizations, 
including information on who participated. I address the demographics and 
characteristics of the participants. I also discuss the data collection methods, data 
analysis, evidence of trustworthiness. Finally, I present the results of the interviews and 
key findings.  
Research Setting 
All interviews were conducted in a private and quiet location. Nine interviews 
took place at community clinics located in the heart of the District. One interview was 
conducted in Ward 2 in a private office space. The interviews were conducted based on 
participants’ support groups or clinic appointments to ensure it did not infringe on their 
daily schedule. The participants chose dates and times to schedule the interviews as were 
convenient for them. The interview dates spanned from September 10 to October 22, 
2019. The interview rooms were medical case management offices or small conference 
rooms which were private. The rooms were very comfortable and quiet, away from the 
clinic activity. There were also medical case managers across from the hall if needed and 
clinic was in session if any of the women needed any intervention due to stress during the 
interview. None of the participants displayed signs of stress requiring intervention. 
However, two participants became emotional as they recounted their experiences stating 
that they had not been able to narrate their experiences in a long time and talking about it 
brought some relief. One of the two participants who became emotional stated that this 
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was her first time in more than 15 years discussing the experience in full and appreciated 
the opportunity. The voice recorder on my HP computer was placed next to myself and 
the interviewee to allow for eye contact and acknowledgement during the sessions.  
Demographics 
The 10 participants are all residents of the District of Columbia, the location for 
the study. Seventy percent (70%) of the participants were either born in Ward 8, Ward 7, 
raised in Ward 8 or just moved to Ward 8. Together, Wards 7 and 8 are areas of high 
HIV/AIDS prevalence in the District of Columbia (District of Columbia Department of 
Health, HIV/AIDS, Hepatitis, STD and Tuberculosis Administration, 2016). The study 
was open to any DC resident who was female and matched the other study eligibility 
criteria, but many of the women who volunteered to speak about their experiences and 
were interviewed lived in Ward 8. Among the others, one was from Ward 7, one was 
from Ward 1, and two were from Ward 5 respectively. The location of respondents is 
important, as findings are relevant to targeting interventions at the heart of HIV infection 
in the District.  
Participant age ranged from the youngest at 39 years old to the oldest at 60 years 
old. All the women had lived with the infection for 10 years or more. They were all 
infected during reproductive ages of 22 years up to 45 years and 60% were diagnosed 
during pregnancy.  Among the 10 women, three were married and lived with their 
spouses. Seven participants reported they were currently single, had never been married, 
and were not in a committed relationship.  Six single participants reported having and 
raising four to a total of 21 children without a spouse.  Half (five) of the participants were 
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employed and had jobs in the healthcare sector counseling other women as peer support 
and the other half (five) were unemployed. The participants’ level of education included 
no education, 10th grade, high school attempted, high school diploma, some college, to 
master’s degree.  
Table 1 
Demographics of Participants 




1 53 Some 
College 
Employed Single 8 
2 43 High School Employed Married 5 
3 44 Some 
College 
Employed Single 5 
4 48 No 
Education 
Unemployed Single 8 
5 40 High School Unemployed Single 8 
6 55 10th Grade Unemployed Single 8 
7 39 High school Unemployed Single 7 
8 55 Some 
College 
Unemployed Single 8 
9 43 Associate 
Degree 
Employed Married 8 







Walden University IRB approved an interview protocol of 42 questions. I 
designed the questions to evince from the study participants answers to the major 
research questions. Primary data were collected from participants during face-to -face 
interviews with open-ended questions. The interview sessions lasted from 40 minutes to 
60 minutes. The setting appeared to be comfortable for the participants as they 
individually volunteered answers to every question asked. Each participant was only 
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interviewed once. In addition, participants were asked if the interview could be recorded 
for ease of transcription. A voice recorder in an HP computer was used to record all 
interviews and later transcribed verbatim.  
Secondary data was collected through the surveillance system of DC Health. DC 
Health and Walden University IRB approved secondary data for triangulation. Data of 
newly diagnosed AA women from the years 2000, 2010, 2015 and 2018 were extracted 
(Table 2). The specific variables were the median viral load at diagnosis, median viral 
load at the end of each of the years, median CD4 count at diagnosis, and median CD4 at 
end of the each of the years. 
Table 2 
Data for triangulation from DC Health/HAHSTA 
Variables 2000 2010 2015 2018 
African American Women 
diagnosed with HIV 
201 123 108 105 
Ages 25 - 34 73    
Ages 35 - 44 77    
Ages 45 - 54 46    
Ages 55 - 60 5    
Median CD4 Count at 
diagnoses 
154.5    
Median Viral load at 
diagnoses 
1205    
Median Viral load at end of 
year 
1205 20 20 20 
Median CD4 at end of the 
year 






 In addition, a cohort of data from all newly diagnosed AA women in 2000, 2010 
and 2018, were extracted. The specific variables of the same cohort were median CD4 
Count and viral load at end of the years 2010 and 2018. The range in ages of newly 
diagnosed in year 2000 were also extracted from the surveillance system. The form below 
was used to extract data from the DC surveillance system for newly diagnosed AA 
women. The collected information was used to discuss the self-reported narratives 
collected from face to face interview of participants. 
Table 3 
 
Women newly diagnosed in 2000 (Ages 35 – 54) through 2018 
 
Variable 2000 2010 2018 
CD4 count end of 
year 
156 586 612 
 
Viral Load end of 
year 
3687 47 46.5 
 
I attempted to use NVivo software to transcribe the recorded interviews. 
However, after two interview transcriptions, I found that the software output was 
incomprehensible. The transcriptions were not coherent for both the questions I posed, 
and the answers participants provided. Thus, I performed a manual transcription, listening 
to the interviews multiple times and transcribe the recorded interviews verbatim. 
Data Analysis 
All interviews were recorded using ‘voice recorder’, software program in my HP 
computer. I transcribed each interview into Microsoft Word. The first step of the data 
analysis was a careful reading and re-reading of each interview transcript. The intent of 
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this reading and re-reading was to gain an overall idea of the content of the women’s 
responses before proceeding to code the responses.  
Coding is a process of combining and analyzing data into categories or themes to 
increase ease of information retrieval at a later stage for comparison (Taylor & Gibbs, 
2010; Adu, 2013). A code represents a phrase or word that pulls the meaning of a data 
point. It is important therefore that it is done as thoroughly as possible. The approach I 
took was to read the responses line by line, sentence by sentence, paragraph by 
paragraph, and then the whole document. Supported by Gibbs (2010), this approach is 
known as an inductive approach. Thomas (2006) further described it as a process used to 
“condense extensive and varied raw text data into a brief, summary format” (p. 241). 
There were no discrepant cases used in the analysis. Specific codes and 18 themes 
emerged from the data. Appendix A is a is a compilation of the themes and codes 
including important quotations that emphasized responses from participants. In addition, 
clinical data of women in DC, generated from DC Health Surveillance system, were 
arranged in tables in a time series. Data of newly diagnosed AA women from the years 
2000, 2010, 2015 and 2018 were extracted (Table 2). Clinical data of the women at time 
of HIV diagnosis in year 2000 were compared to clinical outcomes in 2010, 2018 and 
self-reported clinical data from participants. Specific clinical variables from the same 
cohort were analyzed. Clinical data from surveillance system of newly diagnosed AA 
women, ages 35-54years, were particularly analyzed because this is the age group mostly 
affected by HIV in the District (Table 3).  
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Evidence of Trustworthiness 
Participants were interviewed individually, each seated in a comfortable private 
room. Evidence of trustworthiness comprised of the credibility, transferability, 
dependability and confirmability of the information collected. The interviews sessions 
had an introductory section, which explained who I am, the purpose of the interview and 
if the participants had any reservation in participation. The consent form was signed, and 
interview conducted. At the end of the semi structured interview, the closing statement 
contained an appreciation message and incentive given for participation.  
Credibility 
The credibility of the data was implemented as stated in Chapter 3. Clinical data 
of HIV positive AA women from DC health were used for triangulation of the qualitative 
data collected. Triangulation enhances integrating other sources to confirm data collected 
through interviews. The DC Health surveillance system that houses HIV data for the 
District of Columbia was used to confirm the self- reported clinical outcomes collected 
from the participants. I applied the strategy of reflexive writing in this analysis. This 
meant that my personal feelings were put in control and that enabled objective analysis 
void of bias. In addition, I confirmed the credibility of the data through cross checking 
personal notes obtained during the interviews with the audio recorded interview which I 
transcribed. To avoid ambiguity of information, during the interview, there was reflective 
affirmation to ensure participant’s information was understood. At the end of the 
interviews, a summary of responses was read back to participants to ensure they were 




A detailed description of the research method was provided to allow for 
replicability by other researchers. There was a rich description of the participants’ 
demographics to enable comparison to other population living in the District of 
Columbia. The data collected was from DC residents. However, the 42 open-ended 
questions in this study can be used in any setting of HIV infection. The ten women’s 
information on lived experience were collected in very private interview rooms in a clinic 
and one in office setting. Each face to face meeting lasted more than 40 minutes. This 
data is specific to AA women in DC but can be generalized to all HIV positive AA 
women receiving treatment in DC. The information and experience can only be limited to 
DC residents due to the generosity of the city making HIV treatment accessible to DC 
residents. The application of the hermeneutic circle in this analysis and triangulation of 
clinical outcome data from the DC surveillance system makes the findings of this study 
generalizable to other HIV positive women from other races living in the District.  
Dependability 
Interviews were transcribed verbatim using Microsoft word. I kept daily and 
weekly activities during the data collection interviews to ensure correct information was 
obtained. Each participant was asked the same questions, time given to ensure 
information obtained was accurate. Participants were also allowed to ask questions before 
and after the interviews. Clarity was also provided in case where the participant may not 
understand the words used. Audio recorder provided data used verbatim to avoid recall 
bias. In addition, each interview was transcribed independently to ensure no information 
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was mixed or credited to the wrong participant. Triangulation of data was conducted. 
Triangulation also helped to make sense of any inconsistent or conflicting data. 
Confirmability 
The strategy to ensure confirmability included description of the participants. I 
searched within the interview transcripts for negative instances that may contradict prior 
data and these were none. All participants provided information to all 42 questions asked. 
Each audio-recorded interview was transcribed within 48 hours and corroborated with the 
interview notes. Triangulation of data was conducted by use of the DC surveillance 
system and for newly diagnosed AA women in, 2000, 2010, and 2018 (Table 2). The 
clinical data was consistent with self-reported data from the participants. Another strategy 
employed here was use of writing memos. This strategy ensure confirmability in 
qualitative study. All transcripts were read many times, line-by-line, sentence by sentence 
to ensure that all ideas are from participants. 
Study Results 
The three main research questions were thoroughly answered through data 
collected from the 10 participants. The results are presented according to the questions. 
There was other subquestions that also proffered answers to the research questions. 
Hermeneutic approach was used for the analysis of the data in understanding the lived 
HIV experiences. Results of this study was collated from all the responses from the 10 
participants who answered 42 open-ended-questions. Eighteen different themes were 




Research Question 1 
The first research question was: What are the lived experiences of African 
American women with HIV/AIDS in DC? Four themes emerged related to this question. 
These themes are: (a) Theme 1: Diagnosed at reproductive age; (b) Theme 2: Adaptive 
ability to lived experience; (c) Theme 3: Intense expectations for cure; and (d) Theme 4: 
Positive strengths that contributes to resilience. The following section addresses each 
them in turn. 
Table 4 
Specific codebook and themes from question 1 
 
Question  Theme Description 
Question 1 1.Diagnosed at 
reproductive age 
2.Adaptative ability to 
lived experience 
3.Era of denials and not 
involved in care 
4.Positive strengths that 
contributes to resilience 
 
Infection at age of planning families and 
future 
Growing up in a family culture 
Denials of diagnosis 
Spirituality as strength to survive 
Self -efficacy  
Empowerment 
Involvement in Support groups 
Relationships 
Receiving the diagnosis and when 
effects of such diagnosis at the time of 
diagnosis and subsequently 
 
 
Theme 1: Diagnosed at reproductive age. The participants were diagnosed 
during various years, the longest lived experience with a diagnosis made in 1992, and the 
shortest lived experience with a diagnosis made in 2007. Nine of the women were 
diagnosed with HIV at ages between 22 to 36 years old and only one was diagnosed at 
age 45 years. Sixty percent of the participants were diagnosed while pregnant (See Table 
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5 for age at diagnoses) and 40% diagnosed at sickness. They had gone for prenatal care 
and got tested for HIV. Participant 5 said that, she was diagnosed at age 23 when 
pregnant with her 4th child. She went ahead to have 3 more babies and one of her children 
is HIV positive. The positive baby was born 18 months before the next pregnancy when 
the diagnosis was made. Participant 4 (diagnosed age -36years) went to a clinic for a 
pregnancy test and they asked her “do you know you are HIV and pregnant right? Until 
that moment, she did not know, saying during the interview, “it was really hard, life 
changing’. Eighty percent (80%) of the participants have children. 
Table 5 






















22 150 1000000 
Cases\\PARTICIPANT 
3 44 30 132 950000 
Cases\\PARTICIPANT 
4 48 36 150 500000 
Cases\\PARTICIPANT 
5 40 23 69 1000000 
Cases\\PARTICIPANT 
6 55 45 3 1000000 
Cases\\PARTICIPANT 
7 39 23 5 1000000 
Cases\\PARTICIPANT 
8 55 28 150 1000000 
Cases\\PARTICIPANT 
9 43 25 2 1000000 
Cases\\PARTICIPANT 
10  60 34 215 1000000 
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Participant 7 (diagnosed at 23years) stated she was losing so much weight and 
could not hold any food and experienced constant blackouts. She decided to go a clinic 
where she was diagnosed with HIV. According to her, “my health deteriorates very bad, 
my mother took me to the hospital… the hospital did not disclose to my mother, I 
explained everything to her’. The age of diagnoses for all the participants were at a 
reproductive age ranging from 22 to 45 years. Many of them were at the period of life 
when they are planning their future when their diagnoses were received. However, 100% 
of the participants discussed the effects of the diagnoses, initial denials, empowerment, 
resilience, and the point of turnaround to embrace the diagnosis and learn to live with the 
disease. 
Theme 2: Adaptive ability to lived experience. Many of the participants were 
not raised in a two- parents households, 50% were raised  only by their mothers, who 
they said were very strong and stood by them through the experience, 20% were 
homeless and going from one foster home to another while growing up, 10% (1) was 
raised by a grandmother and an older sister. The other 20% had relationships with both 
mother and father in the same household. 
For the 80% that had a mother, grandmother and parents in the home, they 
described the positive influence of their backgrounds on surviving HIV. Participant 1 
stated “my mom kept telling me that I have a purpose to live”. According to Participant 2, 
“I was slow to learn… special aid, born drug addicted baby, and was not going to make 
it…I did not know that I was on special aid in school. My grandmother said you are not 
slow or stupid, it is that you learn different than others”. Upbringing and family culture 
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where the participant grew up had some influence on how they have dealt with the 
experiences living with the disease. Some participants had negative influences while 
growing up in the home, such as drug addicted parents, drug addicted single mothers, 
lived in abusive foster homes, but developed adaptive ability which helped to turn around 
all the negative influences somewhere in the HIV journey. 
For some participants, the point of behavior change, turnaround and decision to 
survive HIV was dramatic while others achieved it slowly. However, at the initial time of 
HIV diagnoses, denial was more at the forefront for 80% of the women.  
Theme 3: Era of denials and not involved in care. Many of the women 
described a period of denial after the diagnosis. Out of fear, anger and bewilderment, 
60% of the participants denied the diagnosis and went on with their lives as if nothing 
happened. The ones diagnosed during sickness, once they felt better, or those diagnosed 
during pregnancy, once babies were born, disengaged from receiving treatment. 
Participant 6 said, “I immediately went into denial, did not believe it, I had no feeling”. 
Participant 7 also said, “I was in denial at time of diagnosis and wanted to kill 
everybody… I never had issue accessing care, just not interested, in denial”. It took some 
of the participants sometimes, up to years and Participant 2 specifically stated that it took 
her about 10 to 15 years after diagnosis to get involved in treatment. According to 
Participant 10, “there was nothing to live for, no history, gonna die anyway…did drugs 
heavily for 4 years”. At this denial era, the participants were not involved in HIV 
treatment, which meant, there was increased HIV virus in their community, which may 
lead to more infections among their sexual partners. 
110 
 
Theme 4: Positive strengths that contributes to resilience. Theme 4 tapped into 
strengths that related to resilience. I grouped these strengths into subthemes. The 
subthemes are decision to survive and thrive, drawing on spirituality for strength, 
involvement in support groups, and identifying other supportive relationships. 
Subtheme 4a: Decision to survive and thrive. There was resilience embedded in 
all the responses from the participants. After the initial stage of denial, 100% of the 
participants although still struggling with some individual difficulties, decided to thrive 
and live with HIV. Participant 8 stated “different things were going on in my mind, how 
am I going to raise them, take care of me, provide, all by myself… the father is not there 
on regular basis to help with day to day, so I went through different changes’… I found 
peace in my chaos”. Some of the survival and resilience statements among the women 
included, a decision to live for the children’s sake. For example, Participant 2 shared 
“have two kids to live for, that stayed in my mind, keep my mindset”. Others stated, “my 
kids, its mine kids, I don’t want to just die for anybody to raise them…sick, tired, I’ve got 
to get off my butts, they depend on me to do everything… it is not for me, it is for them 
(Participant 5) and ‘the children are the motivation to stay alive (Participant 7). For some, 
the sheer decision to stay alive and not allow HIV to define who they are motivated their 
interest to engage in HIV treatment. 
Subtheme 4b: Spirituality as strength for survival on the lived HIV journey. 
Spirituality plays a vital role in the lived experienced of AA HIV positive women. One of 
the survival hallmarks is having a relationship with a higher being, often called God. The 
women discussed improving their ability to manage their HIV status through praying to 
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God and having the will to take control and live. Participant 9 was very adamant about 
how God told her that she was going to leave her profession to tell others about the 
disease. She started speaking publicly about the disease in seminars and among young 
girls. Living with HIV was also described as an emotional and spiritual journey. “God 
has kept me going... he is my healer, keep positive attitude, keep my eyes on the prize, I 
will be fine, that what I hold onto” (Participant 4). 
“When I got pregnant with my 3rd child, I went back to church where I started 
from… when I got myself together in the church that helped me to really digest and 
grasp” (Participant 8). There was deep rooted relationship with spiritual leader, who 
functioned as role father model that influenced one of the women. One participant 
decided to stop using drugs that God had things better for her. To the extent that 
Participant 4, will have to pray for the medicine to work before taking her daily 
antiretroviral medication. She stated, “Everyday say a prayer, God let this medicine work, 
God is good”. In all, there is a belief among the participants, that on a daily living, 
involving God will make the HIV experience better.  
Subtheme 4c: Involvement in support group. Among the keys to living well with 
HIV was engagement in support groups.  All the participants mentioned support groups 
as a life saver. Forty percent of the participants are also engaged as peer educators in 
various support groups. According to Participant 1, her support group “is a safe place to 
vent, cry, disseminate information, give each other encouragement”. Having a place and 
people one can relate with without fear of being judged was seen as a critical need for the 
women. Some women do not have families, so instead being in a support group becomes 
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a key factor to surviving. Participant 10 stated “I got involved in many support groups 
and is better”.  ‘This is a disease that cripples you, not just physically but mentally, if you 
are not built for it and don’t have a support system, this is another key factor you have to 
have a support system in place in case anything in life happens, what type of support 
system do you have? That’s the lot of life” (Participant 8). Some called for mental health 
support groups, self-esteem groups, more psychiatrists, including setting up HIV hotlines 
to assist newly infected people navigate the health system to get help. 
Subtheme 4d: Positive relationships. A gender issue raised was the role of men in 
the lives of women after the infection. Some of the participants were able to find love 
again. Among those that found love, whether the men were HIV positive or negative, 
they have been a source of strength in the lived HIV experience. They are not judged by 
their new partners and some because of the role of the men in their lives, have been 
shielded from stigma. In one participant, the spouse was instrumental in her stopping a 
life of prostitution and drugs, According to her, “Plus the dude told me, I come for you a 
lot but I am not coming back no more because you act like you don’t want nothing better 
and I said Oh Oh, I slapped myself up… I said, girl snap out of it, I decided am gonna 
live right, gonna do my part… I met a guy who seemed to care more about me than I 
cared for myself, but I met him in my addiction and prostitution…that my husband, so he 
takes good care of me. We have been married 22 years” (Participant 10). Participant 4 
met her spouse, who is HIV negative and states, “God is good, I found a man that loves 
me, he encourages me to take my medication, he encourages me to keep positive attitude, 
there is life after HIV, really is”. And for participant 9, her HIV negative husband has 
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been the strength she needed to survive the disease. He also publicly acknowledges his 
HIV positive wife further reducing her stigma and shame. “My husband had a T-shirt 
which reads ‘my mate is beautifully made regardless of the HIV’… my husband is God’s 
gift, celebrated 18years of marriage” (Participant 9). Participant 2 acknowledges never 
experienced stigma because her husband in also positive and they work things together at 
home ensuring that their children stays HIV negative. Forty percent (40%) of the 
participants have positive relationships with their spouses and boyfriend, who provide 
emotional strength and support.  
Subquestion 1a 
Subquestion 1a asked, what are their daily routines in relation to medication 
adherence? Four themes emerged related to this question. These themes are: (a) Theme 5: 
Importance of daily medication adherence; (b) Theme 6: Unfettered access to good HIV 
treatment; (c) Theme 7: Intense expectations for cure; and (d) Theme 8: Conscientization- 
personal transformation to engage in HIV care. The following section addresses each 













Specific codebook and themes from subquestion 1a 
 
Question Theme Description 
Subquestion 
1a 
5. Importance of daily 
medication adherence 
6.Unfettered access to 
good HIV care treatment 
7.Intense expectation for 
cure of HIV 
8.Conscientization-
personal transformation to 
engage in HIV care 
Individualized uniqueness in taking 
medication 
The need for a cure 
Good access to HIV care in District of 
Columbia 
The need to survive and not die 
Daily routines of medication adherence 
Access to treatment 
Satisfaction with care 
 
 
Theme 5: Importance of daily medication adherence. The women understood 
the importance of taking antiretroviral medications on a daily basis. They built individual 
skills to ensure adherence. Eighty percent are virally suppressed for many years while 
twenty percent have achieved viral suppression sometime in the journey but currently not 
suppressed. Among the ten women interviewed, each had a unique way of describing the 
daily routine of taking antiretroviral medications. Not taking medication was likened to 
abandoning children in the subway. According to Participant 5, “It is like leaving your 
children in the subway and get off, anyone of them dies, you die”, I take it every day just 
to live for them. I may miss sometimes but I get back to it”. Taking medication daily has 
become part of life, either taking it in the morning or before bed. Some of the women 
who take medication once a day profess how easy and convenient it is to be consistent 
and take just one pill a day. The simplification of HIV medication was a vital factor to 
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living well with the disease especially for women who were infected when there was little 
to no medication. According to Participant 3 “Biktarvy once a day, that’s all”. “One time 
a day with food, I take it in the afternoon, I don’t miss it. Because I take other heart 
medicines” (Participant 2), “I take the medicine every night at 9pm, all the time, if the 
medicine don’t work, it’s out of my control, I don’t have control of anything. The only 
thing I have control is taking it” (Participant 4). “They are in bubble pack, Triumeq once 
a day with food… prefers to take it in the morning as can forget in evening’ (Participant 
10). According to Participant 8, a perfect reminder is to put the medication by the pillow 
in the bedroom “It is by my pillow where I can see it before I sleep”. I see it, grab it and 
take it. If not in my face, I will forget, it is not intentional, if you have a busy life like 
mine”.  
However, taking medication is still a challenge for all the women. This is not 
necessarily because the participants do not understand the importance, rather because of 
other life challenges. Participant 10 has a swallowing problem and Participant 7 can’t 
take pills, shots including cough medicine and she was wondering, “if they make a patch, 
all medicine in one into a patch. They have patches for cigarette, why can’t they make a 
patch for HIV”.  
Despite all challenges in medication adherence, medical providers and other 
health workers who care for the participants play vital role in encouraging adherence. 
Participant 2 stated “the way the medical provider treated me, she gave me the push, no 
excuses, your numbers are good, but you have other health issues”. According to her, the 
provider made her own her care by recommending to “call it your name”.  Then 
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Participant 2 stated that “mine is cocktail”. Using such names made her feel comfortable 
taking the medications and she no longer refers to them as medication but as a cocktail. 
Participant 6 was encouraged by her medical provider to join research study where she 
was treated with utmost respect, became part of the research family, which played vital 
positive role in her being adherent to treatment and medication. 
Theme 6: Unfettered access to good HIV treatment. All of the 10 women 
interviewed are satisfied with access to care and the care they receive in District of 
Columbia. It was unanimous that some places that do not specialize in HIV treatment did 
not do a good job, but wherever they were next referred after being diagnosed provided 
great HIV care. One of the participants made the statement that “DC is a good place for 
HIV treatment…no matter what you have you will never be turned away in DC” 
(Participant 1). Their experiences with HIV treatment in the District of Columbia has 
been very positive. According to participant 6, “I did not have problem accessing care, I 
am engaged in the hospital that diagnosed me, I have been here all these years”. Other 
statements confirming good HIV treatment and access to care in DC include, “I have 
always had good care” (Participant 5),  “I never had issue accessing care, just not 
interested, in denial” (Participant 7) and Participant 9 stated “I am 103% satisfied, Father, 
Son and Holy Ghost.” 
 However, Participant 8 discussed things that might be missing or lacking in DC HIV 
care. According to her “DC don’t have services that really meet anything for people like 
us and when they do, they have different types of rules and guidelines that you have to 
cross all the “t” and dots all the “I”, I got my own wagon but you have to jump all these 
117 
 
hoops just to get some help”. She said this with particular reference to financial help. 
“Right now, its financial challenges, when I tried to get disability, it’s like pulling teeth, 
that is the struggle right there. They want you to be close to death before they give you 
anything. I can close up and lie and say I am mental and get it” Participant 8). Participant 
9 put it succinctly: “From what I understand, some people play the mental health card just 
to get a check”. However, Participant 10 summarized the discussion and put it in a 
different perspective: “We are well and now we are looking for something to complain 
about… because people are mad that they are not paying for their house anymore. 
Because you live longer than they expected you to, where do you think the money go 
come from?”. The participants agreed that the District of Columbia provide adequate 
access to HIV treatment, but HIV positive women have other pressing issues that equally 
need to be addressed in addition to HIV 
Theme 7. Intense expectations for cure. One of the findings in this study is 
during the interviews; some of the participants conveyed a desire for a cure to be 
developed for HIV. Some of the women expressed a desire to be cured and look forward 
to when they could stop taking antiretroviral medications. The women made statements 
such as: “One day, there will be a cure…even though it did not have a cure, I could still 
live a long healthy life with medications and things of that nature” (Participant 6). 
Participant 7 wanted to know if there was a medication to cure HIV, “do you think they 
already have a cure, they need a cure”. Another participant expressed satisfaction with 
the care she received but still need to be cured, “I am satisfied with care but I wanna be 
cured, can they cure us”? (Participant 10). Researches in HIV have continued but there 
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are no news of HIV cure yet and that is a concern for some of the women that believe that 
HIV cure should be discovered sooner than later. 
Theme 8: Conscientization-personal transformation to engage in HIV care. 
All the participants discussed times of denial and powerlessness as well as reaching an 
empowered status. They attributed their empowered status to taking active role in 
learning about the disease, getting involved in support groups, and linking up with other 
women, churches, and other avenues to get information. Participant 9 stated, “I learned 
about HIV, viral load, CD4”.  Participant 9 speaks publicly about the disease in seminars 
and recall an incident at a Walmart store with her supportive HIV negative status 
husband. She stated that she wore a T-shirt written “I am HIV challenged, make sure you 
are not”, while at same time, her husband wore had a T-shirt that read, “My mate is 
beautifully made regardless of the HIV”. Many of the customers and staff at Walmart 
stare at them.  Another participant stated “I found these things by myself, I pitched 
around to find anything that would educate me” (Participant 4). She reflected that, 
“through HIV, I became empowered’ and Participant 3 stated that, “I advocate for 
myself, asks for medicine ahead of time just in case they are needed”. Participant 6 said, 
“this thing wont beat me, I will beat it, I did my part and still doing my part, I am a 
survivor, being here is a testimony that I have survived the disease…I have come a long 
way, as long as am taking my medicine, my virus is suppressed, I can’t stop”. One 
common denominator among the women was coming to a point, when the reality of 
living with the disease was conscientized and the personal transformation to be involved 




Subquestion 1b asked: What constitutes stigma and discrimination faced on daily 
living? Three themes emerged related to this question. These themes are: (a) Theme 9: 
Negative effects of HIV stigma on HIV Disclosures; (b) Theme 10: Stigma, self -
stigma/blame and engagement in care; and (c) Theme 11: Challenges in the ‘lived’ HIV 
journey. The following section addresses each them in turn. 
Table 7 
Specific codebook and themes from subquestion 1b 
 
Question Theme Description 
Question 1b 9.Negative effects of HIV 
stigma on disclosures 
10.Stigma, Self-
stigma/Blame and 
engagement in care 
11.Challenges in the 
‘lived’ HIV journey  
 
Ignorance, fear of the unknown, 
uneducated, gossiping, false rumor and 
hearsay 
Complications of the disease 
Financial challenges 
Taking medications daily 
Swallowing difficulties 




Theme 9: Negative effects of HIV stigma on HIV Disclosures. According to 
participants, stigma and discrimination include ignorance, fear of the unknown, lack of 
education, gossip, the spreading of false rumors and hearsay. One hundred percent 
(100%) of the women acknowledge the presence of stigma in the community. Half of 
them reported having never experienced stigma personally but that they have heard other 
women discuss stigma and personal journeys in their support groups. The participants 
think ignorance and being uneducated about the disease is a major factor propelling the 
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stigma and discrimination. To the extent that a mother would not accept food from her 
HIV positive daughter because she was HIV positive but when a second daughter 
(Participant 3) became positive, the mother had learned a lot about the disease and treated 
the second daughter better than the first. Meanwhile, the second daughter was fearful 
about disclosing because of the mistreatment she witnessed against her sister. But all the 
participants have a very defiant attitude towards people propagating stigma. According to 
participant 5, “it is on them…it is their rumor and ignorance and has nothing to do with 
me”. Other experiences with stigma and discrimination are summarized in the statements 
below: 
• When you tell anyone that you have HIV, the first question they ask is how did 
you contract it, nobody asks how you contract diabetes or other diseases 
(Participant 1) 
• I don’t face stigma on a daily basis, there is too much stigma around, stigma has 
to be broken, know your status is not enough, you must do more than that, that’s 
why I am in the field am working with young women, when I come across them, I 
share my story to give hope’ (Participant 3) 
• There is so much stigma with HIV than any other disease…if they come to me, I 
will ask them what they got, who are you to judge me, what you got? (Participant 
6) 
• Now, I don’t care, work in the hospital, has never affected my job… it took a 




Stigma is a barrier to some of the participants acknowledging the disease within their 
families or in a public space. Stigma affects disclosures for some of the women while 
others speak publicly about their diagnosis and will not be bordered about who is aware 
of the status or not. The participants during individual interviews acknowledged that 
stigma must stop for HIV infection to decrease. 
Theme 10: Stigma, Self -Stigma/Blame and engagement in care. Among the 
lived experiences, that the women shared was stigma, self-stigma/blame and overcoming 
them to engage in HIV care. Self-stigma/blame was expressed as in part being aware and 
having heard about HIV but not thinking that she herself would ever become infected. 
Anger against self and self-blame became a barrier initially to engage in treatment. 
According to Participant 1, “it took me a longtime to forgive myself, the shame of it…it 
is bad enough that outside world to shame you, it is worst, personal shame”.   
However, some of the participants devise measures to deal with stigma. Amongst 
them is keep a circle of other AA women especially in peer support groups. Some 
participants are prepared to defend themselves if disrespected or ignore the attacker. 
Participant 5 stated “I don’t argue with them, whatever you think, run with yourself, it 
does not matter, and they might be messed up themselves’. Participant 6 affirmed that 
there was a lot of stigma in society in general, though not among healthcare providers. 
She added, “if they come to me, I will ask them what they got, who are you to judge me, 
what you got?”. The Participants became empowered to challenge anything that may be 
an expression of stigma in their daily living. Participant 9 shared an experience she had 
while providing education to young women about HIV disease. She stated 
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Recently, I was invited to give a talk in one of my mentor’s shop in a live 
program. I am speaking to a lot of girls. I told them that I was HIV challenged, I 
call it HIV challenged, told them to be careful as young girls. One of the ladies 
stood up. ‘I am taking my daughter out of here, coming here and boasting as if 
HIV is a beautiful thing’. I was in shock; I was messed up and held my hand. 
Before I could put it down, two other ladies stood up, I am not a part of this, you 
people are dangerous to us who are normal. 
According to Participant 9, in the live meeting, she asked the group if anyone wanted to 
leave because she must complete her task. And she said,  
Before I continue, does anyone wants to leave because these ones want to stay in 
their mindset, I am here to let you know we have medications, they start out with 
one pill and now we have more than twenty. 
According to this participant, in her eighteen years of living with the disease she had 
experienced stigma only about three times. All participants in this study expressed full 
engagement in HIV care despite the stigma in the community. 
Theme 11: Challenges in the ‘lived’ HIV journey. For many of the participants, 
there are difficulties faced on a daily basis. Although all participants expressed positive 
attitudes towards dealing and living with the disease, they unanimously agreed that there 
are difficulties in the journey that is unique to HIV. Participant 4 stated, “living with HIV 
is really hard, life changing…this is disease that cripples you not just physically but 
mentally… the mental aspect of HIV is bigger than the physical, the mental and the 
physical needs to go together”. For Participant 8, it “triggers feelings of depression” and 
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Participant 6 expressed having, “mental health problems, depression…had bouts of 
depressing modes”.  
Another challenge is taking medication. The newest antiretroviral medications 
have less intense side effects and are easier to take, especially the one-a-day pills. No 
matter how simplified the regimen might be, some participants continues to have 
problems physically swallowing the medication. “Not great at taking medicine, because 
the pills are huge, they stuck in my throat” (Participant 10). Participant 7 would prefer the 
medication to be patch. “They have patches for cigarette why can’t they make a patch for 
HIV?”. Participant 5 has been struggling with medication adherence and expressed 
frustration stating, “the only issue was to adjust to taking medications daily, taking the 
medicine is the greatest challenge, I forget to take them many times, not taking them”. 
Despite having a positive attitude towards dealing with the effects of the disease 
on daily living, the women reflected on the devastation that the HIV diagnosis has had on 
their lives. “You don’t die with HIV but all the complications that comes with it, now I 
understand, that’s the scary part”, (Participant 4).  It is a life-altering event, often 
resulting in starting life afresh with new friends as old ones disappears. There are basic 
housing and financial challenges that are on top of dealing with an HIV diagnosis, 
especially in DC with its rising housing costs and overall high cost of living. Many of the 
interviewed participants are single (70%), with children (80%). Half of the interviewed 
women are unemployed. According to Participant 8, “housing is a challenge especially 
raising 4 kids, you have to drag them from place to place, then they put you out, you 
move to another”. Participant 10 offered a possible reason for the housing challenge, 
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“Cause people are mad that they are not paying for their house anymore, because you live 
longer than they expected you to, where do you think the money go come from?”. Other 
issues going on in someone’s life may affect engagement in HIV care sometimes, but all 
interviewed participants are engaged in HIV treatment. 
Research Question 2 
The second research question was: How do HIV positive African American 
female describe/explain viral suppression? Two themes emerged related to this question. 
These themes are: (a) Theme 12: Importance of viral suppression; and (b) Theme 13: 
Improved clinical outcomes. The following section addresses each them in turn. 
Table 8 
Specific codebook and themes from question 2 
 
Question Theme Description 
Question 2 12.Importance of 




Knowledge of viral suppression at 
diagnosis 
Current understanding of viral suppression 
Improved CD4 count  
Improved immune system 
Achieving viral suppression and improved 
CD4 count among newly diagnosed ages 35 
-54 years from year 2000 to 2018 
Clinical outcome evidenced by self-reports 
and medical records 
Clinical outcomes evidenced by 
triangulation data from DC Health 
 
Theme 12: Importance of viral suppression. All the 10 participants 
acknowledge the importance of virally suppressed. Each person had achieved viral 
suppression at least one time during the course of her HIV journey. Eight (8) of the 
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participant’s self- reported as currently virally suppressed. The 2 participants not virally 
suppressed are at 540 and 119000 HIV copies, respectively. One (1) has been off 
medication for the summer and the other off medication for 3 months. The goal of HIV 
treatment is to achieve viral suppression. Achieving this status reduces inflammation and 
is associated with various positive clinical outcomes. 
Subtheme 12a: Knowledge of viral suppression at diagnosis. In this study, what 
the women reported through the interviews as being taught at diagnosis especially with 
reference to the importance of viral suppression, was assessed. Some of the participants 
indicated that they did not receive any education on importance of viral suppression at 
time of diagnosis. The experiences of the women with particular reference education of 
viral suppression at diagnosis was unanimously negative. Seventy percent (70%) of the 
women stated they were never taught at diagnosis the importance of engaging, remaining 
and achieving viral suppression. Interviewed participants made clear statement below of 
not receiving vital information at time of diagnosis:  
• “I did not learn about viral suppression and that HIV affects aging” (Participant 1) 
• “No education on viral suppression at diagnosis. The place that first diagnosed did 
not discuss viral suppression… first diagnosed virus was in millions, dying” 
(Participant 2) 
• “They did not teach me anything but refer me to teaching hospital clinic” 
(Participant 3) 
• “At diagnosis, they did not say anything that stuck” (Participant 4) 
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• “No one communicated diagnosis in small clinic, here you go, HIV pamphlet and 
here you go with lots of people in the waiting room looking at your HIV 
pamphlet” (Participant 5) 
• “The thing that messed me up was that I did not have a social worker, I did not 
have help, I did not know nothing” (Participant 9), 
• “At that time, they were just trying to save our lives” (Participant 10) 
However, 20% of the women acknowledged receiving some general information 
on HIV but they either were not in the right frame of mind to receive any education 
and/or were much more focused on making sure that their babies were not born with 
HIV. According to Participant 3, she was told “If you take this medicine, you will live 
longer, and baby won’t have it”.  And Participant 7 stated, “Education at the time of 
diagnosis, not in a right frame of mind to understand teaching”. Only one Participant (6) 
acknowledged receipt of education about viral suppression at time of diagnosis by her 
medical provider, who also referred her to get involved in a research study. Overall, 70% 
of the participants were not provided information on the best goal of HIV treatment, 
taking medication to achieve viral suppression and reduce viral inflammation 
Subtheme 12b: Current knowledge of viral suppression. After living with HIV 
for ten years or more, 100% of the participants exhibited knowledge of the meaning of 
viral suppression. They take joy in being virally suppressed. With reference to Table 9, 
80% of the women are virally suppressed. Nonetheless, all the women have experienced 
viral suppression during some point in their journey.  
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For the two participants who indicated that they were not currently virally 
suppressed, when considering a jump in viral load, expressed confidence in their 
knowledge about what to do to get the viral count back in order. Participant 1’s viral load 
is 540 copies. She stated, “I was taking medication, but in summertime, the sun makes 
me to itch, affects my stomach… I had to do what is best for…stop taking medicine 
during summertime and resume after 3 months break”. Participant 5 has been off 
medication, non-adherent due to housing issues and moving, and she states, “was 
undetectable, I will get it right back”. All interview participants expressed knowledge of 
importance of achieving viral suppression and take pride in discussing the 
accomplishments. The increased knowledge was attributed to years of engagement in 
HIV care and attending support groups 
Theme 13: Improved clinical outcomes.  
The clinical outcomes for the participants were collected through self-reports. 
Some of the self-reports were actual laboratory documents from the laboratories and 
medical records. Some of the participants have access to patient portal in their clinics to 
look up CD4 count and Viral load values and read medical providers notes. Part of the 
improved health outcomes were also assessed through surveillance aggregated data 
obtained from DC Health 
Subtheme 13a: Evidenced by self-reports and medical records. Table 9 shows 
the clinical outcomes of the interviewed participants. At diagnosis, viral load was at 
millions while 80% are currently virally suppressed. The immune system also shows a 
rebound immune reconstitution. At diagnosis, 100% 0f the women were diagnosed as 
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AIDS status with CD4 counts below 200, while current CD4 counts are above 350 cells 
per cubic millimeter for 80% of the participants. Participant 7 acknowledged, “been a 
roller coaster, having missed so many medications, been on salvage, this is my last 
option… built many resistances due to non-adherence”. 
Table 9 




























150 584 1000000 20 
Cases\\PARTICIPANT 
3 44 30 132 1300 950000 20 
Cases\\PARTICIPANT 
4 48 36 150 763 500000 20 
Cases\\PARTICIPANT 
5 40 23 69 160 1000000 119000 
Cases\\PARTICIPANT 
6 55 45 3 485 1000000 20 
Cases\\PARTICIPANT 
7 39 23 5 219 1000000 160 
Cases\\PARTICIPANT 
8 55 28 150 375 1000000 20 
Cases\\PARTICIPANT 
9 43 25 2 824 1000000 20 
Cases\\PARTICIPANT 
10  60 34 215 1400 1000000 40 
 
Subtheme 13b: Evidenced by triangulation data. Data for triangulation obtained 
from DC Health confirmed the clinical outcomes obtained from the participants. Table 3 
shows the number of AA women diagnosed with HIV in Washington DC. The median 
viral load at diagnosis was 1205 in 2000. Of the women diagnosed in 2000, 73 were 
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between the ages of 25 and 34, 77 of them ages 35 to 44 years, 46 women between 45 
and 54, and 5 were ages between 55 to 60 years. At the same time, CD4 counts at 
diagnosis was at AIDS defined status (156 viral copies) when CD4 count is below 200. 
Table 3 also shows an analysis of the AA women between ages 35 and 54 years and 
diagnosed in year 2000. The clinical outcomes of the same cohort in year 2010 and 2018 
are also displayed in Table 3. The clinical outcomes show a reduction in viral load from a 
median load of 3,687 in the year 2000, 47 in 2010 and 46.5 in 2018.  Also relevant is the 
median CD4 count in year 2000 which steadily increased to 586 in 2010 and 612 in 2018. 
This data supports the positive clinical outcomes the participants self-reported during the 
individual interviews in Table 9.  
Research Question 3 
The third research question was: How do HIV positive AA women 
explain/describe the high rate of HIV infection among African Americans women in the 
District of Columbia? Five themes emerged related to this question. These themes are: (a) 
Theme 14: Unprotected Sex and nonuse of condoms; (b) Theme 15: Gender Roles/Issues 
in HIV infection; (c) Theme 16: Nondisclosure of HIV Status; (d) Theme 17: The 
importance of high community viral load; and (e) Theme 18: Importance of community 
education and knowledge of HIV transmission. The following section addresses each 







Specific codebook and themes from question 3 
 
Question Theme Description 
Question 3 14.Unprotected sex and 
multiple sex partners in 
closed area 
15.Gender role/Issues in 
HIV infection 
16. Non-Disclosure of 
HIV status 
17.The importance of high 
community viral load 
18. Importance of 
community education and 
knowledge of HIV 
transmission 
 
Presence of multiple partners in closed area 
Search for love, acceptance and loneliness 
Denials of HIV at diagnosis 
Among the population 
Incarceration and nonuse of condom 
Unable to disclosure HIV status to sex 
partner 
Reducing HIV infection among AA women 
 
Theme 14: Unprotected Sex and nonuse of condoms. According to the 10 
participants, unprotected sex was mentioned as the main culprit of the high rate of HIV 
among AA women in the District. As described, at the end of the day, no matter what one 
is seeking, if condoms are used, transmission would definitely decrease. One hundred 
percent (100%) of the participants discussed having multiple sex partners in the same 
neighborhood.  The following quotations describe the role of unprotected sex in the high 
rates of HIV: 
•  “You don’t think of anything until it is over and you wind up with STD. you are 
to blame, you did not put it (condom) on” (Participant 2) 
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•  “Women are having unprotected sex” (Participant 6) 
• “Women not knowing to protect themselves” (Participant 7) 
• “Women are not protecting ourselves; we think men will protect us” (Participant 
8) 
• “The nonchalant protection of themselves, you don’t just go sleep with any guy... 
We are not using protection, protection is there, there are female condoms that 
give protection for 8 hours, whole 8 hours to keep condom inside, why are you 
not using condom”? (Participant 9) 
Other reasons adduced by the women are what participants called “ignorance”, 
“loneliness” and “looking for love in the wrong places”.  All participants also called for 
people to learn their HIV status as a means to reducing the infection rate. “People not 
knowing their status and who they are dealing with” (Participant 3). In addition, 
Participant 6 stated, “knowing status is not enough but honesty in communication” and 
Participant 5 reinforced the same line of thought stating, “No one is communicating, lack 
of honesty… before you lay your legs open, know your status”. The need among women 
to belong and have a sense of belonging was also raised. “People are just lonely, and 
people use sex as water, black woman thinks having a man means love, sex is not 
love…ignorant among black people and they keep themselves ignorant, there are too 
much stuff out there to cling to ignorance (Participant 4). Interviewed participants echoed 
in many ways the need to have sex with condom, get tested to learn one’s status in order 
to prevent from acquiring HIV. 
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Theme 15: Gender Roles/Issues in HIV infection. The primary gender issue 
identified by participants was regarding men returning from incarceration and multiple 
sex partners in same neighborhood. All of the 10 participants discussed men as the 
central force for HIV transmission in their communities. Specifically reported that men 
returning from incarceration. “Men going to prison, coming back and infect women, I 
think because in South East… might go with cousin and cousin with another person, 
multiple partners in the close area… have multiple partners in same area” (Participant 1). 
According to Participant 3, ‘Man coming from incarceration and not telling truthful, … 
knowing you have something like that, coming home, just spreading, it’s crazy … but 
while having sex, having sex dealing with different sex partners”. The participants 
believe that men returning from prison have a secret life while in prison. Participant 5 
stated, “It is not women, it’s the men, 99% of the time, it came from the men that has 
been with another men, came home and spread it… come back to love women, whole 
time had a boyfriend”. Participants in their individual interviews lay blame on men for 
the high rate of HIV infection among the heterosexual women in the black community.  
Theme 16: Non-Disclosure of HIV Status. The 10 participants discussed non-
disclosure issues as another factor contributing to the high rate of infection in the District 
of Columbia. The reason for non-disclosures sometimes hinges on previous experiences 
of breach of confidentiality from friends and family members. Once the trust was broken, 
the women shut down and swore to never disclose to others, including sexual partners for 
fear of how they may react and mistreat them. One participant was so afraid of her 
partner that she hid her medications for months.  “Someone I knew who I told about 
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status, co-worker told others, others did not want to work with me- the co-worker I told, 
told other coworkers” (Participant 3). Participant 5 stated, “confided in a sister then she 
became the enemy, one day, something did not go her way and now she is talking bad 
and disclosed to others”. Although some participants would not allow their bad 
experience to prevent them from disclosing to close family members and significant 
others believing that it is the right thing to do. Disclosure brings peace of mind according 
to Participant 6 and Participant 8 would only disclose if God led her to do so. When HIV 
status is not disclosed, the sexual partner does not take precaution to prevent from getting 
infected leading to more HIV infections among the multiple sex partners. 
Theme 17: The importance of high community viral load. The participants 
acknowledged having HIV virus in the blood in millions counts when diagnosed. With all 
the ten participants having virus in millions shows that the community viral load was 
very high and anyone having sex in such community have a higher chance of being 
infected with HIV. After diagnosis, 8 of the participants denied the diagnosis of HIV and 
went about living a ‘normal lifestyle’ in pretense while spreading the virus. All the10 
participants described the treachery among many people who live in the community. 
They denounced the culture of secrecy and denials of HIV in the black community. Eight 
of the interviewed women mentioned a time when they were in denial about the diagnosis 
and went about acting as if everything was normal. And in that timeframe, they were 
having sex as usual without protection. Participant number 10 did drugs heavily for 4 
years and had sex with everyone as she was selling sex in the street. It took another 
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participant 10 to 15 years to acknowledge the diagnosis and get in care (Participant 2). At 
the time of denials, life was going on as usual with unprotected sex. 
Theme 18: Importance of community education and knowledge of HIV 
transmission. The 10 participants complained about great ignorance in the black 
community of health education and lack of knowledge about HIV transmission. The 
average black person on the street of the District of Columbia lack information of what 
happens in their body. The lack of knowledge of how HIV is contracted, and its mode of 
transmission. According to Participant 4, “ignorance among black people and they keep 
themselves ignorant, there are too much information out there to cling to ignorance.” 
Participant 8 stated, “People said, don’t touch, phobia, like you touch it, it is 
contaminated, fool, where is your literature, where is research at, they don’t know 
nothing about it, they put you on an Island”. The reference was made to young people 
who have indiscriminate sex encounters. According to  participant 6, “Start at 8 years old, 
teaching more ladies to care about their bodies…Start educating and teaching in the 
homes and schools, you cannot get it any other way, eating behind someone, unprotected 
sex is the key factor…educating young people.. Kids having sex, not knowing what sex 
means, 8 to 9 years old having babies”. In addition, ignorance of transmission is also seen 
among older women who believe they will not get pregnant but forget that there are other 
infections including HIV. The women advocated for different messages for young people 
whether positive or negative. In their community, the disease is still regarded as gay 
disease and heterosexual males are not interested in anything gay (Participant 1). The 
participants expressed concern at heterosexual males, whom they described as lacking 
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health education, does not like to go to the doctor, as the major vehicle that propagates 
the spread of the HIV disease among black females. Participants in this study discussed 
the need to educate the black community and get the community to get engaged in health 
knowledge. In addition, participants discussed organizing community days, where people 
get tested and if they are negative, be engaged in the pre exposure prophylaxis (PrEP), 
take a pill once a day and if positive to get engaged in HIV treatment at once. 
Summary 
This chapter presented the results of the research. Ten AA women who took part 
in the research provided answers to the research questions. Data collections involved one-
to-one interviews with the participants answering open-ended questions. In this chapter 
also is the results of the data collected from the participants. The three research questions 
and sub-questions were interrelated to gain a more thorough understanding of the lived 
HIV experiences of the women interviewed. The questions explored how the women 
describe their lived experience, how they have lived and are still living with the disease 
for 10 years or more.  
The results to question 1 indicate the interrelationships between many factors and 
the meaning of the lived experience. The women shared among other things, the age of 
infection (reproductive age/pregnancy), family culture, era of denials of infection and 
noninvolvement in HIV care, positive strengths that contributes to resilience, spirituality, 
support groups and relationships.  
The aim of subquestion 1a was to glean in more details what antiretroviral 
medication and treatment adherence looked like for the interviewed women. Results for 
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subquestion 1a showed that all the women are experienced with antiretroviral medication 
and are in various stages of medication adherence. Some expressed difficulty with the 
medication such as swallowing issues and side effects but these difficulties did not stop 
them from diligently taking the medication to remain alive. In addition, the results 
indicate that the women did not experience challenges in getting access to care in the 
District of Columbia and became empowered in living with the disease.  
Subquestion 1b was asked to learn more about the women’s experience with 
stigma and some of the effects of living with the disease. In response, the women 
described stigma and discrimination as ignorance, fear of the unknown, lack of education, 
gossip and hearsay. Many of them have never experienced stigma directly but have 
knowledge of colleagues that have and decry its practice. Answers to this question also 
revealed struggles with self -stigma and other challenges that the women had to deal with 
daily.  
The aim of research question 2 was to acquire specific information about what the 
women knew at the time of HIV infection on one of the goals of treatment and to learn 
more about the education they received at that crucial time of diagnosis. Answers to 
research question 2 revealed the unavailability of education to increase or acquire skills 
on what to do to achieve viral suppression. Many were diagnosed with a very low CD4 
count and high viral load. In contrast, women demonstrated that they have since then 
gained much more extensive knowledge regarding viral suppression. They have positive 
clinical outcomes, low viral loads and high CD4 counts, substantiated with surveillance 
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data from DC Health. Their clinical outcome data showed their rebound from AIDS 
status to being HIV positive per CDC staging of the disease. 
The last question was intended to solicit the women’s perspectives on what 
factors are contributing to the high infection rate of AA women in the District of 
Columbia. The participants’ answers to research question 3 identified unprotected sex as 
the major cause of infection among these women in the District. Other factors mentioned 
were denials of HIV diagnosis, gender roles and issues related to high incarceration rates 
among men. The participants also discussed the impact of nonuse of condoms among 
men and women and non-disclosure of status to sexual partners.  
In Chapter 5, I provided an interpretation of the findings, an exploration of 
implications, a discussion on limitations of the study, recommendations for policy, future 
research and conclusion. The potential impact of social change was also described. As 
part of Chapter 5, strong recommendations for practice were provided and discussed 




Chapter 5: Discussion, Conclusions, and Recommendations 
Introduction 
This qualitative study was conducted to increase the understanding of HIV infection 
and viral suppression from the perspectives of AA women living with HIV. The study 
used a phenomenological approach to uncover the lived experiences of HIV positive AA 
women and viral suppression, including how HIV positive AA women describe and 
explain both the actual stigma of the disease and the discrimination coming from family, 
friends and the community.  
Another aspect of this research was the use of a feminist lens to understand black 
women’s unequal position regarding HIV infection. Pursuant to understanding their lived 
experience, it is important to understand the increases in HIV infection among this 
particular group. There are findings that support gender as the basic framework that 
conditions women to an increased risk of HIV infection. This point of view means that 
issues of gender roles and socialization have to be explored further to understand HIV 
vulnerability among AA women. This study equally confirmed that geo-behavior is a link 
to vulnerability to HIV infection. Examining the lives of this group of women provided a 
new and better opportunity to learn how they experience this disease, what prevention 
methods might be most effective, and how their experiences link to achieving successful 
viral suppression which is a prelude to ending HIV infection. 
Key Findings 
HIV AA women who are living in DC have exhibited resiliency and 
empowerment in their lived experiences with HIV infection. HIV positive AA women are 
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dependent on many factors unique to them and their community when surviving and 
living with this disease. All of the women were infected at reproductive age of 22 to 45 
years. Participants in my study discussed their resilience and empowerment toward being 
infected in their prime of planning families, getting education, and raising children. They 
relied on self-efficacy, spirituality, support groups, and relationships as major strengths to 
address and handle their unique challenges. At the initial time of diagnosis, many were in 
denial, but this issue was conquered. Positive relationships with spouses or significant 
others played a critical role in supporting their survival. Most importantly, the 
participants expressed an increased understanding of viral suppression after many years 
of lack of education on its importance, especially at the time of diagnosis. Viral 
suppression as a goal of HIV treatment was well understood, as these women adhered to 
antiretroviral medication to achieve suppression of the virus. Access to HIV treatment 
and antiretroviral medication in DC was expressed as unfettered providing these AA 
women the platform to survive the adversity of their infection.  
My respondents explained the high rate of HIV infection among AA women as 
mainly attributed to unprotected sex. According to them, heterosexual men and nonuse of 
condoms propagated increased instances of HIV infection among AA women in the 
District. In addition, AA women are more vulnerable to HIV because of where they live, 
and their potential pool for sex and relationships in their neighborhood. This study added 
to the knowledge that HIV stigma negatively affects the patient’s engagement in HIV 
care. Although, the AA women in my study have devised positive means and better ways 
to actively connect to care and not allow stigma to affect engagement in HIV treatment. 
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However, stigma, they said, affects their disclosures and leads to people engaging in 
sexual practices without disclosing HIV status to their partners and not wearing condoms. 
The more condomless (unprotected) sex there is in a community that has a high viral load 
becomes a recipe for disaster via the incidence of increased HIV infection. 
Interpretation of the Findings 
The findings were interpreted in three major ways. New information obtained 
geared towards advancing new knowledge in HIV care, treatment and/or prevention. The 
second part of the interpretation discussed the confirmations of other literature from peer 
review articles. In the third aspect, findings were also interpreted from the theoretical 
framework of resilience and empowerment theories applied in the study. 
Advancing New Knowledge 
This study offers new knowledge and information relevant to answering all three 
of the research questions. The most important knowledge gained is this research is that 
my study participants were not provided education on viral suppression as a goal of HIV 
treatment and its subsequent benefits of reducing HIV inflammation at the time of 
diagnosis. However, these HIV positive AA women became very knowledgeable after 
living with the disease for 10 years or more and engaging in HIV treatment. The 
knowledge was acquired because of the women’s tenacity to learn and know all they 
could about the disease. However, they had to go search out this knowledge from both 
HIV clinics and churches. Viral suppression is a clinical outcome that is positively 
associated with an improved health outcome. Women in this study achieved viral 
suppression at least once in their course of the disease with an improved CD4 count from 
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the time when their diagnosis of infection was confirmed. Providing information on the 
benefits of viral suppression may thus be beneficial to women to help them engage in 
HIV treatment as a precursor to achieving and maintaining viral suppression. 
Another critical key finding of my study that advances the HIV/AIDS knowledge 
is that HIV positive AA women interviewed have unfettered access to HIV treatment in 
the District of Columbia. The women laid emphasis that Health Care Services operating 
in the District of Columbia who receive Ryan White Funds for HIV treatment do not 
discriminate against women who are HIV positive. Antiretroviral medications are 
available to all AA women who are un-insured or underinsured and have no other means 
of paying for their HIV treatment. All the AA women interviewed were referred to clinics 
that specialize in HIV care. After diagnosis. The women also have access to all Food and 
Drugs Administration (FDA) approved HIV medications to treat their infection.   
One of the positive strengths that contributed to the women’s resiliency in this 
study group is involvement in a good relationship with a HIV positive or negative 
significant other or spouse. Positive relationships with spouses or significant others play a 
critical role in supporting survival. According to the women in this study, good 
relationship with men is a positive strength that can shield from experiencing stigma in 
the community. 
Although 8 of the participants achieved viral suppression, defined as viral load 
below 200 by CDC (2018) and Cohen et al. (2016), they also described difficulties 
adhering to the prescribed medications. The quest for a cure for HIV is paramount in the 
minds of these longtime survivors. Many respondents described praying and hoping for a 
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cure, while others were looking for another way of taking their HIV medications. Some 
new HIV medications under development may offer solutions to some of these needs, 
especially with long-acting, monthly or bimonthly injectable (Simoni et al. 2019). 
Women who have trouble taking daily medications or experiencing swallowing 
difficulties may benefit from these new drugs coming into the pipeline once they are 
approved.  
Support for Findings of Other Studies 
The resilience of these women after HIV infection was well elucidated in this 
study. The respondents in this research attributed their survival of the disease to 
numerous things, including developing positive strengths in the face of adversity. The 
decision to deal with HIV infection and engage in treatment was personal. It was 
attributed to various things depending on the person who was infected. There was a 
decision to survive and thrive, regardless of the circumstances. The interviewed AA 
women have great attachment to their children and for many of them, their children are 
the thread to which life is attached, confirming a study by Islam, Minichiello and Scott, 
(2018).  
The women in my study stated spirituality was another pillar of resilience which 
helped them to build self-efficacy. There was lots of praying including praying over 
medication to work effectively in the body among the participants. When someone is a 
believer in a higher power and God, self-efficacy is built to conquer adversity. According 
to Nokes, et al. (2012), enhancing one’s self-efficacy was found to be a predictor of 
medication adherence. Multifaceted interventions approach that are used to reduce 
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stigma, provide social support network, HIV education, provide support groups, as 
studied by Stewart, Hong and Powell (2018) may also provide relief and improve the 
continuum of care. The AA women in the study developed a connection to God 
(spirituality), engaged in support groups, and have a strong determination to live for their 
children’s sake, thus supporting the study by Dalmida, et al., (2017) that found that  
religious attendance and social support are significant predictors of adherence to 
antiretroviral medications. The participants attachment to their support groups provided 
them with a safe place where they met and discuss challenges and proffer solutions.  
Another key finding is the importance of medication adherence for HIV positive 
AA women in the District. They devised different means to ensure that they remain 
adherent to their medication. The 10 participants understood that continued adherence to 
medication results in viral suppression. My study showed that 8 of the respondents were 
adherent and virally suppression. These respondents also understood the importance of 
medication adherence and the role of consistent medication for healthy outcomes. When 
an HIV positive individual is on medication and adherent, viral suppression is achieved. 
Adherence to medication at least 95%of the time is clearly associated with improved 
health outcomes (CDC, 2013). Care providers are encouraged to assess periodically for 
medication adherence to identify the people at risk for non-adherence. Analysis of 
Medicaid data showed that 57% failed to restart ART after 18 months of stopping 
(Zhang, Shireman, Youn, Lee & Wilson, 2018) and adults are more adherent to medical 
visits and experience greater viral suppression than younger females (Waldrop-Valverde, 
Guo, Ownby, Rodriguez & Jones, 2013). The mean age (48 years) for this study, 
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supported the findings that adults experience greater viral suppression than younger 
females. My qualitative sample supported findings in the literature of larger quantitative 
study (Castel et al. 2016) and gave a contextual understanding of how AA HIV positive 
women talk and understand these issues. The findings of this study support Castel et al. 
who stated that 83% of people who had ARV adherence in the past seven days were 
engaged in care compared to 69% of people who were out of care. Although in my study, 
100% of the women were engaged and retained in care, two of them still had personal 
reasons not to adhere to their medications, which resulted in not being virally suppressed. 
According to Musinguzi (2018), interruption of HIV treatment often leads to increased 
immune activation, which then negatively affects health outcome.  
This study added qualitative support to the fact that AA women in DC are at high 
risk of HIV infection because of where they live and who they are with. According to 
Brawner (2014), despite efforts to reduce risk, people who are located in areas where 
there are higher concentrations of HIV infected people still face a higher vulnerability of 
infection, which is referred to as geo-behavioral vulnerability to HIV. 
Although everyone in this study had unfettered access to antiretroviral 
medications (ARV), 8 out of the ten participants were virally suppressed. This study 
finding supports the study by Robertson et al (2017) and their comparative analysis of 
two groups who received care coordination and followed for 24 months. There was no 
difference noted in their access to medication, but a difference was attributed to 
adherence. The two non-virally suppressed women in this study reported non-adherence 
to ARV and taking medication holidays. However, this small qualitative sample of 10 
145 
 
women provides a snapshot of high viral suppression rate. The national average of viral 
suppression is 49% (CDC, 2017). 
The HIV Care Continuum  
The care continuum in this study supports the Ryan White care continuum for 
women living in the District with 80% viral suppression in 2018. However, there is still a 
gap in viral suppression to meet the goal in the Mayor’s ending the HIV epidemic plan 
(Bowser, 2017). A description of HIV care continuum in this small qualitative sample of 
10 AA women when laid beside large quantitative studies of HIV care continuum is 
noteworthy. There is a support for DC Ryan White HIV Care Continuum in 2018, the DC 
HIV general population and the national HIV Care Continuum, as portrayed in the table 
below: 
Table 11 
Comparison of HIV Continuum of Care 
 











% Diagnosed 100% 100% 100% 85% 
% Receiving Care 100% 73% 98% 62% 
% Retained in care 100% 95% 79% 48% 
% Virally 
Suppressed 




The viral suppression snapshot of this qualitative study supports the viral 
suppression of the Ryan White Program in DC at 80%. However, there is still a gap of 
10% that needs to be targeted to achieve 90% viral suppression goal by year 2020 as 
articulated by the DC 90-90-90-50 goal plan to ending the HIV epidemic in the District 
(Bowser, 2017). 
High Community Viral Load 
Study respondents reported being diagnosed during pregnancy (8), and 2 were 
very sick when diagnosed. The viral load at diagnosis ranged from 500,000 to millions. 
Depicting that the viral load for my respondents at diagnoses were very high. One of the 
hallmarks of high infectivity of HIV is a high community viral load (Castel et al, 2012; 
Das et al. 2010; Das, 2012). According to Brawner (2014), community viral load is a 
population marker for the infectivity of people living in a specific geosocial area, and 
Castel (2012) was able to demonstrate that a reduced community viral load is associated 
with the reduced incidence of HIV. This current study supports such knowledge. 
Increases in HIV Infection Among AA Women  
My respondents reported HIV acquisition primarily through having heterosexual 
unprotected sex with men supporting the study by Drayton & Grant, 2017 and CDC 
(2018) report. The lack of knowledge of HIV transmission among African American did 
not translate into making less risky choices, as discussed by Klein, Sterk and Elifson 
(2016). The same way, knowledge of HIV transmission did not translate into reduction in 
the acquisition of the disease, as my study supported Perkins, Stennis, Spriggs, Kwegyir-
Afful and Prather (2014). Many of the participants reported unprotected sex with men 
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who did not know their own HIV status or refused to disclose their status. In a study by 
Lindong, Edwards, Dennis and Fajobi (2017), AA youths did not perceive themselves as 
having highly risky behavior and knowledge of HIV did not deter these young girls from 
high risk behavior even in detention facilities (Baillargeon et al, 2017; Raidford, Seth, 
Fasula, & DiClemente, 2017). Increased effort to create more awareness and deliver HIV 
education in these communities are necessary and indeed critical to reducing HIV 
infection. The study participants reported that lack of knowledge for how HIV is 
transmitted among the AA population is attributed to ignorance, seeking love and 
acceptance. Any program that targets AA women living in DC may be able to make 
progress in reducing the rate of infection by including these topics.  
Gender Is Associated with Increased HIV Infection Risk 
Of the 10 women interviewed for this study, 4 live with their husband or 
significant other. Some respondents have children and the father of the children are not 
part of their daily living or care. Brawner (2014) proposed a gender responsive model as 
an initial step to more dialogue and examination of HIV/AIDS as a social issue. Issues of 
gender roles and socialization may also have to be explored to understand the nature of 
HIV vulnerability among African American women. Nine (9) of the women interviewed 
were infected by heterosexual contact with men whom they were in relationship with, and 
one was raped. All of the participants reported men as the central force for HIV 
transmission in the AA community especially men returning from incarceration. This 
finding supports Bradley, Geter, Lima, Sutton, and Hubbard McCree (2018) that there is 
disparity in AA HIV infection due to high rate of incarceration among black men.  The 
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study by Rice, et al. (2018) was also supported as they mentioned that gender was one of 
the multiple interrelated social determinants that continues to perpetuate HIV stigma.  In 
this study, gender was indeed associated with an increased risk of HIV infection. 
Findings in the Context of the Theoretical and/or Conceptual Framework 
For this study, I applied truly relevant theories of resiliency and empowerment. 
These theories supplied the framework that guided the development of the semi-
structured interview questions that were used.  The focus was on strength, either innate or 
built from family interactions, overcoming adversity, staying on medication, and 
achieving positive health outcomes. Based on these findings, resiliency and 
empowerment played critical roles in women’s ability to survive the disease. Resiliency 
is appropriate, as it is built alongside the continuum of care from diagnosis, engagement 
in care, and taking medication to viral suppression and especially the resilience constructs 
of self –efficacy, motivation, and protective factors. According to Dr Catherine Panter—
Bricks, resiliency is not a one-time achievement, but must be sustained over time along 
with the continuum of care (Southwick, et al, 2014). Using the empowerment theory, 
women turned inwards and identified the source of their disenfranchisement and took 
charge to ensure better life outcomes (Turner & Maschi, 2015). Some became involved in 
support groups, focused on raising children, got more education, and ultimately made the 
decision to live. These decisions helped them overcome the trauma and adversity of HIV 
infection, leading to their surviving HIV for 10 years or more and achieving positive 
health outcomes. The construct of nurture and nature in this study showed how home 
discipline and family culture may positively affect one’s adaptive ability. This resilience 
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guided study also allowed the researcher to emphasize successful adaptation for 
overcoming negative challenges. These two theories were indeed a best fit for this study. 
Methodology: A Phenomenological Approach 
A phenomenological approach was applied in the data analysis using the 
hermeneutic loop. Each participant’s understanding and meaning of their experience 
brought meaning to the whole. Participants also showed uniqueness in their experiences. 
They discussed the meaning of their infection, as each tried to look for meaning and 
action. A cyclical loop, at the first stage, indicated that some were in denial and without 
any treatment spanning 2 years all the way up to 15 years. After which, their engagement 
in HIV treatment became a part of life. As they continued to gather information and 
knowledge of the disease, they had to deal with challenges, such as taking daily 
medication, attending medical visits, and having laboratory visits. More reflection on 
what the disease meant triggered more challenges, a personal reflection to survive, and 
greater understanding of the need to remain in care and be virally suppressed. Eighty 
percent (80%) of the participants are virally suppressed while one hundred percent 
(100%) currently retained in HIV treatment.  
Each participant expressed an understanding of their whole experience, and many 
used spiritual and religious arguments to cement their positive experiences. This 
methodology was very effective in the current study, allowing for personal uniqueness of 
a lived experienced to be described by these women. Each person’s uniqueness and 
understanding of their adversity was exclusive for them and not related to others’ 
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experiences. Using this method made all the women, experts in their experiences, and 
able to discuss those experiences profusely and profoundly. 
Limitations of the Study 
One notable limitation was the use self-reported information. The participants 
may have tried to impress the interviewer by stating details that may not have necessarily 
been accurate. It is also possible that someone may have said certain things just to 
impress or create an atmosphere of strength when they were actually struggling. There is 
no way to really verify such distinctions. However, the two variables, viral load and CD4 
count for health outcomes were verified through data triangulation and produced similar 
results as reported by the participants.  
Another limitation may be what Creswell (2014) called the power relationship 
between researcher and participants. Although the researcher did not work with, know, or 
relate to the participants, purposeful and snowball recruitment may have influenced the 
participants. Some may have discussed the HIV knowledge of the researcher with their 
peers which then could have influenced their responses to questions. Two participants 
came from the same organization, seven from another, while one came from a still 
different organization. These participants also attend various support groups and may 
have discussed the study and the researcher in them. Interested participants were still 
calling to be part of the study after the study was completed because they heard about the 
study from others and exchanged information about the study among the group. 
Being a qualitative study, these findings may not be generalizable outside of the 
study sample and the District of Columbia. The sample was not conducted using a 
151 
 
random sampling design, thus creating a limitation wherein the sample may not  have 
been  the best possible  representation of HIV positive AA women. In addition, many of 
the participants reside in Wards, 1, 5, 7 and 8 and thus may not geographically represent 
all the nine (9) wards in the District of Columbia.  
Recommendations 
The importance of viral suppression to the treatment of HIV and its health 
outcome is synonymous to surviving the disease. Even when infected women are not 
ready to receive education about the importance of viral suppression, providers should 
not abandon the idea and its goal and need rather to continue to provide the information 
at every encounter with their patients. Spirituality, involvement with support groups, self-
efficacy, relationships with significant others should also be assessed by healthcare 
providers and incorporated into each patient’s treatment plan. According to Dalmida, et 
al. (2017), the factors that affect treatment adherence should be considered in the 
treatment plan by the care team that includes mental health providers, social workers and 
pastoral counselors. These inclusions should reinforce the factors that will help AA 
women the most to remain in and continue their HIV care.  
The lived experiences of HIV positive AA women researched through this 
qualitative study provides information that is very critical to the ongoing reduction of 
HIV infection among the black population. Policy makers and DC Health should 
incorporate all the factors identified by these women as strengths that led to their 
surviving this adversity and develop these factors into a comprehensive assessment tool 
to use to develop better interventions for HIV positive women. Further still, develop key 
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social marketing strategies for community education and engagement that addresses 
unprotected sex, stigmas, disclosure of HIV status to sexual partners and multiple sex 
partners. Social marketing techniques could be used to create greater awareness of these 
issues in the community while at the same time equipping clinics with more clinical 
providers to serve more patients/clients who will hopefully return to engage in HIV care. 
Most importantly, this study supports that gender is a factor that affects the 
increased rate of infection among AA women. Both community education and 
engagement targeting especially AA men reentering society after incarceration, 
organizing town hall meetings on the issue of HIV awareness, testing and linkages to 
HIV treatment can indeed be beneficial in reducing HIV infection in AA community and 
in DC.  
Future Research 
In the past 10 years or more, AA women entered HIV care late in the progression 
of their disease with a very low CD4 count and high viral loads. Thus, future research 
may want to investigate whether this trend has changed, especially by looking at AA 
women who have been diagnosed in the last one or two years. Another future research 
topic might be to conduct the same type of research among White females and Hispanic 
females in order to compare the three populations and more adequately discuss health 





Implications for Positive Social Change 
The findings of this study have the potential for positive social change for black 
AA women living in the district. Most important is the social change in the advancement 
of HIV treatment and prevention in the era of the Mayor Bowser 90 -90 – 90 - 50 
initiative plan in the District (Bowser, 2017). This study calls for a more concerted effort 
to target AA women for achieving 90% viral suppression by 2020. At the moment, this 
study finding shows the level of viral suppression at 80% and thus 10% away from 
reaching the DC goal. The end of HIV/AIDS is indeed contingent upon diagnosing all 
infected persons and providing full access to ARV to ensure successful viral suppression 
for all persons with HIV disease.  
This study contributes new knowledge on the lack of education for viral 
suppression among HIV positive AA women at diagnosis.  HIV positive AA women do 
not receive education on one of the hallmark outcomes of HIV treatment, namely, viral 
suppression. Interventions can be developed with well-crafted education on viral 
suppression that is provided to all AA women who test positive for HIV. The knowledge 
gained will be critical to engaging in treatment to achieve greater viral suppression. 
Developing and implementing such education in all Ryan White clinics in the District 
will also contribute needed information on the importance of medication adherence to 
achieve viral suppression as well as the importance of viral suppression. According to the 
research, when viral suppression is achieved, inflammation is drastically reduced thereby 
leading to better health outcomes sooner and for longer periods (Eshleman et al. 2017; 
Cohen, McCarley & Gamble, 2011; Crepaz et al, 2016). 
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In addition, the findings of this study will impact how to address health 
disparities. This study identified spirituality, support groups, and positive relationship 
with men as some of the strengths that helped these AA women to engage and continue to 
remain in care after many years of living with the disease. This knowledge could lead to 
policy changes to include all these factors and combine them into a more comprehensive 
assessment tool in every clinic that is serving AA women in the District.  
The knowledge gained in this study will be beneficial for addressing the high rate 
of infection among AA women. DC Health/HAHSTA can thus develop community 
education that will address unprotected sex, stigma, disclosure of HIV status to sexual 
partners and multiple sex partners. Social marketing techniques could be used to create 
awareness of these issues in the community while also equipping clinics with more 
clinical providers to serve more people who will choose to return to engage in the 
important HIV treatment. 
Conclusions 
In summary, the strongest predictor for surviving HIV among AA women in the 
District of Columbia is having unfettered access to HIV treatment, a level of spirituality, 
the availability of antiretroviral medication, engagement in support groups, and viral 
suppression. To achieve viral suppression, one must adhere to antiretroviral medication. 
Discussion on the importance of viral suppression at the time of diagnosis and during the 
course of treatment is very important. This study provided increased knowledge to target 
prevention of HIV transmission and highlight the importance of heterosexual 
transmission for HIV in DC. Viral suppression predicts positive health outcomes and 
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improved immune system. Therefore, any experience of achieving viral suppression will 
hopefully translate into decreasing HIV transmission and the community’s viral load.  
This study also adds to the wealth of knowledge of stigma on disclosures of HIV status to 
sexual partners and the non-use of condoms during sexual intercourse. Targeted HIV 
education for DC’s black community should continue to include information on 
transmission, biology, treatment and care to provide greater support for all women who 
live with HIV. 
A compelling argument can be made to support that AA women’s lived 
experiences from this qualitative study in the District of Columbia can be generalized to 
other women in the District. These study findings illustrated somewhat themes related to 
living with HIV including resiliency, self-efficacy, support, spirituality, adherence, viral 
suppression, stigma and community education. The accessibility of treatment, 
medication, and support groups around the city offers a positive platform that can support 
engagement in care. Developing interventions using this new knowledge might be critical 
to reducing HIV infection overall.  
As the District of Columbia plans to end the HIV epidemic (Bowser, 2017), 
taking greater care to develop District wide interventions to address the difficulties 
identified in this study is critical. As the nation and the world plans to end the HIV 
epidemics (HIV.gov, 2019b; United Nations on AIDS, 2014), the lived experiences of 
HIV positive AA women should be incorporated. Prevention interventions can be 
informed by the findings of this study and thus help prevent new infections among this 
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group and enhance their level of engagement in ongoing focused and effective HIV 
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Appendix A: Specific Codes and Themes that Emerged from Data and Quotations from 
Participants 
 




ability to lived 
experience 
3.Era of denials 
and not involved 
in care 
4.Positive strength 





















• Everyday say a prayer, God let this 
medicine work, God is good 
• God kept me going, he is my healer, 
keep positive attitude, keep my eyes 
on the prize, I will be fine 
• By the grace of God, the meds are 
working in your favor because the 
meds do not always work in people 
favor 
• When I got pregnant with my 3rd 
child, I went back to church where I 
started from… when I got myself 
together in the church that helped me 
to really digest and grasp 
• The Lord has seen me all of that 
• Diagnosed when pregnant with first 
child 
• Went to doctor for pregnancy care in 
2007 
• Diagnosed when pregnant at 23 years 
with 4th child 
• A safe place to vent, cry, disseminate 
information, give each other 
encouragement 
• HIV is past in my mind, that is why I 
do support group 
• Did drugs heavily for 4 years 
• There was nothing to live for, no 
history, gonna die anyway 
• If the medicine don’t work, it is out 
of my control. The only thing I have 
control is taking it 
• I was undetectable, I will get it right 
back                             
                                 (table continues) 




• I immediately went into denial, did 
not believe it, I had no feeling 
• I was in denial at time of diagnosis 
and wanted to kill everybody 
• It took me 10-15 years to get into 
care 
• I have the knowledge that using 
medication, will survive and that kept 
me going 
• But there were times, I was tired 
about going to the doctors, the only 
thing that made me afraid is that I 
might catch cold and die 
• I don’t want to get sick and die 
• God is good, I found a man that loves 
me, he encourages me to take my 
medication, he encourages me to 
keep positive attitude, there is life 
after HIV, really is’   
• Support group save my life 
• Housing and support group for 
women 
• Self-esteem groups 
• Participate in groups 
• I got involved with many support 





Appendix B: Responses to Question 1a 
 
Responses to question 1a  
Themes Codes Some Quotations from participants 
5.Unfettered access 











engage in HIV care 












Need for cure 
Need to survive 
 
• DC is a good place for HIV 
treatment 
• No matter what you have, you will 
never be turned away in DC 
• I did not have problems finding 
clinic 
• Biktarvy once a day, that’s all 
• I found peace in the midst of my 
chaos 
• I advocate for myself, asks for 
medicine ahead of time just in case 
they are needed 
• You have to take medicine, keep all 
your doctor’s appointments, if not 
you deteriorate really fast 
• I take it in the afternoon, I don’t 
miss it because I take other heart 
medicines 
• It’s about taking medicine 
• Forgetting to take the medicine is 
like leaving your children at the 
subway station and leave them, if 
any of them die, you will die 
• One day, there will be a cure 
• Even though it did not have a cure, I 
could still live a long healthy life 
with medications and things of that 
nature 
• I think they can make a pill for 
that… and I am going to be part of 
it... I am a superstar, very special 
superstar 
• Do you think they already have a 
cure, they need a cure? 
• I am satisfied with care but I wanna 





Appendix C: Responses to Question 1b 
Responses to Question 1b 
Themes Codes Some Quotations from participants 
9.Negative effects 
















• It took me a longtime to forgive 
myself, the shame of it…It is bad 
enough that outside world to shame 
you, it is worst -personal shame 
• When you tell anyone that you have 
HIV, the first question they ask is 
how did you contract it? nobody asks 
how you contract diabetes or other 
diseases 
• I only self- disclose since my friend 
used it against me 
• I live on daily basis with stigma, I 
am very careful in disclosing  
• Taking a chance, meeting someone 
and when do you tell? 
• Confided in a sister then she became 
the enemy, one day, something did 
not go her way and now she is 
talking bad and disclosed to 
others...It did not affect me, it does 
not stop a man from trying to take 
my draws 
• It has been a life altering thing that I 
face day to day 
• This is disease that cripples you not 
just physically but mentally 
• It was really hard, life changing 
• I tried to kill myself, I did, thank 
God it did not work, thank God, it 












Appendix D: Responses to Question 2 
 
Themes Codes Some Quotations from participants 
12.Importance of 
education of viral 
suppression 
13.Improved 














• I did not learn about viral 
suppression 
• The first that first diagnosed did not 
discuss viral suppression 
• They did not teach me anything but 
refer me to teaching hospital clinic 
• At diagnosis, they did not say 
anything that stuck 
• They did not teach me nothing 
• No one communicated diagnosis in 
small clinic, here you go, HIV 
pamphlet and here you go with lots 
of people in the waiting room 
looking at your HIV pamphlet 
• She really helped me to come to grip 
to understand that what I have, even 
though it did not have a cure, I could 
still live a long healthy life with 
medication and things of that nature  
• Education at the time of diagnosis, 
not in a right frame of mind to 
understand teaching 
• They started me on medication and 
the medicine started working 
gradually from 2 cells up to 5…CD4 
829, undetectable 





Appendix E: Responses to Question 3 
Responses to question 3 
Themes Codes Some Quotations from Participants 
14.Unprotected 
sex and multiple 













18. Importance of 
community 
education and 
















• Multiple partners in close areas 
• Lots of females do not like condom 
• They don’t care about their body 
• You don’t think of anything until it is 
over and you wind up with STD 
• People not knowing their status and 
who they are dealing with 
• Having sex, having sex dealing with 
different sex partners 
• Black woman thinks having a man 
means love, sex is not love 
• Men return from prison 
• Man coming from incarceration and 
not telling the truth 
• It is not women, it’s the men, 99% of 
the time, it came from the men that 
has been with another men, came 
home and spread it 
• Education is a key 
• They should have different messages 
for young people positive and 
negative 
• Black men in their manhood cannot 
put themselves in anything gay 
• Health education for everyone, health 
education should tell you everything 
• It is the biggest thing if we have 
health education included in groups 
• Start at 8 years old, teaching more 
ladies to care about their 
bodies…Start educating and teaching 
in the homes and schools, you cannot 
get it any other way, eating behind 
someone, unprotected sex is the key 
factor…Educating young people.. 
kids having sex, not knowing what 
sex means, 8-9 years old having 
babies 
• Education, education got to matter 
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• They need hotlines for HIV for 
people to talk and get help 
• On community days, get tested and 
you don’t have it, take this pill 
• We need to reach young people walk 
to community and talk to people, 
some of the other places young 
people go to, in the schools, like they 



































Appendix F: Permission to Alter Survey Question 
From: Machtinger, Edward < 
Sent: Monday, August 12, 2019 5:19 PM 
To: Christie Olejemeh  
Subject: Re: Permission to modify one of your questions from research study 
  
I’m delighted that you found this question helpful and you have my permission to use it. 




Edward Machtinger, MD 
Professor of Medicine  
UCSF 
Sent from my iPhone 
On 12 Aug 2019, at 1:47 PM, Christie Olejemeh <christie.olejemeh@waldenu.edu> 
wrote: 
Good day Professor Edward 
My name is Christie Olejemeh, a doctoral student of Public Health at Walden 
University.  I am making a request to include one of the question in your research in my 
study. The referenced journal articles is titled 'An expressive therapy group disclosure 
intervention for women living with HIV improves social support, self-efficacy, and the 
safety and quality of relationship: A qualitative analysis.  Journal of the association of 
nurses in AIDS care. 20(2): 187 – 198.http://dx.doi.org/10.1016/j.jana.2014.05.001 
 
 
The question I want to modify and use states "What was your experience disclosing your 
status publicly on stage? and  What  if any, impact did this experience have on you, your 
interaction with others, family and relationships? 
I hope to get your permission to use this question. Please let me know. Thank you 
 
 
Sincerely 
Christie Olejemeh 
 
 
 
 
